EurekaMag PDF full texts Chapter 72,899

Maugard, M.; Vigneron, P.-A.; Bolaños, J.P.; Bonvento, G. 2021: L-Serine links metabolism with neurotransmission. Progress in Neurobiology 197: 101896

Zeng, L.; Lin, L.; Chen, L.; Xiao, W.; Gong, Z. 2021: L-Theanine Ameliorates d-Galactose-Induced Brain Damage in Rats via Inhibiting AGE Formation and Regulating Sirtuin1 and BDNF Signaling Pathways. Oxidative Medicine and Cellular Longevity 2021: 8850112

Raj, K.; Gupta, G.D.; Singh, S. 2021: L-Theanine ameliorates motor deficit, mitochondrial dysfunction, and neurodegeneration against chronic tramadol induced rats model of Parkinson's disease. Drug and Chemical Toxicology 2021: 1-12

Bi, A.; Hang, Q.; Huang, Y.; Zheng, S.; Bi, X.; Zhang, Z.; Yin, Z.; Luo, L. 2020: L-Theanine attenuates neointimal hyperplasia via suppression of vascular smooth muscle cell phenotypic modulation. Journal of Nutritional Biochemistry 82: 108398

Xue, X.; He, H.; Liu, C.; Wang, L.; Wang, L.; Wang, Y.; Wang, L.; Yang, C.; Wang, J.; Hou, R. 2022: L-Theanine improves emulsification stability and antioxidant capacity of diacylglycerol by hydrophobic binding β-lactoglobulin as emulsion surface stabilizer. Food Chemistry 366: 130557

Gellrich, L.; Heitel, P.; Heering, J.; Kilu, W.; Pollinger, J.; Goebel, T.; Kahnt, A.; Arifi, S.; Pogoda, W.; Paulke, A.; Steinhilber, D.; Proschak, E.; Wurglics, M.; Schubert-Zsilavecz, M.; Chaikuad, A.; Knapp, S.; Bischoff, I.; Fürst, R.; Merk, D. 2020: L-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ. Journal of Medicinal Chemistry 63(13): 6727-6740

Khaleel, E.F. 2021: L-Thyroxine induces left ventricular remodeling and fibrosis in rats by upregulating miR-21 in a reactive oxygen-dependent mechanism: a protective role of N -acetylcysteine. Drug and Chemical Toxicology 2021: 1-11

Broekhuizen, M.; Klein, T.; Hitzerd, E.; de Rijke, Y.B.; Schoenmakers, S.; Sedlmayr, P.; Danser, A.H.J.; Merkus, D.; Reiss, I.K.M. 2020: L-Tryptophan-Induced Vasodilation Is Enhanced in Preeclampsia: Studies on its Uptake and Metabolism in the Human Placenta. Hypertension 76(1): 184-194

Jiang, Y.; Sheng, Q.; Wu, X-Yu.; Ye, B-Ce.; Zhang, B. 2020: L-arginine production in Corynebacterium glutamicum : manipulation and optimization of the metabolic process. Critical Reviews in Biotechnology 2020: 1-14

Khedr, N.F.; Werida, R.H. 2022: L-carnitine modulates autophagy, oxidative stress and inflammation in trazodone induced testicular toxicity. Life Sciences 290: 120025

Jäckel, S.; Pipp, F.C.; Emde, B.; Weigt, S.; Vigna, E.; Hanschke, B.; Kasper, L.; Siddharta, A.; Hellmann, J.ür.; Czasch, S.; Schmitt, M.W. 2021: L-citrulline: a preclinical safety biomarker for the small intestine in rats and dogs in repeat dose toxicity studies. Journal of Pharmacological and Toxicological Methods 110: 107068

Zhang, H.; Wang, Z.; Li, Z.; Wang, K.; Kong, B.; Chen, Q. 2022: L-glycine and l-glutamic acid protect Pediococcus pentosaceus R1 against oxidative damage induced by hydrogen peroxide. Food Microbiology 101: 103897

Alamshah, A.; Spreckley, E.; Norton, M.; Kinsey-Jones, J.S.; Amin, A.; Ramgulam, A.; Cao, Y.; Johnson, R.; Saleh, K.; Akalestou, E.; Malik, Z.; Gonzalez-Abuin, N.; Jomard, A.; Amarsi, R.; Moolla, A.; Sargent, P.R.; Gray, G.W.; Bloom, S.R.; Murphy, K.G. 2017: L-phenylalanine modulates gut hormone release and glucose tolerance, and suppresses food intake through the calcium-sensing receptor in rodents. International Journal of Obesity 41(11): 1693-1701

Pereira, M.F.; Amaral, Iês.M.; Lopes, Cátia.; Leitão, C.; Madeira, D.; Lopes, Jão.P.; Gonçalves, F.Q.; Canas, P.M.; Cunha, R.A.; Agostinho, P. 2021: L-α-aminoadipate causes astrocyte pathology with negative impact on mouse hippocampal synaptic plasticity and memory. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(8): e21726

Foley, K.P.; Chen, Y.; Barra, N.G.; Heal, M.; Kwok, K.; Tamrakar, A.K.; Chi, W.; Duggan, B.M.; Henriksbo, B.D.; Liu, Y.; Schertzer, J.D. 2021: Inflammation promotes adipocyte lipolysis via IRE1 kinase. Journal of Biological Chemistry 296: 100440

Malaspina, L.A.; Genoni, A.; Grabowsky, S. 2021: LamaGOET: an interface for quantum crystallography. Journal of Applied Crystallography 54(Part 3): 987-995

Fallah Mehrabadi, M.H.; Ghalyanchilangeroudi, A.; Charkhkar, S.; Hosseini, H.; Zabihipetroudi, T.; Shayganmehr, A.; Esmaeelzadeh Dizaji, R.; Aghaeean, L. 2021: Laying Farm: up to Date Data on a Fowlpox Outbreak in Phylogenetic Analysis in Iran, 2018. Archives of Razi Institute 75(4): 501-508

Oliveira, T.P.; Moral, R.A.; Zocchi, S.S.; Demetrio, C.G.B.; Hinde, J. 2020: Lcc: an R package to estimate the concordance correlation, Pearson correlation and accuracy over time. Peerj 8: E9850

Jablonski, P.E.; Jablonski, L.M.; Pintado, O.; Sriranganathan, N.; Hovde, C.J. 1996: Ldentification of Pasteurella multocida tryptophan synthase β-subunit by antisera against strain PI059. Microbiology 142(5): 1331

Gozzer, E.; Canchihuamán, F.; Chalco, V.; Huari, G.; Cisneros-Dionisio, A.; Quispe, W.; Espinoza, R.én. 2021: Length of ministerial tenure and public health achievements in Peru. Revista Peruana de Medicina Experimental y Salud Publica 38(2): 326-336

Gordon, M.Grace.; Inoue, F.; Martin, B.; Schubach, M.; Agarwal, V.; Whalen, S.; Feng, S.; Zhao, J.; Ashuach, T.; Ziffra, R.; Kreimer, A.; Georgakopoulos-Soares, I.; Yosef, N.; Ye, C.Jimmie.; Pollard, K.S.; Shendure, J.; Kircher, M.; Ahituv, N. 2020: LentiMPRA and MPRAflow for high-throughput functional characterization of gene regulatory elements. Nature Protocols 15(8): 2387-2412

Roubin, R.; Naert, K.; Popovici, C.; Vatcher, G.; Coulier, F.; Thierry-Mieg, J.; Pontarotti, P.; Birnbaum, D.; Baillie, D.; Thierry-Mieg, D. 1999: Let-756, a C. elegans fgf essential for worm development. Oncogene 18(48): 6741-6747

Spolverini, A.; Fuchs, G.; Bublik, D.R.; Oren, M. 2017: Let-7b and let-7c micro RNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery. Oncogene 36(42): 5819-5828

Luo, K.; Qin, Y.; Ouyang, T.; Wang, X.; Zhang, A.; Luo, P.; Pan, X. 2021: Let-7c-5p Regulates CyclinD1 in Fluoride-Mediated Osteoblast Proliferation and Activation. Toxicological Sciences: An Official Journal of the Society of Toxicology 182(2): 275-287

Contursi, A.; Arconzo, M.; Cariello, M.; Piglionica, M.; D'Amore, S.; Vacca, M.; Graziano, G.; Gadaleta, R.M.; Valanzano, R.; Mariani-Costantini, R.; Villani, G.; Moschetta, A.; Piccinin, E. 2021: Let-7e downregulation characterizes early phase colonic adenoma in APCMin/+ mice and human FAP subjects. Plos one 16(4): E0249238

Chhabra, R. 2018: Let-7i-5p, miR-181a-2-3p and EGF/PI3K/SOX2 axis coordinate to maintain cancer stem cell population in cervical cancer. Scientific Reports 8(1): 7840

Hallam, S.J.; Jin, Y. 1998: Lin-14 regulates the timing of synaptic remodelling in Caenorhabditis elegans. Nature 395(6697): 78-82

Chen, X.; He, Y.; Zhu, Y.; Du, J.; Sun, H. 2021: Linc-AAM Facilitates Gene Expression Contributing to Macrophage Activation and Adaptive Immune Responses. Cell Reports 34(1): 108584

Huang, M.; Huang, X.; Jiang, B.; Zhang, P.; Guo, L.; Cui, X.; Zhou, S.; Ren, L.; Zhang, M.; Zeng, J.; Huang, X.; Liang, P. 2020: Linc00174-EZH2-ZNF24/Runx1-VEGFA Regulatory Mechanism Modulates Post-burn Wound Healing. Molecular Therapy. Nucleic Acids 21: 824-836

Tang, H.; Han, X.; Feng, Y.; Hao, Y. 2020: Linc00968 inhibits the tumorigenesis and metastasis of lung adenocarcinoma via serving as a ceRNA against miR-9-5p and increasing CPEB3. Aging 12(22): 22582-22598

Huang, G.-W.; Chen, Q.-Q.; Ma, C.-C.; Xie, L.-H.; Gu, J. 2021: Linc01305 promotes metastasis and proliferation of esophageal squamous cell carcinoma through interacting with IGF2BP2 and IGF2BP3 to stabilize HTR3A mRNA. International Journal of Biochemistry and Cell Biology 136: 106015

Xue, Z.; Zhang, Z.; Liu, H.; Li, W.; Guo, X.; Zhang, Z.; Liu, Y.; Jia, L.; Li, Y.; Ren, Y.; Yang, H.; Zhang, L.; Zhang, Q.; Da, Y.; Hao, J.; Yao, Z.; Zhang, R. 2019: LincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation. Cell Death and Differentiation 26(1): 130-145

FernÁndez-Rojas, M.A.; Melendez-Zajgla, J.; Lagunas, V.M. 2020: LincRNA-RP11400K9.4 Regulates Cell Survival and Migration of Breast Cancer Cells. Cancer Genomics and Proteomics 17(6): 769-779

Feng, K.; Liu, J.; Wei, P.; Ou, S.; Wen, X.; Shen, G.; Xu, Z.; Xu, Q.; He, L. 2020: LincRNA_Tc13743.2-miR-133-5p-TcGSTm02 regulation pathway mediates cyflumetofen resistance in Tetranychus cinnabarinus. Insect Biochemistry and Molecular Biology 123: 103413

Guttman, M.; Donaghey, J.; Carey, B.W.; Garber, M.; Grenier, J.K.; Munson, G.; Young, G.; Lucas, A.Bergstrom.; Ach, R.; Bruhn, L.; Yang, X.; Amit, I.; Meissner, A.; Regev, A.; Rinn, J.L.; Root, D.E.; Lander, E.S. 2011: LincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477(7364): 295-300

Gvozdev, M.Y.; Arefyeva, O.A.; Dzhuraeva, M.D. 2021: Linical case: enterocele after radical cystectomy with heterotopic bladder plastic surgery. Urologiia 2: 90-93

Manzini, S.; Busnelli, M.; Colombo, A.; Kiamehr, M.; Chiesa, G. 2020: Liputils: a Python module to manage individual fatty acid moieties from complex lipids. Scientific Reports 10(1): 13368

Cuervo, N. 2005: Lmmunogenicity in humans of an edible vaccine for hepatitis B. Virologie 9(3): 248

El-Khazragy, N.; Elshimy, A.A.; Hassan, S.S.; Shaaban, M.H.; Bayoumi, A.H.; El Magdoub, H.M.; Ghozy, S.; Gaballah, A.; Aboelhussein, M.M.; Abou Gabal, H.H.; Bannunah, A.M.; Mansy, A.E.-S. 2020: Lnc-HOTAIR predicts hepatocellular carcinoma in chronic hepatitis C genotype 4 following direct-acting antivirals therapy. Molecular Carcinogenesis 59(12): 1382-1391

Geng, X.; Zhao, J.; Huang, J.; Li, S.; Chu, W.; Wang, W.-S.; Chen, Z.-J.; Du, Y. 2021: Lnc-MAP3K13-7:1 Inhibits Ovarian GC Proliferation in PCOS via DNMT1 Downregulation-Mediated CDKN1A Promoter Hypomethylation. Molecular Therapy: the Journal of the American Society of Gene Therapy 29(3): 1279-1293

Xu, Z.; Chen, Q.; Zeng, X.; Li, M.; Liao, J. 2021: Lnc-NLC1-C inhibits migration, invasion and autophagy of glioma cells by targeting miR-383 and regulating PRDX-3 expression. Oncology Letters 22(3): 640

Prabhakar, B.; Lee, S.; Bochanis, A.; He, W.; Manautou, J.é E.; Rasmussen, T.P. 2021: Lnc-RHL, a novel long non-coding RNA required for the differentiation of hepatocytes from human bipotent progenitor cells. Cell Proliferation 54(2): E12978

Zhu, P.; Wang, Y.; Huang, G.; Ye, B.; Liu, B.; Wu, J.; Du, Y.; He, L.; Fan, Z. 2016: Lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal. Nature Structural and Molecular Biology 23(7): 631-639

Huang, G.; Jiang, H.; Lin, Y.; Wu, Y.; Cai, W.; Shi, B.; Luo, Y.; Jian, Z.; Zhou, X. 2018: LncAKHE enhances cell growth and migration in hepatocellular carcinoma via activation of NOTCH2 signaling. Cell Death and Disease 9(5): 487

Li, S.; Zhu, K.; Liu, L.; Gu, J.; Niu, H.; Guo, J. 2020: LncARSR sponges miR-34a-5p to promote colorectal cancer invasion and metastasis via hexokinase-1-mediated glycolysis. Cancer science 111(10): 3938-3952

Bryzghalov, O.; Makałowska, I.; Szcześniak, M.ł W. 2021: LncEvo: automated identification and conservation study of long noncoding RNAs. Bmc Bioinformatics 22(1): 59

García-Venzor, A.; Mandujano-Tinoco, E.A.; Ruiz-Silvestre, A.; Sánchez, J.é M.; Lizarraga, F.; Zampedri, C.; Melendez-Zajgla, J.; Maldonado, V. 2020: LncMat2B regulated by severe hypoxia induces cisplatin resistance by increasing DNA damage repair and tumor-initiating population in breast cancer cells. Carcinogenesis 41(11): 1485-1497

Liao, F.; Tan, Y.; Wang, Y.; Zhou, C.; Wang, Q.; Li, J.; He, L.; Peng, X. 2021: LncRNA AABR07005593.1 potentiates PM2.5-induced interleukin-6 expression by targeting MCCC1. Ecotoxicology and Environmental Safety 226: 112834

Dang, Y.; Zhou, Y.; Ou, X.; Wang, Q.; Wei, D.; Xie, F. 2021: LncRNA AC007207.2 Promotes Malignant Properties of Osteosarcoma via the miR-1306-5p/SIRT7 Axis. Cancer Management and Research 13: 7277-7288

Yang, G.; Li, Z.; Dong, L.; Zhou, F. 2021: LncRNA ADAMTS9-AS1 promotes bladder cancer cell invasion, migration, and inhibits apoptosis and autophagy through PI3K/AKT/mTOR signaling pathway. International Journal of Biochemistry and Cell Biology 140: 106069

Zhang, X.; Zhou, Y.; Mao, F.; Lin, Y.; Shen, S.; Sun, Q. 2020: LncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression. Scientific Reports 10(1): 7662

Lu, Q.; Wang, L.; Gao, Y.; Zhu, P.; Li, L.; Wang, X.; Jin, Y.; Zhi, X.; Yu, J.; Li, X.; Qin, X.; Zhou, P. 2021: LncRNA APOC1P1-3 promoting anoikis-resistance of breast cancer cells. Cancer Cell International 21(1): 232

Ma, Y.; Sun, W.; Zhang, Q.; Gao, B.; Cai, W.; Liu, Q.; Liao, J.; Wang, X. 2021: LncRNA BSG-AS1 is hypoxia-responsive and promotes hepatocellular carcinoma by enhancing BSG mRNA stability. Biochemical and Biophysical Research Communications 566: 101-107

Li, X.; Mo, J.; Li, J.; Chen, Y. 2020: LncRNA CASC2 inhibits lipopolysaccharide‑induced acute lung injury via miR‑27b/TAB2 axis. Molecular Medicine Reports 22(6): 5181-5190

Zhao, Q.; Dong, D.; Chu, H.; Man, L.; Huang, X.; Yin, L.; Zhao, D.; Mu, L.; Gao, C.; Che, J.; Liu, Q. 2021: LncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway. Cell Cycle 2021: 1-16

Yan, L.; Li, K.; Feng, Z.; Zhang, Y.; Han, R.; Ma, J.; Zhang, J.; Wu, X.; Liu, H.; Jiang, Y.; Zhang, Y.; Zhu, Y. 2020: LncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression. Molecular Carcinogenesis 59(10): 1199-1208

Gao, J.; Chen, Q.; Zhao, Y.; Hou, R. 2020: LncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis. Oncotargets and Therapy 13: 9225-9234

Li, Y.; Zong, J.; Zhao, C. 2020: LncRNA CTBP1-AS2 promotes proliferation and migration of glioma by modulating miR-370-3p-Wnt7a-mediated epithelial-mesenchymal transition. Biochemistry and Cell Biology 98(6): 661-668

Tian, Q.; Yan, X.; Yang, L.; Liu, Z.; Yuan, Z.; Zhang, Y. 2021: LncRNA CYTOR promotes cell proliferation and tumor growth via miR-125b/SEMA4C axis in hepatocellular carcinoma. Oncology Letters 22(5): 796

Li, X.; Zhou, S.; Fan, T.; Feng, X. 2020: LncRNA DGCR 5/miR‑27a‑3p/BNIP3 promotes cell apoptosis in pancreatic cancer by regulating the p38 MAPK pathway. International Journal of Molecular Medicine 46(2): 729-739

Daneshvar, K.; Ardehali, M.Behfar.; Klein, I.A.; Hsieh, F-Kai.; Kratkiewicz, A.J.; Mahpour, A.; Cancelliere, S.O.L.; Zhou, C.; Cook, B.M.; Li, W.; Pondick, J.V.; Gupta, S.K.; Moran, S.P.; Young, R.A.; Kingston, R.E.; Mullen, A.C. 2020: LncRNA DIGIT and BRD3 protein form phase-separated condensates to regulate endoderm differentiation. Nature Cell Biology 22(10): 1211-1222

Han, S.; Qi, Y.; Xu, Y.; Wang, M.; Wang, J.; Wang, J.; Yuan, M.; Jia, Y.; Ma, X.; Wang, Y.; Liu, X. 2021: LncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p. Cancer Cell International 21(1): 376

Feng, B.; Li, S.; Wang, Q.; Tang, L.; Huang, F.; Zhang, Z.; Mahboobe, S.; Shao, C. 2021: LncRNA DMRT2-AS acts as a transcriptional regulator of dmrt2 involving in sex differentiation in the Chinese tongue sole (Cynoglossus semilaevis). Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 253: 110542

Li, L.; Chen, P.; Huang, B.; Cai, P. 2021: LncRNA DSCAM-AS1 facilitates the progression of endometrial cancer via miR-136-5p. Oncology Letters 22(6): 825

Chen, Z.; Xu, C.; Pan, X.; Cheng, G.; Liu, M.; Li, J.; Mei, Y. 2021: LncRNA DSCR8 mediates miR-137/Cdc42 to regulate gastric cancer cell proliferation, invasion, and cell cycle as a competitive endogenous RNA. Molecular Therapy Oncolytics 22: 468-482

Hu, Y.; Zhang, X.; Zai, H.-Y.; Jiang, W.; Xiao, L.; Zhu, Q. 2020: LncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1. Molecular Therapy Oncolytics 19: 308-322

Wang, J.; Lin, Z.; Yang, Z.; Liu, X. 2020: LncRNA Eif4g2 improves palmitate-induced dysfunction of mouse β-cells via modulation of Nrf2 activation. Experimental Cell Research 396(2): 112291

Yao, X.; Gao, X.; Bao, Y.; El-Samahy, M.A.; Yang, J.; Wang, Z.; Li, X.; Zhang, G.; Zhang, Y.; Liu, W.; Wang, F. 2021: LncRNA FDNCR promotes apoptosis of granulosa cells by targeting the miR-543-3p/DCN/TGF-β signaling pathway in Hu sheep. Molecular Therapy. Nucleic Acids 24: 223-240

He, J.; Wang, L.; Ding, Y.; Liu, H.; Zou, G. 2021: LncRNA FER1L4 is dysregulated in osteoarthritis and regulates IL-6 expression in human chondrocyte cells. Scientific Reports 11(1): 13032

Liang, M.; Li, Y.; Dai, T.; Chen, C. 2021: LncRNA FEZF1-AS1 regulates biological behaviors of cervical cancer by targeting miRNA-1254. Food Science and Nutrition 9(9): 4722-4737

Zhang, G.; Yang, W.; Li, D.; Li, X.; Huang, J.; Huang, R.; Luo, J. 2020: LncRNA FEZF1‑AS1 promotes migration, invasion and epithelial‑mesenchymal transition of retinoblastoma cells by targeting miR‑1236‑3p. Molecular Medicine Reports 22(5): 3635-3644

Cai, X.; Zhang, P.; Wang, S.; Hong, L.; Yu, S.; Li, B.; Zeng, H.; Yang, X.; Shao, L. 2020: LncRNA FGD5 antisense RNA 1 upregulates RORA to suppress hypoxic injury of human cardiomyocyte cells by inhibiting oxidative stress and apoptosis via miR‑195. Molecular Medicine Reports 22(6): 4579-4588

Zhao, T.; Zhang, J.; Ye, C.; Tian, L.; Li, Y. 2020: LncRNA FOXD2-AS1 promotes hemangioma progression through the miR-324-3p/PDRG1 pathway. Cancer Cell International 20: 189

Shen, Y.; Yang, G.; Zhuo, S.; Zhuang, H.; Chen, S. 2021: LncRNA FTX promotes asthma progression by sponging miR-590-5p and upregulating JAK2. American Journal of Translational Research 13(8): 8833-8846

Li, X.; Zhao, Q.; Qi, J.; Wang, W.; Zhang, D.; Li, Z.; Qin, C. 2018: LncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma. International Journal of Oncology 53(2): 551-566

Li, B.; Wei, Y.; Ge, Q.; Duan, Y.; Guo, L. 2021: LncRNA GABPB1 intronic transcript 1 upregulates pigment epithelium-derived factor via miR-93 to suppress cell proliferation in hepatocellular carcinoma. Oncology Letters 21(4): 260

Cong, C.; Tian, J.; Gao, T.; Zhou, C.; Wang, Y.; Cui, X.; Zhu, L. 2020: LncRNA GAS5 Is Upregulated in Osteoporosis and Downregulates miR-21 to Promote Apoptosis of Osteoclasts. Clinical Interventions in Aging 15: 1163-1169

Liu, Y.; Zhao, J.; Zhang, W.; Gan, J.; Hu, C.; Huang, G.; Zhang, Y. 2015: LncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Scientific Reports 5: 10159

Zhou, D.-L.; Liu, Q.; Xu, B.-H.; Li, Y.; Su, X.; Ye, Z.-L.; Zhang, X.; Peng, J.-L.; Deng, L.; Tang, T.; Shao, Q.; Ma, J.-J.; Yang, X.-H.; He, C.-Y. 2020: LncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance. Cancer Biomarkers: Section a of Disease Markers 29(2): 255-264

Tang, X.; Ruan, H.; Dong, L.; Li, S.; Wu, Z.; Guan, M. 2021: LncRNA GAU1 Induces GALNT8 Overexpression and Potentiates Colorectal Cancer Progression. Gastroenterology Research and Practice 2021: 5960821

Xu, J.; Xu, H.; Ma, K.; Wang, Y.; Niu, B.; Zhang, L.; Li, F. 2021: LncRNA Gm16410 Mediates PM2.5-Induced Macrophage Activation via PI3K/AKT Pathway. Frontiers in Cell and Developmental Biology 9: 618045

Sun, X.; Yan, X.; Liu, K.; Wu, M.; Li, Z.; Wang, Y.; Zhong, X.; Qin, L.; Huang, C.; Wei, X. 2020: LncRNA H19 acts as a ceRNA to regulate the expression of CTGF by targeting miR-19b in polycystic ovary syndrome. Brazilian Journal of Medical and Biological Research 53(11): E9266

Du, Z.; Shi, X.; Guan, A. 2021: LncRNA H19 facilitates the proliferation and differentiation of human dental pulp stem cells via EZH2-dependent LATS1 methylation. Molecular Therapy. Nucleic Acids 25: 116-126

Li, X.; Wang, H.; Yao, B.; Xu, W.; Chen, J.; Zhou, X. 2016: LncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy. Scientific Reports 6: 36340

Cai, Q.; Gao, M.-L.; Huang, L.-S.; Pan, L.-H. 2021: LncRNA H19/miRNA-1: Another potential mechanism for treating myocardial ischemia-reperfusion injury. International Journal of Cardiology 322: 57

Wei, P.; Yang, J.; Zhang, D.; Cui, M.; Li, L. 2020: LncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis. Oncotargets and Therapy 13: 4523-4531

Si, Z.; Zhou, S.; Shen, Z.; Luan, F.; Yan, J. 2021: LncRNA HAND2-AS1 is downregulated in osteoarthritis and regulates IL-6 expression in chondrocytes. Journal of Orthopaedic Surgery and Research 16(1): 68

Jing, G.-Y.; Zheng, X.-Z.; Ji, X.-X. 2021: LncRNA HAND2-AS1 overexpression inhibits cancer cell proliferation in hepatocellular carcinoma by downregulating RUNX2 expression. Journal of Clinical Laboratory Analysis 35(4): E23717

Yamada, H.; Takahashi, M.; Watanuki, M.; Watanabe, M.; Hiraide, S.; Saijo, K.; Komine, K.; Ishioka, C. 2021: LncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma. Oncology Letters 21(6): 455

Si, L.; Chen, J.; Yang, S.; Liu, Z.; Chen, Y.; Peng, M.; Jia, Y. 2020: LncRNA HEIH accelerates cell proliferation and inhibits cell senescence by targeting miR-3619-5p/CTTNBP2 axis in ovarian cancer. Menopause 27(11): 1302-1314

Chen, C.; Gu, C.; Ren, Q.; Ding, F.; Pan, Q.; Niu, Y.; Ma, D.; Wu, L. 2020: LncRNA HEIH, an indicator of high malignancy and poor prognosis, functions as an oncogene in breast cancer. Molecular Medicine Reports 22(4): 2869-2877

Liu, Y.; Zhang, Y.; Chen, C.; Li, Y. 2021: LncRNA HIF1A-AS2: a potential oncogene in human cancers (Review). Biomedical Reports 15(4): 85

Chao, P.; Yongheng, F.; Jin, Z.; Yu, Z.; Shiyong, Y.; Kunxing, Y.; Yong, M. 2021: LncRNA HOTAIR knockdown suppresses gastric cancer cell biological activities. Food Science and Nutrition 9(1): 123-134

Topel, H.; Bagirsakci, E.; Comez, D.; Bagci, G.; Cakan-Akdogan, G.; Atabey, N. 2020: LncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cells. Cell Communication and Signaling: Ccs 18(1): 110

Li, F.; Xu, Y.; Xu, X.; Ge, S.; Zhang, F.; Zhang, H.; Fan, X. 2020: LncRNA HotairM1 Depletion Promotes Self-Renewal of Cancer Stem Cells through HOXA1-Nanog Regulation Loop. Molecular Therapy. Nucleic Acids 22: 456-470

Song, C.; Yang, Z.; Jiang, R.; Cheng, J.; Yue, B.; Wang, J.; Sun, X.; Huang, Y.; Lan, X.; Lei, C.; Chen, H. 2020: LncRNA IGF2 AS Regulates Bovine Myogenesis through Different Pathways. Molecular Therapy. Nucleic Acids 21: 874-884

Zhang, P.; Sun, J.; Liang, C.; Gu, B.; Xu, Y.; Lu, H.; Cao, B.; Xu, H. 2020: LncRNA IGHCγ1 Acts as a ceRNA to Regulate Macrophage Inflammation via the miR-6891-3p/TLR4 Axis in Osteoarthritis. Mediators of Inflammation 2020: 9743037

Cao, J.; Yang, Z.; An, R.; Zhang, J.; Zhao, R.; Li, W.; Xu, L.; Sun, Y.; Liu, M.; Tian, L. 2020: LncRNA IGKJ2-MALLP2 suppresses LSCC proliferation, migration, invasion, and angiogenesis by sponging miR-1911-3p/p21. Cancer Science 111(9): 3245-3257

Hong, S.; Li, S.; Bi, M.; Yu, H.; Yan, Z.; Liu, T.; Wang, H. 2021: LncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2. Molecular Therapy. Nucleic Acids 24: 1012-1023

Li, R.; Zhang, J.; Ma, S.; Zhao, G.; Li, J.; Li, J.; Wang, X.; Hui, B. 2021: LncRNA IUR upregulates miR-34a to inhibit pancreatic adenocarcinoma cell migratory and invasive abilities. Oncology Letters 22(1): 567

Duan, Q.; Cai, L.; Zheng, K.; Cui, C.; Huang, R.; Zheng, Z.; Xie, L.; Wu, C.; Yu, X.; Yu, J. 2020: LncRNA KCNQ1OT1 knockdown inhibits colorectal cancer cell proliferation, migration and invasiveness via the PI3K/AKT pathway. Oncology Letters 20(1): 601-610

Ding, P.; Liang, B.; Shou, J.; Wang, X. 2020: LncRNA KCNQ1OT1 promotes proliferation and invasion of glioma cells by targeting the miR‑375/YAP pathway. International Journal of Molecular Medicine 46(6): 1983-1992

Wang, Y.; Wang, J.; Hao, H.; Luo, X. 2020: LncRNA KCNQ1OT1 promotes the proliferation, migration and invasion of retinoblastoma cells by upregulating HIF-1α via sponging miR-153-3p. Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 68(8): 1349-1356

Zhou, W.; Li, H.; Shang, S.; Liu, F. 2021: LncRNA KCNQ1OT1 reverses the effect of sevoflurane on hepatocellular carcinoma progression via regulating the miR-29a-3p/CBX3 axis. Brazilian Journal of Medical and Biological Research 54(7): E10213

Mu, Y.; Tang, Q.; Feng, H.; Zhu, L.; Wang, Y. 2020: LncRNA KTN1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑505‑3p. Oncology Reports 44(6): 2645-2655

Gong, X.; Dong, T.; Niu, M.; Liang, X.; Sun, S.; Zhang, Y.; Li, Y.; Li, D. 2020: LncRNA LCPAT1 Upregulation Promotes Breast Cancer Progression via Enhancing MFAP2 Transcription. Molecular Therapy. Nucleic Acids 21: 804-813

Wang, Q.; Wu, J.; Huang, H.; Jiang, Y.; Huang, Y.; Fang, H.; Zheng, G.; Zhou, X.; Wu, Y.; Lei, C.; Hu, D. 2020: LncRNA LIFR-AS1 suppresses invasion and metastasis of non-small cell lung cancer via the miR-942-5p/ZNF471 axis. Cancer Cell International 20: 180

Qi, Z.-Y.; Wang, L.-L.; Qu, X.-L. 2021: LncRNA LINC00355 Acts as a Novel Biomarker and Promotes Glioma Biological Activities via the Regulation of miR-1225/FNDC3B. Disease Markers 2021: 1683129

Xu, S.-H.; Bo, Y.-H.; Ma, H.-C.; Zhang, H.-N.; Shao, M.-J. 2021: LncRNA LINC00473 promotes proliferation, migration, invasion and inhibition of apoptosis of non-small cell lung cancer cells by acting as a sponge of miR-497-5p. Oncology Letters 21(6): 429

Ruan, X.; Zheng, J.; Liu, X.; Liu, Y.; Liu, L.; Ma, J.; He, Q.; Yang, C.; Wang, D.; Cai, H.; Li, Z.; Liu, J.; Xue, Y. 2020: LncRNA LINC00665 Stabilized by TAF15 Impeded the Malignant Biological Behaviors of Glioma Cells via STAU1-Mediated mRNA Degradation. Molecular Therapy. Nucleic Acids 20: 823-840

Zhao, Y.; Chen, Y.; Hu, X.; Zhang, N.; Wang, F. 2020: LncRNA LINC01535 upregulates BMP2 expression levels to promote osteogenic differentiation via sponging miR‑3619‑5p. Molecular Medicine Reports 22(6): 5428-5435

Zhou, X.; Liu, M.; Deng, G.; Chen, L.; Sun, L.; Zhang, Y.; Luo, C.; Tang, J. 2021: LncRNA LOC102724169 plus cisplatin exhibit the synergistic anti-tumor effect in ovarian cancer with chronic stress. Molecular Therapy. Nucleic Acids 24: 294-309

He, X.; Xiao, H.; Yang, R.; Chen, H.; Wang, B. 2021: LncRNA LOC339524 inhibits the proliferation of bladder cancer cells by targeting the miR-875-5p/COPS7A signaling axis. Experimental and Therapeutic Medicine 22(5): 1202

Yu, W.; Dai, Y. 2021: LncRNA LOXL1-AS1 promotes liver cancer cell proliferation and migration by regulating the miR-377-3p/NFIB axis. Oncology Letters 22(2): 624

Liao, S.-A.; Guan, J.; Mo, H.; He, J.-L.; Zhan, X.-L. 2020: LncRNA LSINCT5 Regulates miR-20a-5p/XIAP to Inhibit the Growth and Metastasis of Osteosarcoma Cells. Oncotargets and Therapy 13: 8209-8221

Wei, H.; Tang, Q.; Wang, A.; Zhang, Y.; Qin, Z.; Li, W.; Xu, Z.; Wang, J.; Pu, J. 2021: LncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis. Journal of Oncology 2021: 5547345

Liu, F.; Deng, W.; Wan, Z.; Xu, D.; Chen, J.; Yang, X.; Xu, J. 2021: LncRNA MAGI2-AS3 overexpression had antitumor effect on Hepatic cancer via miRNA-23a-3p/PTEN axis. Food Science and Nutrition 9(5): 2517-2530

Wang, R.; Lu, X.; Yu, R. 2020: LncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway. Oncotargets and Therapy 13: 4049-4061

Sun, L.; Zhang, P.; Lu, W. 2021: LncRNA MALAT1 Regulates Mouse Granulosa Cell Apoptosis and 17β-Estradiol Synthesis via Regulating miR-205/CREB1 Axis. Biomed Research International 2021: 6671814

Zhao, L.; Lou, G.; Li, A.; Liu, Y. 2020: LncRNA MALAT1 modulates cancer stem cell properties of liver cancer cells by regulating YAP1 expression via miR‑375 sponging. Molecular Medicine Reports 22(2): 1449-1457

Xiao, L.; Wang, W.; Zhao, J.; Xu, H.; Li, S.; Yang, X. 2020: LncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR-101/EZH2 axis in oral squamous cell carcinoma. Oncology Letters 20(5): 164

Li, X. 2021: LncRNA MALAT1 promotes diabetic retinopathy by upregulating PDE6G via miR-378a-3p. Archives of Physiology and Biochemistry 2021: 1-9

Zhao, Y.; Wang, Z.; Gao, M.; Wang, X.; Feng, H.; Cui, Y.; Tian, X. 2021: LncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p. Open Medicine 16(1): 931-943

Huang, B.; Guo, X.; Li, Y. 2020: LncRNA MALAT1 regulates the expression level of miR-21 and interferes with the biological behavior of colon cancer cells. Journal of Buon: Official Journal of the Balkan Union of Oncology 25(2): 907-913

Hou, C.; Wang, X.; Du, B. 2020: LncRNA MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p. Experimental and Therapeutic Medicine 20(2): 978-984

Zhang, J.; Song, L.; Ma, Y.; Yin, Y.; Liu, X.; Luo, X.; Sun, J.; Wang, L. 2020: LncRNA MEG8 Upregulates miR-770-5p Through Methylation and Promotes Cell Apoptosis in Diabetic Nephropathy. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy 13: 2477-2483

Xie, W.; Jiang, L.; Huang, X.; Shang, H.; Gao, M.; You, W.; Tan, J.; Yan, H.; Sun, W. 2021: LncRNA MEG8 is downregulated in osteoarthritis and regulates chondrocyte cell proliferation, apoptosis and inflammation. Experimental and Therapeutic Medicine 22(4): 1153

Zhou, X.; Zhang, W.; Jin, M.; Chen, J.; Xu, W.; Kong, X. 2017: LncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy. Cell Death and Disease 8(7): E2929

Ling, J.; Tan, K.; Lu, L.; Yang, F.; Luan, L. 2020: LncRNA MIAT increases cell viability, migration, EMT and ECM production in age-related cataracts by regulating the miR-181a/CTGF/ERK signaling pathway. Experimental and Therapeutic Medicine 20(2): 1053-1063

Zhu, X.; Liu, L.; Wang, Y.; Cong, J.; Lin, Z.; Wang, Y.; Liu, Q.; Wang, L.; Yang, B.; Li, T. 2021: LncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma. Frontiers in Oncology 11: 651693

Lu, Y.; Zhao, X.; Liu, Q.; Li, C.; Graves-Deal, R.; Cao, Z.; Singh, B.; Franklin, J.L.; Wang, J.; Hu, H.; Wei, T.; Yang, M.; Yeatman, T.J.; Lee, E.; Saito-Diaz, K.; Hinger, S.; Patton, J.G.; Chung, C.H.; Emmrich, S.; Klusmann, J-Henning.; Fan, D.; Coffey, R.J. 2017: LncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling. Nature Medicine 23(11): 1331-1341

Ma, J.; Kong, F.-F.; Yang, D.; Yang, H.; Wang, C.; Cong, R.; Ma, X.-X. 2021: LncRNA MIR210HG promotes the progression of endometrial cancer by sponging miR-337-3p/137 via the HMGA2-TGF-β/Wnt pathway. Molecular Therapy. Nucleic Acids 24: 905-922

Zhu, K.; Miao, C.; Tian, Y.; Qin, Z.; Xue, J.; Xia, J.; Zhu, S.; Xu, A.; Yang, J.; Wang, Z. 2020: LncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis. Journal of cellular and molecular medicine 24(17): 10013-10026

Wang, S.-M.; Pang, J.; Zhang, K.-J.; Zhou, Z.-Y.; Chen, F.-Y. 2021: LncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis. Molecular Therapy Oncolytics 21: 62-73

Su, X.; Lv, L.; Li, Y.; Fang, R.; Yang, R.; Li, C.; Li, T.; Zhu, D.; Li, X.; Zhou, Y.; Shan, H.; Liang, H. 2020: LncRNA MIRF Promotes Cardiac Apoptosis through the miR-26a-Bak1 Axis. Molecular Therapy. Nucleic Acids 20: 841-850

Zhang, S.; Xu, J.; Chen, Q.; Zhang, F.; Wang, H.; Guo, H. 2021: LncRNA MT1JP-overexpression abolishes the silencing of PTEN by miR-32 in hepatocellular carcinoma. Oncology Letters 22(2): 604

Chen, J.-X.; Wang, Y.-P.; Zhang, X.; Li, G.-X.; Zheng, K.; Duan, C.-Z. 2020: LncRNA Mtss1 promotes inflammatory responses and secondary brain injury after intracerebral hemorrhage by targeting miR-709 in mice. Brain Research Bulletin 162: 20-29

Zhou, Y.; Zhang, F.; Xu, F.; Wang, Q.; Wu, J.; Peng, W.; Dong, W. 2021: LncRNA NEAT1 regulates CYP1A2 and influences steroid-induced necrosis. Open Life Sciences 16(1): 969-980

Bird, L. 2018: LncRNA NKILA: a killer regulator. Nature Reviews. Immunology 18(11): 666-667

Zhao, J.; Lin, X.; Sun, H.; Zhao, D.; Ma, Q.; Lau, W.B.; Cheng, Z.; Li, F.; Liu, J.; Fan, Q. 2021: LncRNA NONHSAT069381 and NONHSAT140844 Increase in Aging Human Blood, Regulating Cardiomyocyte Apoptosis. Oxidative Medicine and Cellular Longevity 2021: 9465300

Tian, Q.; Yan, X.; Yang, L.; Liu, Z.; Yuan, Z.; Shen, Z.; Zhang, Y. 2020: LncRNA NORAD promotes hepatocellular carcinoma progression via regulating miR-144-3p/SEPT2. American Journal of Translational Research 12(5): 2257-2266

Wang, Y.; Zhou, B.; Yan, L.; Wu, J.; Xing, Z.; Zhang, S.; Xiang, F. 2021: LncRNA NORAD promotes the progression of osteosarcoma via targeting of miR-155-5p. Experimental and Therapeutic Medicine 21(6): 645

Zhang, Q.; Li, T.; Wang, Z.; Kuang, X.; Shao, N.; Lin, Y. 2020: LncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway. Journal of cellular and molecular medicine 24(14): 8236-8247

Yang, L.; Li, G.; Gao, Y.; Ou, N.; Yu, T.; Ren, S. 2020: LncRNA NR4A1AS Upregulates miR-221 Through Demethylation to Promote Cell Proliferation in Oral Squamous Cell Carcinoma. Cancer Management and Research 12: 5285-5292

Yan, K.; Hou, L.; Liu, T.; Jiao, W.; Ma, Q.; Fang, Z.; Zhang, S.; Song, D.; Liu, J.; Gao, X.; Fan, Y. 2020: LncRNA OGFRP1 functions as a ceRNA to promote the progression of prostate cancer by regulating SARM1 level via miR-124-3p. Aging 12(10): 8880-8892

Wang, Y.; Yang, T.; Han, Y.; Ren, Z.; Zou, J.; Liu, J.; Xi, S. 2020: LncRNA OTUD6B-AS1 Exacerbates As2O3-Induced Oxidative Damage in Bladder Cancer via miR-6734-5p-Mediated Functional Inhibition of IDH2. Oxidative Medicine and Cellular Longevity 2020: 3035624

Niu, X.; Pu, S.; Ling, C.; Xu, J.; Wang, J.; Sun, S.; Yao, Y.; Zhang, Z. 2020: LncRNA Oip5-as1 attenuates myocardial ischaemia/reperfusion injury by sponging miR-29a to activate the SIRT1/AMPK/PGC1α pathway. Cell Proliferation 53(6): E12818

Ma, X.; Mao, Z.; Zhu, J.; Liu, H.; Chen, F. 2021: LncRNA PANTR1 Upregulates BCL2A1 Expression to Promote Tumorigenesis and Warburg Effect of Hepatocellular Carcinoma through Restraining miR-587. Journal of Immunology Research 2021: 1736819

Liu, H.; Zhu, C.; Xu, Z.; Wang, J.; Qian, L.; Zhou, Q.; Shen, Z.; Zhao, W.; Xiao, W.; Chen, L.; Zhou, Y. 2020: LncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma. Cancer science 111(11): 4129-4141

Shen, Y.'e.; Cui, X.; Xu, N.; Hu, Y.; Zhang, Z. 2021: LncRNA PART1 mitigates MPP+-induced neuronal injury in SH-SY5Y cells via micRNA-106b-5p/MCL1 axis. American Journal of Translational Research 13(8): 8897-8908

Luo, J.; Zheng, J.; Hao, W.; Zeng, H.; Zhang, Z.; Shao, G. 2021: LncRNA PCAT6 facilitates cell proliferation and invasion via regulating the miR-326/hnRNPA2B1 axis in liver cancer. Oncology Letters 21(6): 471

Luo, T.; Gao, Y.; Zhangyuan, G.; Xu, X.; Xue, C.; Jin, L.; Zhang, W.; Zhu, C.; Sun, B.; Qin, X. 2020: LncRNA PCBP1-AS1 Aggravates the Progression of Hepatocellular Carcinoma via Regulating PCBP1/PRL-3/AKT Pathway. Cancer Management and Research 12: 5395-5408

Xu, Z.; Meng, L.; Xie, Y.; Guo, W. 2020: LncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma. Brazilian Journal of Medical and Biological Research 53(7): E9271

Yu, Y.; He, Y.; Shao, Y.; Chen, Q.; Liu, H. 2020: LncRNA PCNAP1 predicts poor prognosis in breast cancer and promotes cancer metastasis via miR‑340‑5p‑dependent upregulation of SOX4. Oncology Reports 44(4): 1511-1523

Tang, D.; Geng, L.; Ma, J. 2021: LncRNA PROX1-AS1 mediates the migration and invasion of placental trophoblast cells via the miR-211-5p/caspase-9 axis. Bioengineered 12(1): 4100-4110

Qin, M.; Meng, Y.; Luo, C.; He, S.; Qin, F.; Yin, Y.; Huang, J.; Zhao, H.; Hu, J.; Deng, Z.; Qiu, Y.; Hu, G.; Pan, H.; Qin, Z.; Huang, Z.; Yi, T. 2021: LncRNA PRR34-AS1 promotes HCC development via modulating Wnt/β-catenin pathway by absorbing miR-296-5p and upregulating E2F2 and SOX12. Molecular Therapy. Nucleic Acids 25: 37-52

Cheng, G.; Li, Y.; Liu, Z.; Song, X. 2021: LncRNA PSMA3-AS1 promotes the progression of non-small cell lung cancer through targeting miR-17-5p/PD-L1. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 30(10): 1043-1050

Mirzadeh Azad, F.; Malakootian, M.; Mowla, S.Javad. 2019: LncRNA PSORS1C3 is regulated by glucocorticoids and fine-tunes OCT4 expression in non-pluripotent cells. Scientific Reports 9(1): 8370

Zeng, S.H.G.; Xie, J.-H.; Zeng, Q.-Y.; Dai, S.H.H.; Wang, Y.; Wan, X.-M.; Liu, J.C.H. 2021: LncRNA PVT1 Promotes Metastasis of Non-Small Cell Lung Cancer Through EZH2-Mediated Activation of Hippo/NOTCH1 Signaling Pathways. Cell Journal 23(1): 21-31

Wang, L.; Xiao, B.; Yu, T.; Gong, L.; Wang, Y.; Zhang, X.; Zou, Q.; Zuo, Q. 2021: LncRNA PVT1 promotes the migration of gastric cancer by functioning as ceRNA of miR-30a and regulating Snail. Journal of Cellular Physiology 236(1): 536-548

Zhang, S.; Li, J.; Gao, H.; Tong, Y.; Li, P.; Wang, Y.; Du, L.; Wang, C. 2021: LncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma. Frontiers in Cell and Developmental Biology 9: 656554

Liu, T.; Meng, W.; Cao, H.; Chi, W.; Zhao, L.; Cui, W.; Yin, H.; Wang, B. 2020: LncRNA RASSF8‑AS1 suppresses the progression of laryngeal squamous cell carcinoma via targeting the miR‑664b‑3p/TLE1 axis. Oncology Reports 44(5): 2031-2044

Zhao, L.; Liu, T.; Zhang, X.; Zuo, D.; Liu, C. 2020: LncRNA RHPN1-AS1 Promotes Ovarian Cancer Growth and Invasiveness Through Inhibiting miR-1299. Oncotargets and Therapy 13: 5337-5344

Li, Z.-N.; Ge, M.-X.; Cao, L.-J.; Yuan, Z.-F. 2020: LncRNA RHPN1-AS1 Serves as a Sponge for miR-3133 Modulating the Cell Proliferation of Retinoblastoma through JAK2. Biomed Research International 2020: 3502981

Xie, Z.; Liu, S.; Chu, S.; Liu, Y.; Huang, B.; Zhang, Q. 2021: LncRNA RMRP predicts poor prognosis and mediates tumor progression of esophageal squamous cell carcinoma by regulating miR-613/ neuropilin 2 (NRP2) axis. Bioengineered 12(1): 6913-6922

Zheng, B.; Wang, J.; Fan, K.; Sun, W.; Wan, W.; Gao, Z.; Ni, X.; Zhang, D.; Ni, X.; Suo, T.; Liu, H.; Liu, H.; Shen, S. 2021: LncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC. Molecular Therapy Oncolytics 23: 124-137

Zhou, L.; Liu, R.; Liang, X.; Zhang, S.; Bi, W.; Yang, M.; He, Y.; Jin, J.; Li, S.; Yang, X.; Fu, J.; Zhang, P. 2020: LncRNA RP11-624L4.1 Is Associated with Unfavorable Prognosis and Promotes Proliferation via the CDK4/6-Cyclin D1-Rb-E2F1 Pathway in NPC. Molecular Therapy. Nucleic Acids 22: 1025-1039

Chen, J.; Jiang, F.; Hu, L.; Zhang, F.; Wang, J.; Huang, K.; Wang, Y. 2020: LncRNA RP11-838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma. Biomed Research International 2020: 2806042

Wu, Y.; Cheng, K.; Liang, W.; Wang, X. 2020: LncRNA RPPH1 promotes non-small cell lung cancer progression through the miR-326/WNT2B axis. Oncology Letters 20(4): 105

Wu, M.; Xu, G.; Han, C.; Luan, P.-F.; Xing, Y.-H.; Nan, F.; Yang, L.-Z.; Huang, Y.; Yang, Z.-H.; Shan, L.; Yang, L.; Liu, J.; Chen, L.-L. 2021: LncRNA SLERT controls phase separation of FC/DFCs to facilitate Pol i transcription. Science 373(6554): 547-555

Xu, J.; Yang, R.; Hua, X.; Huang, M.; Tian, Z.; Li, J.; Lam, H.Yun.; Jiang, G.; Cohen, M.; Huang, C. 2020: LncRNA SNHG1 Promotes Basal Bladder Cancer Invasion via Interaction with PP2A Catalytic Subunit and Induction of Autophagy. Molecular Therapy. Nucleic Acids 21: 354-366

Ji, Y.Y.; Meng, M.; Miao, Y. 2020: LncRNA SNHG1 Promotes Progression of Cervical Cancer Through miR-195/NEK2 Axis. Cancer Management and Research 12: 11423-11433

Xiang, J.; Fu, H.-Q.; Xu, Z.; Fan, W.-J.; Liu, F.; Chen, B. 2020: LncRNA SNHG1 attenuates osteogenic differentiation via the miR‑101/DKK1 axis in bone marrow mesenchymal stem cells. Molecular Medicine Reports 22(5): 3715-3722

Zhu, S.; Liu, Y.; Wang, X.; Wang, J.; Xi, G. 2020: LncRNA SNHG10 Promotes the Proliferation and Invasion of Osteosarcoma via Wnt/β-Catenin Signaling. Molecular Therapy. Nucleic Acids 22: 957-970

Zhang, Y.; Zhang, M. 2021: LncRNA SNHG14 involved in trophoblast cell proliferation, migration, invasion and epithelial-mesenchymal transition by targeting miR-330-5p in preeclampsia. Zygote 29(2): 108-117

Tian, Y.; Li, L.; Lin, G.; Wang, Y.; Wang, L.; Zhao, Q.; Hu, Y.; Yong, H.; Wan, Y.; Zhang, Y. 2021: LncRNA SNHG14 promotes oncogenesis and immune evasion in diffuse large-B-cell lymphoma by sequestering miR-152-3p. Leukemia and Lymphoma 2021: 1-15

Tian, F.; Ying, H.; Liao, S.; Wang, Y.; Wang, Q. 2022: LncRNA SNHG14 promotes the proliferation, migration, and invasion of thyroid tumour cells by regulating miR-93-5p. Zygote 30(2): 183-193

Li, J.; Du, B.; Geng, X.; Zhou, L. 2021: LncRNA SNHG17 is Downregulated in Gestational Diabetes Mellitus (GDM) and Has Predictive Values. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy 14: 831-838

Zhao, L.; Ye, J.; Lu, Y.; Sun, C.; Deng, X. 2021: LncRNA SNHG17 promotes pancreatic carcinoma progression via cross-talking with miR-942. American Journal of Translational Research 13(3): 1037-1050

Zhang, L.; Li, G.; Wang, X.; Zhang, Y.; Huang, X.; Wu, H. 2021: LncRNA SNHG3 acts as oncogene in ovarian cancer through miR-139-5p and Notch1. Oncology Letters 21(2): 122

Zhang, H.; Wei, N.; Zhang, W.; Shen, L.; Ding, R.; Li, Q.; Li, S.; Du, Y. 2020: LncRNA SNHG3 promotes breast cancer progression by acting as a miR‑326 sponge. Oncology Reports 44(4): 1502-1510

Yu, L.; Huo, L.; Shao, X.; Zhao, J. 2020: LncRNA SNHG5 promotes cell proliferation, migration and invasion in oral squamous cell carcinoma by sponging miR-655-3p/FZD4 axis. Oncology Letters 20(6): 310

Deng, Y.; Cheng, L.; Lv, Z.; Zhu, H.; Meng, X. 2021: LncRNA SNHG7 promotes cell proliferation in glioma by acting as a competing endogenous RNA and sponging miR-138-5p to regulate EZH2 expression. Oncology Letters 22(1): 565

Xu, W.; Sun, X.; Zang, C.; Jiang, Y. 2020: LncRNA SNHG7 promotes tumorigenesis of nasopharyngeal carcinoma via epithelial-to-mesenchymal transition. Oncology Letters 20(4): 88

Tian, X.; Liu, Y.; Wang, Z.; Wu, S. 2020: LncRNA SNHG8 promotes aggressive behaviors of nasopharyngeal carcinoma via regulating miR-656-3p/SATB1 axis. Biomedicine and PharmacoTherapy 131: 110564

Xuan, L.; Sun, Z.; Wang, J.; Gao, S. 2021: LncRNA SNHG8 promotes ovarian cancer progression through serving as sponge for miR-1270 to regulate S100A11 expression. Journal of Gene Medicine 2021: E3315

Fu, Y.; Li, B.; Yun, J.; Xu, J.; Meng, Q.; Li, X.; Chen, R. 2021: LncRNA SOX2-OT ceRNA network enhances the malignancy of long-term PM2.5-exposed human bronchial epithelia. Ecotoxicology and Environmental Safety 217: 112242

Zhang, Y.; Yang, Y.; Zhang, Y.; Liu, Z. 2021: LncRNA ST8SIA6-AS1 facilitates proliferation and invasion in liver cancer by regulating miR-142-3p. Experimental and Therapeutic Medicine 22(6): 1348

Na, H.; Li, X.; Zhang, X.; Xu, Y.; Sun, Y.; Cui, J.; Chen, Z.; Shi, X.; Ren, S.; Zuo, Y. 2020: LncRNA STEAP3-AS1 Modulates Cell Cycle Progression via Affecting CDKN1C Expression through STEAP3 in Colon Cancer. Molecular Therapy. Nucleic Acids 21: 480-491

Han, R.; Han, L.; Xia, Y.; Guo, M.; Li, H. 2021: LncRNA Sequencing of Antler Mesenchymal Tissue Revealed that the Regulatory Network of Antler Cell Proliferation and Differentiation. Animal Biotechnology 2021: 1-10

Pan, C.-Y.; Tian, M.; Zhang, L.-L.; Tian, D.; Wang, L.-Y.; Sun, Y.-J.; Cui, Y.-F. 2020: LncRNA Signature for Predicting Cerebral Vasospasm in Patients with SAH: Implications for Precision Neurosurgery. Molecular Therapy. Nucleic Acids 21: 983-990

Lv, Y.; Zhang, Z.; Xing, X.; Liu, A. 2020: LncRNA TGFβ2-AS1 promotes ECM production via TGF-β2 in human trabecular meshwork cells. Biochemical and Biophysical Research Communications 527(4): 881-888

Xu, G.; Yang, H.; Liu, M.; Niu, J.; Chen, W.; Tan, X.; Sun, L. 2020: LncRNA TINCR facilities bladder cancer progression via regulating miR‑7 and mTOR. Molecular Medicine Reports 22(5): 4243-4253

Zhou, F.; Wang, J.; Chi, X.; Zhou, X.; Wang, Z. 2020: LncRNA TM4SF1-AS1 Activates the PI3K/AKT Signaling Pathway and Promotes the Migration and Invasion of Lung Cancer Cells. Cancer Management and Research 12: 5527-5536

Wang, Z.; Huang, D.; Huang, J.; Nie, K.; Li, X.; Yang, X. 2020: LncRNA TMPO-AS1 Exerts Oncogenic Roles in HCC Through Regulating miR-320a/SERBP1 Axis. Oncotargets and Therapy 13: 6539-6551

Tang, T.; Wang, L.-X.; Yang, M.-L.; Zhang, R.-M. 2020: LncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR‑106a‑5p‑mediated P38 MAPK signaling. Molecular Medicine Reports 22(6): 4857-4867

Shuai, T.; Khan, M.R.; Zhang, X.D.; Li, J.; Thorne, R.F.; Wu, M.; Shao, F. 2021: LncRNA TRMP-S directs dual mechanisms to regulate p27-mediated cellular senescence. Molecular Therapy. Nucleic Acids 24: 971-985

Chang, K.; Wang, G.; Lou, J.; Hao, S.; Lv, R.; Duan, D.; Zhang, W.; Guo, Y.; Wang, P. 2020: LncRNA TTN‑AS1 upregulates RUNX1 to enhance glioma progression via sponging miR‑27b‑3p. Oncology Reports 44(3): 1064-1074

Zhao, W.; Jiang, X.; Yang, S. 2020: LncRNA TUG1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma via Regulating miR-29c-3p/COL1A1 Axis. Cancer Management and Research 12: 6837-6847

Li, B.; Huang, N.; Wei, S.; Xv, J.; Meng, Q.; Aschner, M.; Li, X.; Chen, R. 2021: LncRNA TUG1 as a ceRNA promotes PM exposure-induced airway hyper-reactivity. Journal of Hazardous Materials 416: 125878

Shi, Z.; Zhu, Q.; Fan, J. 2021: LncRNA TUG1 promotes atherosclerosis progression by targeting miR-382-5p. International Journal of Clinical and Experimental Pathology 14(9): 972-979

Ai, Y.; Chen, M.; Liu, J.; Ren, L.; Yan, X.; Feng, Y. 2020: LncRNA TUG1 promotes endometrial fibrosis and inflammation by sponging miR-590-5p to regulate Fasl in intrauterine adhesions. International Immunopharmacology 86: 106703

Hao, R.; Wang, B.; Wang, H.; Huo, Y.; Lu, Y. 2020: LncRNA TUG1 promotes proliferation and differentiation of osteoblasts by regulating the miR-545-3p/CNR2 axis. Brazilian Journal of Medical and Biological Research 53(11): E9798

Zhang, Y.; Ma, Y.; Gu, M.; Peng, Y. 2020: LncRNA TUG1 promotes the brown remodeling of white adipose tissue by regulating miR‑204‑targeted SIRT1 in diabetic mice. International Journal of Molecular Medicine 46(6): 2225-2234

Chen, X.; Mao, M.; Shen, Y.; Jiang, X.; Yin, Z. 2021: LncRNA TUG1 regulates human pulmonary microvascular endothelial cell apoptosis via sponging of the miR-9a-5p/BCL2L11 axis in chronic obstructive pulmonary disease. Experimental and Therapeutic Medicine 22(2): 906

Sun, Y.; Chen, L.; Pan, L. 2021: LncRNA UASR1 is overexpressed in oral squamous cell carcinoma and regulates cancer cell proliferation by regulating miR-375/JAK2 axis. Oncology Letters 21(4): 288

Zhang, Q.; Chen, Z. 2020: LncRNA UASR1 sponges miR-107 in colorectal cancer to upregulate oncogenic CDK8 and promote cell proliferation. Oncology Letters 20(6): 305

Li, D.; Bao, J.; Yao, J.; Li, J. 2020: LncRNA USP2-AS1 promotes colon cancer progression by modulating Hippo/YAP1 signaling. American Journal of Translational Research 12(9): 5670-5682

Sun, J.-G.; Li, X.-B.; Yin, R.-H.; Li, X.-F. 2020: LncRNA VIM‑AS1 promotes cell proliferation, metastasis and epithelial‑mesenchymal transition by activating the Wnt/β‑catenin pathway in gastric cancer. Molecular Medicine Reports 22(6): 4567-4578

Wang, C.; Xie, Q.; Sun, W.; Zhou, Y.; Liu, Y. 2021: LncRNA WT1-AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53. Experimental and Therapeutic Medicine 22(1): 734

Sun, L.; Zhang, M.; Qu, H. 2021: LncRNA XIST regulates cell proliferation, migration and invasion via regulating miR-30b and RECK in nasopharyngeal carcinoma. Oncology Letters 21(4): 256

Xu, L.; Xu, Q.; Dai, S.; Jiao, C.; Tang, Y.; Xie, J.; Wu, H.; Chen, X. 2021: LncRNA Xist regulates sevoflurane-induced social and emotional impairment by modulating miR-98-5p/EDEM1 signaling axis in neonatal mice. Molecular Therapy. Nucleic Acids 24: 939-950

Gu, L.; Sun, H.; Yan, Z. 2020: LncRNA ZEB1-AS1 is downregulated in diabetic lung and regulates lung cell apoptosis. Experimental and Therapeutic Medicine 20(6): 225

Qian, W.; Cai, X.; Qian, Q.; Peng, W.; Yu, J.; Zhang, X.; Tian, L.; Wang, C. 2019: LncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial-mesenchymal transition by competitively binding miR-141-3p. Cell Death and Disease 10(2): 129

Cheng, Z.; Liu, L.; Li, Q. 2020: LncRNA ZEB2-AS1 stimulates cardiac hypertrophy by downregulating PTEN. Experimental and Therapeutic Medicine 20(5): 92

Mahboobeh, Z.; Pegah, M.; Fatemeh, S.; Elham, K.; Hanieh, A.; Milad, R.; Mohammad, S. 2020: LncRNA ZEB2-AS1: a promising biomarker in human cancers. Iubmb Life 72(9): 1891-1899

Yang, Y.; Tai, W.; Lu, N.; Li, T.; Liu, Y.; Wu, W.; Li, Z.; Pu, L.; Zhao, X.; Zhang, T.; Dong, Z. 2020: LncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging 12(10): 9085-9102

Wang, H.; Hu, H.; Ma, J.; Jiang, Y.; Cheng, R. 2021: LncRNA ZFAS1 promotes the ox-LDL induced proliferation, invasion and migration of vascular smooth muscle cells. Experimental and Therapeutic Medicine 22(2): 835

Jin, H.; Du, W.; Huang, W.; Yan, J.; Tang, Q.; Chen, Y.; Zou, Z. 2021: LncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment. Molecular Therapy. Nucleic Acids 25: 613-637

Zhang, L.; Zhao, X.; Wang, W. 2021: LncRNA and mRNA sequencing of the left testis in experimental varicocele rats treated with Morinda officinalis polysaccharide. Experimental and Therapeutic Medicine 22(4): 1136

Wang, Q-Chen.; Wang, Z-Yu.; Xu, Q.; Chen, X-Liang.; Shi, R-Zheng. 2021: LncRNA expression profiles and associated ceRNA network analyses in epicardial adipose tissue of patients with coronary artery disease. Scientific Reports 11(1): 1567

Wen, J.; Liu, J.; Jiang, H.; Wan, L.; Xin, L.; Sun, Y.; Zhang, P.; Sun, Y.; Zhang, Y.; Du, X.; Wang, X.; Wang, J. 2020: LncRNA expression profiles related to apoptosis and autophagy in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FEBS open bio 10(8): 1642-1654

Chen, X.; Sun, C.; Liu, C.; Wu, J. 2021: LncRNA in hepatic glucose and lipid metabolism: a review. Sheng Wu Gong Cheng Xue Bao 37(1): 40-52

Pan, W.; Wang, H.; Ruan, J.; Zheng, W.; Chen, F.; Kong, J.; Wang, Y. 2021: LncRNA myocardial infarction-associated transcript (MIAT) knockdown alleviates LPS-induced chondrocytes inflammatory injury via regulating miR-488-3p/sex determining region Y-related HMG-box 11 (SOX11) axis. Open Life Sciences 16(1): 511-522

Huang, P.; Li, F.; Li, L.; You, Y.; Luo, S.; Dong, Z.; Gao, Q.; Wu, S.; Brünner, N.; Stenvang, J. 2018: LncRNA profile study reveals the mRNAs and lnc RNAs associated with docetaxel resistance in breast cancer cells. Scientific Reports 8(1): 17970

Ronchetti, D.; Manzoni, M.; Agnelli, L.; Vinci, C.; Fabris, S.; Cutrona, G.; Matis, S.; Colombo, M.; Galletti, S.; Taiana, E.; Recchia, A.G.; Bossio, S.; Gentile, M.; Musolino, C.; Di Raimondo, F.; Grilli, A.; Bicciato, S.; Cortelezzi, A.; Tassone, P.; Morabito, F.; Ferrarini, M.; Neri, A. 2016: LncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome. Blood Cancer Journal 6(9): E468

Xu, C.; Liang, H.; Zhou, J.; Wang, Y.; Liu, S.; Wang, X.; Su, L.; Kang, X. 2020: LncRNA small nucleolar RNA host gene 12 promotes renal cell carcinoma progression by modulating the miR‑200c‑5p/collagen type Xi α1 chain pathway. Molecular Medicine Reports 22(5): 3677-3686

Liu, H.; Shen, Y.; Xu, Y.; Wang, L.; Zhang, C.; Jiang, Y.; Hong, L.; Huang, H.; Liu, H. 2021: LncRNA transcription factor 7 is related to deteriorating clinical features and poor prognosis in multiple myeloma, and its knockdown suppresses disease progression by regulating the miR-203-mediated Jagged1-Notch1 signaling pathway. Oncology Letters 21(5): 412

Senmatsu, S.; Asada, R.; Oda, A.; Hoffman, C.S.; Ohta, K.; Hirota, K. 2021: LncRNA transcription induces meiotic recombination through chromatin remodelling in fission yeast. Communications Biology 4(1): 295

Senmatsu, S.; Asada, R.; Abe, T.; Hoffman, C.S.; Ohta, K.; Hirota, K. 2019: LncRNA transcriptional initiation induces chromatin remodeling within a limited range in the fission yeast fbp1 promoter. Scientific Reports 9(1): 299

Wu, H.; Jiang, M.; Liu, Q.; Wen, F.; Nie, Y. 2020: LncRNA uc.48+ regulates immune and inflammatory reactions mediated by the P2X7 receptor in type 2 diabetic mice. Experimental and Therapeutic Medicine 20(6): 230

Li, M.; Wang, Q.; Xue, F.; Wu, Y'an. 2019: LncRNA- CYTOR Works as an Oncogene Through the CYTOR /miR-3679-5p/ MACC1 Axis in Colorectal Cancer. Dna and Cell Biology 38(6): 572-582

Ali, H.S.; Boshra, M.S.; El Meteini, M.S.; Shafei, A.E.-S.; Matboli, M. 2020: LncRNA- RP11-156p1.3, novel diagnostic and therapeutic targeting via CRISPR/Cas9 editing in hepatocellular carcinoma. Genomics 112(5): 3306-3314

Tang, L.; Xiang, Q.; Xiang, J.; Li, J. 2021: LncRNA-Associated Competitive Endogenous RNA Regulatory Network in an Aβ25-35-Induced AD Mouse Model Treated with Tripterygium Glycoside. Neuropsychiatric Disease and Treatment 17: 1531-1541

Wu, J.; Niu, Q.; Yuan, J.; Xu, X.; Cao, L. 2020: LncRNA-CD160 decreases the immunity of CD8+ T cells through epigenetic mechanisms in hepatitis B virus infection. Oncology Letters 20(1): 235-247

Zhou, H.; Ni, J.; Wu, S.; Ma, F.; Jin, P.; Li, S. 2021: LncRNA-CR46018 positively regulates the Drosophila Toll immune response by interacting with Dif/Dorsal. Developmental and Comparative Immunology 124: 104183

Yang, Y.; Liu, N. 2021: LncRNA-H19 participates in the progression of synovial inflammation in collagen induced arthritis(CIA) mice by promoting the activity of fibroblast-like synovial cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 37(10): 865-871

Yao, J.; Lin, C.; Jiang, J.; Zhang, X.; Li, F.; Liu, T.; Diao, H. 2021: LncRNA-HEIM Facilitated Liver Fibrosis by Up-Regulating TGF-β Expression in Long-Term Outcome of Chronic Hepatitis B. Frontiers in Immunology 12: 666370

Qiu, S.; Sun, J. 2020: LncRNA-MALAT1 expression in patients with coronary atherosclerosis and its predictive value for in-stent restenosis. Experimental and Therapeutic Medicine 20(6): 129

Yan, L.; Zhang, Y.; Zhang, W.; Deng, S.-Q.; Ge, Z.-R. 2020: LncRNA-NRF is a Potential Biomarker of Heart Failure After Acute Myocardial Infarction. Journal of Cardiovascular Translational Research 13(6): 1008-1015

Sun, P.; Quan, J.-C.; Wang, S.; Zhuang, M.; Liu, Z.; Guan, X.; Wang, G.-Y.; Wang, H.-Y.; Wang, X.-S. 2021: LncRNA-PACER upregulates COX-2 and PGE2 through the NF-κB pathway to promote the proliferation and invasion of colorectal-cancer cells. Gastroenterology Report 9(3): 257-268

Chen, B.W.; Zhou, Y.; Wei, T.; Wen, L.; Zhang, Y.-B.; Shen, S.-C.; Zhang, J.; Ma, T.; Chen, W.; Ni, L.; Wang, Y.; Bai, X.-L.; Liang, T.-B. 2021: LncRNA-POIR promotes epithelial-mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR-182-5p. Journal of Cellular Biochemistry 122(1): 130-142

Liu, J.; Zhan, Y.; Wang, J.; Wang, J.; Guo, J.; Kong, D. 2020: LncRNA-SNHG17 promotes colon adenocarcinoma progression and serves as a sponge for miR-375 to regulate CBX3 expression. American Journal of Translational Research 12(9): 5283-5295

Liang, Y.; Zhang, D.; Zheng, T.; Yang, G.; Wang, J.; Meng, F.; Liu, Y.; Zhang, G.; Zhang, L.; Han, J.; Hui, P.; Chen, Z.; Liu, Y.; Wang, M.; Jiang, H.; Liu, L. 2020: LncRNA-SOX2OT promotes hepatocellular carcinoma invasion and metastasis through miR-122-5p-mediated activation of PKM2. Oncogenesis 9(5): 54

Li, L.; Jia, X.; Liu, Y.; He, Y.; Pang, Y.; Shen, Y.; Xu, X.; Li, J. 2021: LncRNA-SUMO3 and lncRNA-HDMO13 modulate the inflammatory response by binding miR-21 and miR-142a-3p in grass carp. Developmental and Comparative Immunology 121: 104082

Ding, Z.; Ying, W.; He, Y.; Chen, X.; Jiao, Y.; Wang, J.; Zhou, X. 2021: LncRNA-UCA1 in the diagnosis of bladder cancer: a meta-analysis. Medicine 100(11): E24805

Fan, J-Lin.; Zhu, T-Ting.; Xue, Z-Yu.; Ren, W-Qing.; Guo, J-Qi.; Zhao, H-Yi.; Zhang, S-Liang. 2020: LncRNA-XIST protects the hypoxia-induced cardiomyocyte injury through regulating the miR-125b-hexokianse 2 axis. In Vitro Cellular and Developmental Biology. Animal 56(4): 349-357

Nie, H.-X.; Zhang, L.; He, T.; Wang, L.; Wan, B.-S.; Wang, X.-Q.; Han, F. 2020: LncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p. Frontiers in Oncology 10: 620550

Zhao, Y.; Yu, Z.; Ma, R.; Zhang, Y.; Zhao, L.; Yan, Y.; Lv, X.; Zhang, L.; Su, P.; Bi, J.; Xu, H.; He, M.; Wei, M. 2021: LncRNA-Xist/miR-101-3p/KLF6/C/EBPα axis promotes TAM polarization to regulate cancer cell proliferation and migration. Molecular Therapy. Nucleic Acids 23: 536-551

Jiao, L.; Li, M.; Shao, Y.; Zhang, Y.; Gong, M.; Yang, X.; Wang, Y.; Tan, Z.; Sun, L.; Xuan, L.; Yu, Q.; Li, Y.; Gao, Y.; Liu, H.; Xu, H.; Li, X.; Zhang, Y.; Zhang, Y. 2019: LncRNA-ZFAS1 induces mitochondria-mediated apoptosis by causing cytosolic Ca 2+ overload in myocardial infarction mice model. Cell Death and Disease 10(12): 942

Zhu, H.; Cheng, Q.; Cai, H. 2021: LncRNA-ZFAS1 promotes the progression of endometrial carcinoma by targeting miR-34b to regulate VEGFA expression. Open Medicine 16(1): 1472-1481

Ghasemi, T.; Khalaj-Kondori, M.; Hosseinpour Feizi, M.A.; Asadi, P. 2020: LncRNA-miRNA-mRNA interaction network for colorectal cancer; An in silico analysis. Computational Biology and Chemistry 89: 107370

Pan, J.; Lin, H.; Yang, T.; Yang, J.; Hu, C.; Zhu, J.; Tan, T.; Li, J.; Xia, H.; He, J.; Zou, Y. 2020: LncRNA-uc003opf.1 rs11752942 A>G polymorphism decreases neuroblastoma risk in Chinese children. Cell Cycle 19(18): 2367-2372

Wang, C.; Yang, S.-H.; Niu, N.; Tao, J.; Du, X.-C.; Yang, J.-H.; Zhu, M.-X.; Wang, Y.-N.; Zhao, W. 2021: LncRNA028466 regulates Th1/Th2 cytokine expression and associates with Echinococcus granulosus antigen P29 immunity. Parasites and Vectors 14(1): 295

Li, J.; Xia, L.; Liu, F.; Tian, Y.; Chen, R.; Su, Z. 2021: LncRNA187415.1 silence in BCAMs ameliorated breast cancer progression by blocking C/EBPβ-lncRNA187415.1-CISH axis and reversing pro-tumor characteristic of BCAMs. Clinical and Translational Medicine 11(5): E407

Zhu, Y.; Yang, Z.; Chen, H.; Pan, Y.; Gong, L.; Chen, F.; Jin, X.; Wen, S.; Li, Y.; Chen, G. 2020: LncRNAHIF1A-AS2 Promotes Renal Carcinoma Cell Proliferation and Migration via miR-130a-5p/ERBB2 Pathway. Oncotargets and Therapy 13: 9807-9820

Qu, Y.; Li, H.; Shi, C.; Qian, M.; Yang, N.; Wang, L.; Gao, X.; Ni, C. 2020: LncRNAs Are Involved in Sevoflurane Anesthesia-Related Brain Function Modulation through Affecting Mitochondrial Function and Aging Process. Biomed Research International 2020: 8841511

Gong, C.; Maquat, L.E. 2011: LncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature 470(7333): 284-288

Dinger, M.E. 2011: LncRNAs: finding the forest among the trees?. Molecular Therapy: the Journal of the American Society of Gene Therapy 19(12): 2109-2111

Zhang, X.; Zou, Y.; Zheng, J.; Ji, S.; Wen, X.; Ye, F.; Liu, J.; Li, X.; Lei, J.; Qiu, M. 2020: LncRNA‑MM2P downregulates the production of pro‑inflammatory cytokines in acute gouty arthritis. Molecular Medicine Reports 22(3): 2227-2234

Zhu, R.; Feng, X.; Wei, Y.; Guo, D.; Li, J.; Liu, Q.; Jiang, J.; Shi, D.; Huang, J. 2021: LncSAMM50 Enhances Adipogenic Differentiation of Buffalo Adipocytes with no Effect on its Host Gene. Frontiers in Genetics 12: 626158

Zhao, J.; Song, X.; Wang, K. 2016: LncScore: alignment-free identification of long noncoding RNA from assembled novel transcripts. Scientific Reports 6: 34838

Gao, X.; Guo, X.; Xue, H.; Qiu, W.; Guo, X.; Zhang, J.; Qian, M.; Li, T.; Liu, Q.; Shen, J.; Deng, L.; Li, G. 2017: LncTCF7 is a negative prognostic factor, and knockdown of lncTCF7 inhibits migration, proliferation and tumorigenicity in glioma. Scientific Reports 7(1): 17456

Fukuse, S.; Terajima, C.; Koontz, A.; Kelley, M.; Webb, D.R.; Devens, B.H. 1992: Lnterleukin-2 Stimulates the Development of Anergy via the Activation of Nonspecific Suppressor T Cells. International Archives of Allergy and Immunology 99(2-4): 411-415

Kishimoto, T. 1992: Lnterleukin-6 and its Receptor; from Cloning to Clinic. International Archives of Allergy and Immunology 99(2-4): 172-177

Faurbye, A. 1949: Lobotomy; an overview of the indications of prefrontal lobotomy in mental disorders. Ugeskrift for Laeger 111(36): 986-992

Restivo, G.; Diener, J.; Cheng, P.F.; Kiowski, G.; Bonalli, M.; Biedermann, T.; Reichmann, E.; Levesque, M.P.; Dummer, R.; Sommer, L. 2017: Low neurotrophin receptor CD271 regulates phenotype switching in melanoma. Nature Communications 8(1): 1988

Ren, J.; Chaisson, M.J.P. 2021: Lra: a long read aligner for sequences and contigs. Plos Computational Biology 17(6): E1009078

Evrard, Y.A.; Lun, Y.; Aulehla, A.; Gan, L.; Johnson, R.L. 1998: Lunatic fringe is an essential mediator of somite segmentation and patterning. Nature 394(6691): 377-381

Spitschan, M.; Mead, J.; Roos, C.; Lowis, C.; Griffiths, B.; Mucur, P.; Herf, M. 2021: Luox: novel open-access and open-source web platform for calculating and sharing physiologically relevant quantities for light and lighting. Wellcome Open Research 6: 69

Xiang, S.; Ma, Y.; Shen, J.; Zhao, Y.; Wu, X.; Li, M.; Yang, X.; Kaboli, P.J.; Du, F.; Ji, H.; Zheng, Y.; Li, X.; Li, J.; Wen, Q.; Xiao, Z. 2020: M5C RNA Methylation Primarily Affects the ErbB and PI3K-Akt Signaling Pathways in Gastrointestinal Cancer. Frontiers in Molecular Biosciences 7: 599340

Chen, H.; Yang, H.; Zhu, X.; Yadav, T.; Ouyang, J.; Truesdell, S.S.; Tan, J.; Wang, Y.; Duan, M.; Wei, L.; Zou, L.; Levine, A.S.; Vasudevan, S.; Lan, L. 2020: M 5 C modification of mRNA serves a DNA damage code to promote homologous recombination. Nature Communications 11(1): 2834

Sun, M.; Xie, M.; Zhang, T.; Wang, Y.; Huang, W.; Xia, L. 2021: M6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pancreatic Cancer. Frontiers in Immunology 12: 739768

Zhang, C.; Ou, S.; Zhou, Y.; Liu, P.; Zhang, P.; Li, Z.; Xu, R.; Li, Y. 2021: M6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer. Frontiers in Oncology 11: 696371

Chen, Y.; Lei, J.; He, S. 2021: M6A Modification Mediates Mucosal Immune Microenvironment and Therapeutic Response in Inflammatory Bowel Disease. Frontiers in Cell and Developmental Biology 9: 692160

Yu, J.; She, Y.; Ji, S.-J. 2021: M6A Modification in Mammalian Nervous System Development, Functions, Disorders, and Injuries. Frontiers in Cell and Developmental Biology 9: 679662

Wang, J.; Sha, Y.; Sun, T. 2021: M6A Modifications Play Crucial Roles in Glial Cell Development and Brain Tumorigenesis. Frontiers in Oncology 11: 611660

Bhattarai, D.P.; Aguilo, F. 2022: M6A RNA Immunoprecipitation Followed by High-Throughput Sequencing to Map N6-Methyladenosine. Methods in Molecular Biology 2404: 355-362

Hu, Y.; Pan, Q.; Wang, M.; Ai, X.; Yan, Y.; Tian, Y.; Jing, Y.; Tang, P.; Jiang, J. 2021: M6A RNA Methylation Regulator YTHDF1 Correlated with Immune Microenvironment Predicts Clinical Outcomes and Therapeutic Efficacy in Breast Cancer. Frontiers in Medicine 8: 667543

Wang, H.; Zhao, X.; Lu, Z. 2021: M6A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma. Frontiers in Genetics 12: 622233

Li, W.; Liu, J.; Ma, Z.; Zhai, X.; Cheng, B.; Zhao, H. 2021: M6A RNA Methylation Regulators Elicit Malignant Progression and Predict Clinical Outcome in Hepatocellular Carcinoma. Disease Markers 2021: 8859590

Chen, L.; Hu, B.; Song, X.; Wang, L.; Ju, M.; Li, Z.; Zhou, C.; Zhang, M.; Wei, Q.; Guan, Q.; Jiang, L.; Chen, T.; Wei, M.; Zhao, L. 2021: M6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma. Frontiers in Oncology 11: 598017

Wu, S.; Zhang, S.; Wu, X.; Zhou, X. 2020: M6A RNA Methylation in Cardiovascular Diseases. Molecular Therapy: the Journal of the American Society of Gene Therapy 28(10): 2111-2119

He, F.; Yu, J.; Yang, J.; Wang, S.; Zhuang, A.; Shi, H.; Gu, X.; Xu, X.; Chai, P.; Jia, R. 2021: M6A RNA hypermethylation-induced BACE2 boosts intracellular calcium release and accelerates tumorigenesis of ocular melanoma. Molecular Therapy: the Journal of the American Society of Gene Therapy 29(6): 2121-2133

Hou, J.; Shan, H.; Zhang, Y.; Fan, Y.; Wu, B. 2020: M6A RNA methylation regulators have prognostic value in papillary thyroid carcinoma. American Journal of Otolaryngology 41(4): 102547

He, P.C.; He, C. 2021: M6 a RNA methylation: from mechanisms to therapeutic potential. Embo Journal 40(3): E105977

Wang, L.; Hui, H.; Agrawal, K.; Kang, Y.; Li, N.; Tang, R.; Yuan, J.; Rana, T.M. 2020: M 6 A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy. EMBO Journal 39(20): E104514

Marnef, A.; Legube, Gëlle. 2020: M 6 A RNA modification as a new player in R-loop regulation. Nature Genetics 52(1): 27-28

Jin, S.; Zhang, X.; Miao, Y.; Liang, P.; Zhu, K.; She, Y.; Wu, Y.; Liu, D-Ao.; Huang, J.; Ren, J.; Cui, J. 2018: M 6 A RNA modification controls autophagy through upregulating ULK1 protein abundance. Cell Research 28(9): 955-957

Zhao, Q.; Zhao, Y.; Hu, W.; Zhang, Y.; Wu, X.; Lu, J.; Li, M.; Li, W.; Wu, W.; Wang, J.; Du, F.; Ji, H.; Yang, X.; Xu, Z.; Wan, L.; Wen, Q.; Li, X.; Cho, C.H.; Zou, C.; Shen, J.; Xiao, Z. 2020: M6A RNA modification modulates PI3K/Akt/mTOR signal pathway in Gastrointestinal Cancer. Theranostics 10(21): 9528-9543

Xu, W.; Tian, X.; Liu, W.; Anwaier, A.; Su, J.; Zhu, W.; Wan, F.; Shi, G.; Wei, G.; Qu, Y.; Zhang, H.; Ye, D. 2021: M6A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma. Frontiers in Oncology 11: 709579

Jin, D.; Guo, J.; Wu, Y.; Yang, L.; Wang, X.; Du, J.; Dai, J.; Chen, W.; Gong, K.; Miao, S.; Li, X.; Sun, H. 2020: M 6 A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Molecular Cancer 19(1): 40

Nagaki, Y.; Motoyama, S.; Yamaguchi, T.; Hoshizaki, M.; Sato, Y.; Sato, T.; Koizumi, Y.; Wakita, A.; Kawakita, Y.; Imai, K.; Nanjo, H.; Watanabe, H.; Imai, Y.; Minamiya, Y.; Kuba, K. 2020: M6 a demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 25(8): 547-561

Wang, B.; Fang, X.; Sun, X.; Du, C.; Zhou, L.; Lv, X.; Li, Y.; Li, H.; Tang, W. 2021: M6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease. Life Sciences 278: 119577

Wang, Z.; Pan, Z.; Adhikari, S.; Harada, B.T.; Shen, L.; Yuan, W.; Abeywardana, T.; Al-Hadid, Q.; Stark, J.M.; He, C.; Lin, L.; Yang, Y. 2021: M6 a deposition is regulated by PRMT1-mediated arginine methylation of METTL14 in its disordered C-terminal region. Embo Journal 40(5): E106309

Lasman, L.; Hanna, J.H. 2018: M 6 A deposition: a boost from TGFβ. Cell Research 28(5): 505-506

Ries, R.J.; Zaccara, S.; Klein, P.; Olarerin-George, A.; Namkoong, S.; Pickering, B.F.; Patil, D.P.; Kwak, H.; Lee, J.Hee.; Jaffrey, S.R. 2019: M 6 A enhances the phase separation potential of mRNA. Nature 571(7765): 424-428

Shi, H.; Zhang, X.; Weng, Y-Lan.; Lu, Z.; Liu, Y.; Lu, Z.; Li, J.; Hao, P.; Zhang, Y.; Zhang, F.; Wu, Y.; Delgado, J.Y.; Su, Y.; Patel, M.J.; Cao, X.; Shen, B.; Huang, X.; Ming, G-Li.; Zhuang, X.; Song, H.; He, C.; Zhou, T. 2018: M 6 A facilitates hippocampus-dependent learning and memory through YTHDF1. Nature 563(7730): 249-253

Wang, Y.; Sun, J.; Lin, Z.; Zhang, W.; Wang, S.; Wang, W.; Wang, Q.; Ning, G. 2020: M6A mRNA Methylation Controls Functional Maturation in Neonatal Murine β-Cells. Diabetes 69(8): 1708-1722

Xia, Z.; Xu, J.; Lu, E.; He, W.; Deng, S.; Gong, A.-Y.; Strass-Soukup, J.; Martins, G.A.; Lu, G.; Chen, X.-M. 2021: M6A mRNA Methylation Regulates Epithelial Innate Antimicrobial Defense Against Cryptosporidial Infection. Frontiers in Immunology 12: 705232

De Jesus, D.F.; Zhang, Z.; Kahraman, S.; Brown, N.K.; Chen, M.; Hu, J.; Gupta, M.K.; He, C.; Kulkarni, R.N. 2019: M 6 A mRNA Methylation Regulates Human β-Cell Biology in Physiological States and in Type 2 Diabetes. Nature Metabolism 1(8): 765-774

Yang, S.; Wei, J.; Cui, Y-Hong.; Park, G.; Shah, P.; Deng, Y.; Aplin, A.E.; Lu, Z.; Hwang, S.; He, C.; He, Y-Ying. 2019: M 6 A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nature Communications 10(1): 2782

Li, H-Bing.; Tong, J.; Zhu, S.; Batista, P.J.; Duffy, E.E.; Zhao, J.; Bailis, W.; Cao, G.; Kroehling, L.; Chen, Y.; Wang, G.; Broughton, J.P.; Chen, Y.Grace.; Kluger, Y.; Simon, M.D.; Chang, H.Y.; Yin, Z.; Flavell, R.A. 2017: M 6 A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways. Nature 548(7667): 338-342

Liu, J.; Eckert, M.A.; Harada, B.T.; Liu, S-Mei.; Lu, Z.; Yu, K.; Tienda, S.M.; Chryplewicz, A.; Zhu, A.C.; Yang, Y.; Huang, J-Tao.; Chen, S-Min.; Xu, Z-Gao.; Leng, X-Hua.; Yu, X-Chen.; Cao, J.; Zhang, Z.; Liu, J.; Lengyel, E.; He, C. 2018: M 6 A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nature Cell Biology 20(9): 1074-1083

Tong, J.; Cao, G.; Zhang, T.; Sefik, E.; Amezcua Vesely, M.Carolina.; Broughton, J.P.; Zhu, S.; Li, H.; Li, B.; Chen, L.; Chang, H.Y.; Su, B.; Flavell, R.A.; Li, H-Bing. 2018: M 6 A mRNA methylation sustains Treg suppressive functions. Cell Research 28(2): 253-256

Wu, R.; Liu, Y.; Zhao, Y.; Bi, Z.; Yao, Y.; Liu, Q.; Wang, F.; Wang, Y.; Wang, X. 2019: M 6 A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner. Cell Death and Disease 10(3): 171

Ji, F.; Lu, Y.; Chen, S.; Lin, X.; Yu, Y.; Zhu, Y.; Luo, X. 2021: M6A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer. Molecular Therapy Oncolytics 22: 574-581

Winkler, R.; Gillis, E.; Lasman, L.; Safra, M.; Geula, S.; Soyris, C.; Nachshon, A.; Tai-Schmiedel, J.; Friedman, N.; Le-Trilling, V.Thuy.Khanh.; Trilling, M.; Mandelboim, M.; Hanna, J.H.; Schwartz, S.; Stern-Ginossar, N. 2019: M 6 A modification controls the innate immune response to infection by targeting type I interferons. Nature Immunology 20(2): 173-182

Takemoto, S.; Nakano, M.; Fukami, T.; Nakajima, M. 2021: M6A modification impacts hepatic drug and lipid metabolism properties by regulating carboxylesterase 2. Biochemical Pharmacology 193: 114766

Ninomiya, K.; Iwakiri, J.; Aly, M.K.; Sakaguchi, Y.; Adachi, S.; Natsume, T.; Terai, G.; Asai, K.; Suzuki, T.; Hirose, T. 2021: M6 a modification of HSATIIi lnc RNAs regulates temperature-dependent splicing. Embo Journal 40(15): E107976

Bushkin, G.Guy.; Pincus, D.; Morgan, J.T.; Richardson, K.; Lewis, C.; Chan, S.Ham.; Bartel, D.P.; Fink, G.R. 2019: M 6 A modification of a 3' UTR site reduces RME1 mRNA levels to promote meiosis. Nature Communications 10(1): 3414

Lang, C.; Yin, C.; Lin, K.; Li, Y.; Yang, Q.; Wu, Z.; Du, H.; Ren, D.; Dai, Y.; Peng, X. 2021: M6 a modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clinical and Translational Medicine 11(6): E426

Xie, J.-W.; Huang, X.-B.; Chen, Q.-Y.; Ma, Y.-B.; Zhao, Y.-J.; Liu, L.-C.; Wang, J.-B.; Lin, J.-X.; Lu, J.; Cao, L.-L.; Lin, M.; Tu, R.-H.; Zheng, C.-H.; Huang, C.-M.; Li, P. 2020: M6A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling. Molecular Cancer 19(1): 114

Zhang, C.; Chen, Y.; Sun, B.; Wang, L.; Yang, Y.; Ma, D.; Lv, J.; Heng, J.; Ding, Y.; Xue, Y.; Lu, X.; Xiao, W.; Yang, Y-Gui.; Liu, F. 2017: M 6 A modulates haematopoietic stem and progenitor cell specification. Nature 549(7671): 273-276

Lence, T.; Akhtar, J.; Bayer, M.; Schmid, K.; Spindler, L.; Ho, C.Hei.; Kreim, N.; Andrade-Navarro, M.A.; Poeck, B.; Helm, M.; Roignant, J-Yves. 2016: M 6 A modulates neuronal functions and sex determination in Drosophila. Nature 540(7632): 242-247

Haussmann, I.U.; Bodi, Z.; Sanchez-Moran, E.; Mongan, N.P.; Archer, N.; Fray, R.G.; Soller, M. 2016: M 6 A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination. Nature 540(7632): 301-304

Yang, X.; Liu, Q-Lan.; Xu, W.; Zhang, Y-Chang.; Yang, Y.; Ju, L-Fang.; Chen, J.; Chen, Y-Sheng.; Li, K.; Ren, J.; Sun, Q.; Yang, Y-Gui. 2019: M 6 A promotes R-loop formation to facilitate transcription termination. Cell Research 29(12): 1035-1038

Chong, W.; Shang, L.; Liu, J.; Fang, Z.; Du, F.; Wu, H.; Liu, Y.; Wang, Z.; Chen, Y.; Jia, S.; Chen, L.; Li, L.; Chen, H. 2021: M6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer. Theranostics 11(5): 2201-2217

Huang, L.; Liang, H.; Wang, S.; Chen, S. 2021: M6A writer complex promotes timely differentiation and survival of retinal progenitor cells in zebrafish. Biochemical and Biophysical Research Communications 567: 171-176

Fu, Y.; Zhuang, X. 2020: M 6 A-binding YTHDF proteins promote stress granule formation. Nature Chemical Biology 16(9): 955-963

Tang, C.; Xie, Y.; Yu, T.; Liu, N.; Wang, Z.; Woolsey, R.J.; Tang, Y.; Zhang, X.; Qin, W.; Zhang, Y.; Song, G.; Zheng, W.; Wang, J.; Chen, W.; Wei, X.; Xie, Z.; Klukovich, R.; Zheng, H.; Quilici, D.R.; Yan, W. 2020: M 6 A-dependent biogenesis of circular RNAs in male germ cells. Cell Research 30(3): 211-228

Zhao, B.Simen.; Wang, X.; Beadell, A.V.; Lu, Z.; Shi, H.; Kuuspalu, A.; Ho, R.K.; He, C. 2017: M 6 A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition. Nature 542(7642): 475-478

Krüttner, S.; Caroni, P. 2019: M 6 A-epitranscriptome modulates memory strength. Cell Research 29(1): 4-5

Rong, D.; Dong, Q.; Qu, H.; Deng, X.; Gao, F.; Li, Q.; Sun, P. 2021: M 6 A-induced LINC00958 promotes breast cancer tumorigenesis via the miR-378a-3p/YY1 axis. Cell Death Discovery 7(1): 27

Zhang, P.; He, Q.; Lei, Y.; Li, Y.; Wen, X.; Hong, M.; Zhang, J.; Ren, X.; Wang, Y.; Yang, X.; He, Q.; Ma, J.; Liu, N. 2018: M 6 A-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progression. Cell Death and Disease 9(12): 1169

Watabe, E.; Togo-Ohno, M.; Ishigami, Y.; Wani, S.; Hirota, K.; Kimura-Asami, M.; Hasan, S.; Takei, S.; Fukamizu, A.; Suzuki, Y.; Suzuki, T.; Kuroyanagi, H. 2021: M6 A-mediated alternative splicing coupled with nonsense-mediated mRNA decay regulates SAM synthetase homeostasis. Embo Journal 40(14): E106434

Xu, F.; Huang, X.; Li, Y.; Chen, Y.; Lin, L. 2021: M6A-related lnc RNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD. Molecular Therapy. Nucleic Acids 24: 780-791

Wang, H.; Song, X.; Song, C.; Wang, X.; Cao, H. 2021: M6A-seq analysis of micro RNAs reveals that the N6-methyladenosine modification of miR-21-5p affects its target expression. Archives of Biochemistry and Biophysics 711: 109023

Sun, H.; Li, K.; Zhang, X.; Liu, J'e.; Zhang, M.; Meng, H.; Yi, C. 2021: M 6 Am-seq reveals the dynamic m 6 Am methylation in the human transcriptome. Nature Communications 12(1): 4778

Zhou, H.; Kimsey, I.J.; Nikolova, E.N.; Sathyamoorthy, B.; Grazioli, G.; McSally, J.; Bai, T.; Wunderlich, C.H.; Kreutz, C.; Andricioaei, I.; Al-Hashimi, H.M. 2016: M(1)A and m(1)G disrupt A-RNA structure through the intrinsic instability of Hoogsteen base pairs. Nature Structural and Molecular Biology 23(9): 803-810

Yao, F.-Y.; Zhao, C.; Zhong, F.-M.; Qin, T.-Y.; Wen, F.; Li, M.-Y.; Liu, J.; Huang, B.; Wang, X.-Z. 2021: M(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression via miR-766-5p/CDKN1A Axis. Frontiers in Oncology 11: 679634

Patil, D.P.; Chen, C-Kan.; Pickering, B.F.; Chow, A.; Jackson, C.; Guttman, M.; Jaffrey, S.R. 2016: M(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537(7620): 369-373

Molinie, B.; Wang, J.; Lim, K.Seong.; Hillebrand, R.; Lu, Z-Xiang.; Van Wittenberghe, N.; Howard, B.D.; Daneshvar, K.; Mullen, A.C.; Dedon, P.; Xing, Y.; Giallourakis, C.C. 2016: M(6)A-LAIC-seq reveals the census and complexity of the m(6)A epitranscriptome. Nature Methods 13(8): 692-698

Tatsuta, T.; Augustin, S.; Nolden, M.; Friedrichs, Börn.; Langer, T. 2007: M-AAA protease-driven membrane dislocation allows intramembrane cleavage by rhomboid in mitochondria. EMBO Journal 26(2): 325-335

Patron, M.; Sprenger, H-Georg.; Langer, T. 2018: M-AAA proteases, mitochondrial calcium homeostasis and neurodegeneration. Cell Research 28(3): 296-306

Pestereva, N.; Ivleva, I.; Zubov, A.; Tikhomirova, M.; Karpenko, M. 2021: M-Calpainis released from striatal synaptosomes. International Journal of Neuroscience 2021: 1-9

Haim-Vilmovsky, L.; Gerst, J.E. 2009: M-TAG: a PCR-based genomic integration method to visualize the localization of specific endogenous mRNAs in vivo in yeast. Nature Protocols 4(9): 1274-1284

Finsterer, J. 2021: M.3243A>G Maculopathy. Klinische Monatsblatter für Augenheilkunde 238(7): 827

Pullyblank, A.M.; Guillou, P.J.; Monson, J.R. 1994: M17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer. British Journal of Cancer 70(4): 753-758

Pan, J.; Huang, Z.; Xu, Y. 2021: M5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma. Frontiers in Oncology 11: 657466

Huang, M.; Zhang, Y.; Ou, X.; Wang, C.; Wang, X.; Qin, B.; Zhang, Q.; Yu, J.; Zhang, J.; Yu, J. 2021: M5C-Related Signatures for Predicting Prognosis in Cutaneous Melanoma with Machine Learning. Journal of Oncology 2021: 6173206

Pan, J.; Huang, Z.; Xu, Y. 2021: M5C-Related lnc RNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology 9: 671821

Chen, X.; Xiong, Y.; Liu, Y.; Chen, Y.; Bi, S.; Zhu, X. 2020: M5CPred-SVM: a novel method for predicting m5C sites of RNA. Bmc Bioinformatics 21(1): 489

Jiang, J.; Song, B.; Tang, Y.; Chen, K.; Wei, Z.; Meng, J. 2020: M5UPred: a Web Server for the Prediction of RNA 5-Methyluridine Sites from Sequences. Molecular Therapy. Nucleic Acids 22: 742-747

Zhou, W.; Xian, Q.; Wang, Q.; Wu, C.; Yan, H.; Li, X.; Lu, L.; Wu, C.; Zhu, D.; Xu, X.; Wu, J. 2021: M6A Methyltransferase 3 Promotes the Proliferation and Migration of Gastric Cancer Cells through the m6A Modification of YAP1. Journal of Oncology 2021: 8875424

Gao, R.; Ye, M.; Liu, B.; Wei, M.; Ma, D.; Dong, K. 2021: M6A Modification: a Double-Edged Sword in Tumor Development. Frontiers in Oncology 11: 679367

Li, F.; Wang, H.; Huang, H.; Zhang, L.; Wang, D.; Wan, Y. 2020: M6A RNA Methylation Regulators Participate in the Malignant Progression and have Clinical Prognostic Value in Lung Adenocarcinoma. Frontiers in Genetics 11: 994

Karthiya, R.; Khandelia, P. 2020: M6A RNA Methylation: Ramifications for Gene Expression and Human Health. Molecular Biotechnology 62(10): 467-484

Holmes, M.J.; Padgett, L.R.; Bastos, M.S.; Sullivan, W.J. 2021: M6A RNA methylation facilitates pre-mRNA 3'-end formation and is essential for viability of Toxoplasma gondii. Plos Pathogens 17(7): E1009335

Paramasivam, A.; Priyadharsini, J.Vijayashree. 2021: M6A RNA methylation in heart development, regeneration and disease. Hypertension Research: Official Journal of the Japanese Society of Hypertension 2021

Cong, R.; Ji, C.; Zhang, J.; Zhang, Q.; Zhou, X.; Yao, L.; Luan, J.; Meng, X.; Song, N. 2021: M6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Translational Andrology and Urology 10(2): 662-679

Zhang, C.; Liu, J.; Guo, H.; Hong, D.; Ji, J.; Zhang, Q.; Guan, Q.; Ren, Q. 2021: M6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer. Bioengineered 12(1): 3159-3176

Zhou, T.; Li, S.; Xiang, D.; Liu, J.; Sun, W.; Cui, X.; Ning, B.; Li, X.; Cheng, Z.; Jiang, W.; Zhang, C.; Liang, X.; Li, L.; Cheng, X.; Hui, L.; Wang, H.; Ding, J. 2020: M6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance. Signal Transduction and Targeted Therapy 5(1): 296

Li, J.; Wang, W.; Zhou, Y.; Liu, L.; Zhang, G.; Guan, K.; Cui, X.; Liu, X.; Huang, M.; Cui, G.; Sun, R. 2021: M6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma. Frontiers in Cell and Developmental Biology 9: 687756

Zhao, H.; Xu, Y.; Xie, Y.; Zhang, L.; Gao, M.; Li, S.; Wang, F. 2021: M6A Regulators Is Differently Expressed and Correlated with Immune Response of Esophageal Cancer. Frontiers in Cell and Developmental Biology 9: 650023

Wang, Y.; Li, M.; Zhang, L.; Chen, Y.; Zhang, S. 2021: M6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer. Molecular Therapy Oncolytics 21: 367-376

Zeng, J.; Zhang, H.; Tan, Y.; Wang, Z.; Li, Y.; Yang, X. 2021: M6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling. Molecular Therapy. Nucleic Acids 25: 277-292

Balzarolo, M.; Engels, S.; de Jong, A.J.; Franke, K.; van den Berg, T.K.; Gulen, M.F.; Ablasser, A.; Janssen, E.M.; van Steensel, B.; Wolkers, M.C. 2021: M6A methylation potentiates cytosolic dsDNA recognition in a sequence-specific manner. Open Biology 11(3): 210030

Xu, J.; Chen, Q.; Tian, K.; Liang, R.; Chen, T.; Gong, A.; Mathy, N.W.; Yu, T.; Chen, X. 2020: M6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation. Oncology Reports 44(3): 973-986

Zhang, Y.; Geng, X.; Li, Q.; Xu, J.; Tan, Y.; Xiao, M.; Song, J.; Liu, F.; Fang, C.; Wang, H. 2020: M6A modification in RNA: biogenesis, functions and roles in gliomas. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 192

Rong, D.; Wu, F.; Lu, C.; Sun, G.; Shi, X.; Chen, X.; Dai, Y.; Zhong, W.; Hao, X.; Zhou, J.; Xia, Y.; Tang, W.; Wang, X. 2021: M6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression. Molecular Therapy. Nucleic Acids 26: 637-648

Qian, B.; Wang, P.; Zhang, D.; Wu, L. 2021: M6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2. Cell Death Discovery 7(1): 157

Zhang, W.; Wang, L.; Zhang, P.; Zhang, Q. 2021: M6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases. Medicine 100(20): E25952

Wu, J.; Pang, R.; Li, M.; Chen, B.; Huang, J.; Zhu, Y. 2021: M6A-Induced LncRNA MEG3 Suppresses the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cell Through miR-544b/BTG2 Signaling. Oncotargets and Therapy 14: 3745-3755

Li, Z.; Li, Y.; Zhong, W.; Huang, P. 2021: M6A-Related lncRNA to Develop Prognostic Signature and Predict the Immune Landscape in Bladder Cancer. Journal of Oncology 2021: 7488188

Huang, S.; Lyu, S.; Gao, Z.; Zha, W.; Wang, P.; Shan, Y.; He, J.; Li, Y. 2021: M6A-Related lnc RNAs Are Potential Biomarkers for the Prognosis of Metastatic Skin Cutaneous Melanoma. Frontiers in Molecular Biosciences 8: 687760

Hao, L.; Wang, J.-M.; Liu, B.-Q.; Yan, J.; Li, C.; Jiang, J.-Y.; Zhao, F.-Y.; Qiao, H.-Y.; Wang, H.-Q. 2021: M6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells. Biochimica et Biophysica Acta. Molecular Cell Research 1868(1): 118878

Wang, Y.; Guo, R.; Huang, L.; Yang, S.; Hu, X.; He, K. 2021: M6AGE: a Predictor for N6-Methyladenosine Sites Identification Utilizing Sequence Characteristics and Graph Embedding-Based Geometrical Information. Frontiers in Genetics 12: 670852

Zou, H.; Yin, Z. 2021: M7G-DPP: Identifying N7-methylguanosine sites based on dinucleotide physicochemical properties of RNA. Biophysical Chemistry 279: 106697

Liu, X.; Liu, Z.; Mao, X.; Li, Q. 2020: M7GPredictor: An improved machine learning-based model for predicting internal m7G modifications using sequence properties. Analytical Biochemistry 609: 113905

Yang, F.; Zou, Q. 2020: MAML: an automated machine learning pipeline with a microbiome repository for human disease classification. Database: the Journal of Biological Databases and Curation 2020

Herr, I.; Posovsky, C.; Böhler, T.; Debatin, K.M. 2000: MAb33 from transduction laboratories specifically binds human CD95-L. Cell Death and Differentiation 7(1): 129-130

Fei, Z.; Hu, S.; Xiao, L.; Zhou, J.; Diao, H.; Yu, H.; Fang, S.; Wang, Y.; Wan, Y.; Wang, W.; He, Y.; Wang, C.; Xu, G.; Wang, Z.; Zhang, Y.; Fei, J. 2012: MBin1b transgenic mice show enhanced resistance to epididymal infection by bacteria challenge. Genes and Immunity 13(6): 445-451

Jo, Y.; LeFevre, A.E.; Ali, H.; Mehra, S.; Alland, K.; Shaikh, S.; Haque, R.; Pak, E.S.; Chowdhury, M.; Labrique, A.B. 2021: MCARE, a digital health intervention package on pregnancy surveillance and care-seeking reminders from 2018 to 2027 in Bangladesh: a model-based cost-effectiveness analysis. Bmj Open 11(4): E042553

Killock, D. 2019: MCRC: sequencing in REVERCE. Nature Reviews. Clinical Oncology 16(2): 67

Pires, D.E.V.; Blundell, T.L.; Ascher, D.B. 2016: MCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance. Scientific Reports 6: 29575

Pires, D.E.V.; Rodrigues, C.H.M.; Ascher, D.B. 2020: MCSM-membrane: predicting the effects of mutations on transmembrane proteins. Nucleic Acids Research 48(W1): W147-W153

Pena, M.M.ça.; Teper, D.; Ferreira, H.; Wang, N.; Sato, K.U.; Ferro, M.I.ês.T.; Ferro, J.A. 2020: MCherry fusions enable the subcellular localization of periplasmic and cytoplasmic proteins in Xanthomonas sp. Plos one 15(7): E0236185

Lehner, K.M.; Stella, N.A.; Calvario, R.C.; Shanks, R.M.Q. 2020: MCloverBlaster: a tool to make markerless deletions and fusions using lambda red and I-Scei in Gram-negative bacterial genomes. Journal of Microbiological Methods 178: 106058

Choksi, K.; Nagaraj, S.; Thielke, R.; Lin, S. 2020: MDB: Monitoring Dysfunctional Behaviors for Patients with Bipolar Disorder. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2020: 5635-5639

Romero, D. 2015: MDCF--new standard-of-care?. Nature Reviews. Clinical Oncology 12(12): 686

Haas, M.S.; Kagey, M.H.; Heath, H.; Schuerpf, F.; Rottman, J.B.; Newman, W. 2021: MDKN-01, a Novel Anti-DKK1 mAb, Enhances Innate Immune Responses in the Tumor Microenvironment. Molecular Cancer Research: Mcr 19(4): 717-725

Xiao, J.; Fiscella, K.A.; Meyerowitz, C. 2021: MDentistry: a powerful tool to improve oral health of a broad population in the digital era. Journal of the American Dental Association 152(9): 713-716

Palazzo, A.F.; Cook, T.A.; Alberts, A.S.; Gundersen, G.G. 2001: MDia mediates Rho-regulated formation and orientation of stable microtubules. Nature Cell Biology 3(8): 723-729

Yu, M.; Yuan, X.; Lu, C.; Le, S.; Kawamura, R.; Efremov, A.K.; Zhao, Z.; Kozlov, M.M.; Sheetz, M.; Bershadsky, A.; Yan, J. 2017: MDia1 senses both force and torque during F-actin filament polymerization. Nature Communications 8(1): 1650

Fu, Z.; Peng, D.; Zhang, M.; Xue, F.; Zhang, R.; He, W.; Xu, T.; Xu, P. 2020: MEosEM withstands osmium staining and Epon embedding for super-resolution CLEM. Nature Methods 17(1): 55-58

Kim, J.; Zhao, T.; Petralia, R.S.; Yu, Y.; Peng, H.; Myers, E.; Magee, J.C. 2011: MGRASP enables mapping mammalian synaptic connectivity with light microscopy. Nature Methods 9(1): 96-102

Yang, S.; Wang, Y.-L.; Lyu, Y.; Jiang, Y.; Xiang, J.; Ji, S.; Kang, S.; Lyu, X.; He, C.; Li, P.; Liu, B.; Wu, C. 2021: MGWAS identification of six novel single nucleotide polymorphism loci with strong correlation to gastric cancer. Cancer and Metabolism 9(1): 34

Montemayor, D.; Sharma, K. 2020: MGWAS: next generation genetic prediction in kidney disease. Nature Reviews. Nephrology 16(5): 255-256

Turner, B.D.; Rook, J.M.; Lindsley, C.W.; Conn, P.Jeffrey.; Grueter, B.A. 2018: MGlu 1 and mGlu 5 modulate distinct excitatory inputs to the nucleus accumbens shell. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 43(10): 2075-2082

Mazzitelli, M.; Neugebauer, V. 2021: MGlu3 Metabotropic Glutamate Receptors-New Hope for Pharmacotherapy of Schizophrenia. Biological Psychiatry 90(6): 356-358

Chaki, S. 2020: MGlu2/3 receptor as a novel target for rapid acting antidepressants. Advances in Pharmacology 89: 289-309

Jing, X.-Y.; Wang, Y.; Zou, H.-W.; Li, Z.-L.; Liu, Y.-J.; Li, L.-F. 2021: MGlu2/3 receptor in the prelimbic cortex is implicated in stress resilience and vulnerability in mice. European Journal of Pharmacology 906: 174231

Zinni, M.; Mairesse, J.ér.ôm.; Pansiot, J.; Fazio, F.; Iacovelli, L.; Antenucci, N.; Orlando, R.; Nicoletti, F.; Vaiman, D.; Baud, O. 2021: MGlu3 receptor regulates microglial cell reactivity in neonatal rats. Journal of Neuroinflammation 18(1): 13

Murray, C.H.; Christian, D.T.; Milovanovic, M.; Loweth, J.A.; Hwang, E.-K.; Caccamise, A.J.; Funke, J.R.; Wolf, M.E. 2021: MGlu5 function in the nucleus accumbens core during the incubation of methamphetamine craving. Neuropharmacology 186: 108452

Cox, S.M.L.; Tippler, M.; Jaworska, N.; Smart, K.; Castellanos-Ryan, N.; Durand, F.; Allard, D.; Benkelfat, C.; Parent, S.; Dagher, A.; Vitaro, F.; Boivin, M.; Pihl, R.O.; Côté, S.; Tremblay, R.E.; Séguin, J.R.; Leyton, M. 2020: MGlu5 receptor availability in youth at risk for addictions: effects of vulnerability traits and cannabis use. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 45(11): 1817-1825

Hu, N-Wei.; Nicoll, A.J.; Zhang, D.; Mably, A.J.; O'Malley, T.; Purro, S.A.; Terry, C.; Collinge, J.; Walsh, D.M.; Rowan, M.J. 2014: MGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo. Nature Communications 5: 3374

Loriol, Céline.; Cassé, Fédéric.; Khayachi, A.; Poupon, Génola.; Chafai, M.; Deval, E.; Gwizdek, C.; Martin, Séphane. 2014: MGlu5 receptors regulate synaptic sumoylation via a transient PKC-dependent diffusional trapping of Ubc9 into spines. Nature Communications 5: 5113

Cartmell, J.; Schaffhauser, H.; Wichmann, J.; Mutel, V. 1997: MGluR-evoked augmentation of receptor-mediated cyclic AMP formation in neonatal and adult rat striatum. British Journal of Pharmacology 121(7): 1263-1268

Nakao, H.; Kishimoto, Y.; Hashimoto, K.; Kitamura, K.; Yamasaki, M.; Nakao, K.; Watanabe, M.; Kano, M.; Kirino, Y.; Aiba, A. 2019: MGluR1 in cerebellar Purkinje cells is essential for the formation but not expression of associative eyeblink memory. Scientific Reports 9(1): 7353

Yamasaki, M.; Aiba, A.; Kano, M.; Watanabe, M. 2021: MGluR1 signaling in cerebellar Purkinje cells: Subcellular organization and involvement in cerebellar function and disease. Neuropharmacology 194: 108629

Barrett, J.E. 2010: MGluR2-Positive allosteric modulators: Therapeutic potential for treating cocaine abuse?. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 35(10): 2007-2008

Kim, J.; An, B.; Kim, J.; Park, S.; Park, S.; Hong, I.; Lee, S.; Park, K.; Choi, S. 2015: MGluR2/3 in the Lateral Amygdala is Required for Fear Extinction: Cortical Input Synapses onto the Lateral Amygdala as a Target Site of the mGluR2/3 Action. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 40(13): 2916-2928

Jin, L.E.; Wang, M.; Yang, S-T.; Yang, Y.; Galvin, V.C.; Lightbourne, T.C.; Ottenheimer, D.; Zhong, Q.; Stein, J.; Raja, A.; Paspalas, C.D.; Arnsten, A.F.T. 2017: MGluR2/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions. Molecular Psychiatry 22(11): 1615-1625

Kelly, E.; Schaeffer, S.M.; Dhamne, S.C.; Lipton, J.O.; Lindemann, L.; Honer, M.; Jaeschke, G.; Super, C.E.; Lammers, S.Ht.; Modi, M.E.; Silverman, J.L.; Dreier, J.R.; Kwiatkowski, D.J.; Rotenberg, A.; Sahin, M. 2018: MGluR5 Modulation of Behavioral and Epileptic Phenotypes in a Mouse Model of Tuberous Sclerosis Complex. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 43(6): 1457-1465

Stoppel, D.C.; McCamphill, P.K.; Senter, R.K.; Heynen, A.J.; Bear, M.F. 2021: MGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence. Frontiers in Psychiatry 12: 718953

Li, X.; Peng, X-Qing.; Jordan, C.J.; Li, J.; Bi, G-Hua.; He, Y.; Yang, H-Ju.; Zhang, H-Ying.; Gardner, E.L.; Xi, Z-Xiong. 2018: MGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism. Scientific Reports 8(1): 3686

Bäckström, P.; Bachteler, D.; Koch, S.; Hyytiä, P.; Spanagel, R. 2004: MGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 29(5): 921-928

Wang, H-Yan.; MacDonald, M.L.; Borgmann-Winter, K.E.; Banerjee, A.; Sleiman, P.; Tom, A.; Khan, A.; Lee, K-Chieh.; Roussos, P.; Siegel, S.J.; Hemby, S.E.; Bilker, W.B.; Gur, R.E.; Hahn, C-Gyu. 2020: MGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia. Molecular Psychiatry 25(4): 750-760

Shin, S.; Kwon, O.; Kang, J.In.; Kwon, S.; Oh, S.; Choi, J.; Kim, C.Hoon.; Kim, D.Goo. 2015: MGluR5 in the nucleus accumbens is critical for promoting resilience to chronic stress. Nature Neuroscience 18(7): 1017-1024

Wang, Y.; He, W.; Zhang, H.; Yao, Z.; Che, F.; Cao, Y.; Sun, H. 2020: MGluR5 mediates ketamine antidepressant response in susceptible rats exposed to prenatal stress. Journal of Affective Disorders 272: 398-408

Feng, L.Rebekah.; Fernández-Martínez, J.Luis.; Zaal, K.J.M.; deAndrés-Galiana, E.J.; Wolff, B.S.; Saligan, L.N. 2018: MGluR5 mediates post-radiotherapy fatigue development in cancer patients. Translational Psychiatry 8(1): 110

Ayala, J.E.; Chen, Y.; Banko, J.L.; Sheffler, D.J.; Williams, R.; Telk, A.N.; Watson, N.L.; Xiang, Z.; Zhang, Y.; Jones, P.J.; Lindsley, C.W.; Olive, M.Foster.; Conn, P.Jeffrey. 2009: MGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 34(9): 2057-2071

De Souza, J.és.M.; Abd-Elrahman, K.S.; Ribeiro, F.M.; Ferguson, S.S.G. 2020: MGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease. Molecular Brain 13(1): 118

Fendt, M.; Schmid, S.; Thakker, D.R.; Jacobson, L.H.; Yamamoto, R.; Mitsukawa, K.; Maier, R.; Natt, F.; Hüsken, D.; Kelly, P.H.; McAllister, K.H.; Hoyer, D.; van der Putten, H.; Cryan, J.F.; Flor, P.J. 2008: MGluR7 facilitates extinction of aversive memories and controls amygdala plasticity. Molecular Psychiatry 13(10): 970-979

Gosnell, H.B.; Silberman, Y.; Grueter, B.A.; Duvoisin, R.M.; Raber, J.; Winder, D.G. 2011: MGluR8 modulates excitatory transmission in the bed nucleus of the stria terminalis in a stress-dependent manner. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 36(8): 1599-1607

Campbell, B.C.; Nabel, E.M.; Murdock, M.H.; Lao-Peregrin, C.; Tsoulfas, P.; Blackmore, M.G.; Lee, F.S.; Liston, C.; Morishita, H.; Petsko, G.A. 2020: MGreenLantern: a bright monomeric fluorescent protein with rapid expression and cell filling properties for neuronal imaging. Proceedings of the National Academy of Sciences of the United States of America 117(48): 30710-30721

Moore, C.; Scherr, T.; Matoba, J.; Sing'anga, C.; Lubinda, M.; Thuma, P.; Wright, D. 2021: MHAT app for automated malaria rapid test result analysis and aggregation: a pilot study. Malaria Journal 20(1): 237

Bismarck, E.; Hammerer, P.; Merseburger, A.S.; Schrader, A.J. 2020: MHSPC-Therapie mit Apalutamid/ADT. Oncology Research and Treatment 43(Suppl 2): 6-12

Byambasuren, O.; Beller, E.; Hoffmann, T.; Glasziou, P. 2020: MHealth App Prescription in Australian General Practice: Pre-Post Study. Jmir Mhealth and Uhealth 8(6): E16497

McLean, A. 2020: MHealth Apps as Effective Persuasive Health Technology: Contextualizing the "Necessary" Functionalities. Jmir Nursing 3(1): E19302

Bai, M.Y.; Mobbs, R.J.; Walsh, W.R.; Betteridge, C. 2020: MHealth Apps for Enhanced Management of Spinal Surgery Patients: a Review. Frontiers in Surgery 7: 573398

Sheppard, M.K. 2020: MHealth Apps: Disruptive Innovation, Regulation, and Trust-A Need for Balance. Medical Law Review 28(3): 549-572

Burns, S.P.; Terblanche, M.; Perea, J.; Lillard, H.; DeLaPena, C.; Grinage, N.; MacKinen, A.; Cox, E.E. 2021: MHealth Intervention Applications for Adults Living with the Effects of Stroke: a Scoping Review. Archives of Rehabilitation Research and Clinical Translation 3(1): 100095

Yu, S.; Duan, Z.; Redmon, P.B.; Eriksen, M.P.; Koplan, J.P.; Huang, C. 2017: MHealth Intervention is Effective in Creating Smoke-Free Homes for Newborns: A Randomized Controlled Trial Study in China. Scientific Reports 7(1): 9276

Bae, J.-W.; Woo, S.-I.; Lee, J.; Park, S.-D.; Kwon, S.W.; Choi, S.H.; Yoon, G.-S.; Kim, M.-S.; Hwang, S.-S.; Lee, W.K. 2021: MHealth Interventions for Lifestyle and Risk Factor Modification in Coronary Heart Disease: Randomized Controlled Trial. Jmir Mhealth and Uhealth 9(9): E29928

Cliffe, B.; Tingley, J.; Greenhalgh, I.; Stallard, P. 2021: MHealth Interventions for Self-Harm: Scoping Review. Journal of Medical Internet Research 23(4): E25140

Odukoya, O.O.; Ohazurike, C.; Akanbi, M.; O'Dwyer, L.C.; Isikekpei, B.; Kuteyi, E.; Ameh, I.O.; Osadiaye, O.; Adebayo, K.; Usinoma, A.; Adewole, A.; Odunukwe, N.; Okuyemi, K.; Kengne, A.P. 2021: MHealth Interventions for Treatment Adherence and Outcomes of Care for Cardiometabolic Disease Among Adults Living with HIV: Systematic Review. Jmir Mhealth and Uhealth 9(6): E20330

Lee, S.B.; Valerius, J. 2020: MHealth Interventions to Promote Anti-Retroviral Adherence in HIV: Narrative Review. Jmir Mhealth and Uhealth 8(8): E14739

Magee, M.R.; McNeilage, A.G.; Avery, N.; Glare, P.; Ashton-James, C.E. 2021: MHealth Interventions to Support Prescription Opioid Tapering in Patients with Chronic Pain: Qualitative Study of Patients' Perspectives. Jmir Formative Research 5(5): E25969

Larkin, C.; Wijesundara, J.; Nguyen, H.L.; Ha, D.A.; Vuong, A.; Nguyen, C.K.; Amante, D.; Ngo, C.Q.; Phan, P.T.; Pham, Q.T.L.; Nguyen, B.N.; Nguyen, A.T.P.; Nguyen, P.T.T.; Person, S.; Allison, J.J.; Houston, T.K.; Sadasivam, R. 2021: MHealth Messaging to Motivate Quitline use and Quitting: Protocol for a Community-Based Randomized Controlled Trial in Rural Vietnam. Jmir Research Protocols 10(10): E30947

Kubo, A.; Aghaee, S.; Kurtovich, E.M.; Nkemere, L.; Quesenberry, C.P.; McGinnis, M.K.; Avalos, L.A. 2021: MHealth Mindfulness Intervention for Women with Moderate-to-Moderately-Severe Antenatal Depressive Symptoms: a Pilot Study Within an Integrated Health Care System. Mindfulness 12(6): 1387-1397

Cajita, M.I.; Zheng, Y.; Kariuki, J.K.; Vuckovic, K.M.; Burke, L.E. 2021: MHealth Technology and CVD Risk Reduction. Current Atherosclerosis Reports 23(7): 36

Kvedar, J.C.; Fogel, A.L. 2017: MHealth advances clinical research, bit by bit. Nature Biotechnology 35(4): 337-339

Kalampalikis, A.; Chatziioannou, S.S.; Protopapas, A.; Gerakini, A.M.; Michala, L. 2021: MHealth and its application in menstrual related issues: a systematic review. European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 2021: 1-8

Erb, M.Kelley.; Karlin, D.R.; Ho, B.K.; Thomas, K.C.; Parisi, F.; Vergara-Diaz, G.P.; Daneault, J-Francois.; Wacnik, P.W.; Zhang, H.; Kangarloo, T.; Demanuele, C.; Brooks, C.R.; Detheridge, C.N.; Shaafi Kabiri, N.; Bhangu, J.S.; Bonato, P. 2020: MHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson's disease. Npj Digital Medicine 3: 6

Erb, M.Kelley.; Karlin, D.R.; Ho, B.K.; Thomas, K.C.; Parisi, F.; Vergara-Diaz, G.P.; Daneault, J-Francois.; Wacnik, P.W.; Zhang, H.; Kangarloo, T.; Demanuele, C.; Brooks, C.R.; Detheridge, C.N.; Shaafi Kabiri, N.; Bhangu, J.S.; Bonato, P. 2020: MHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson's disease. Npj Digital Medicine 3(1): 6

Aguilera, A.; Figueroa, C.A.; Hernandez-Ramos, R.; Sarkar, U.; Cemballi, A.; Gomez-Pathak, L.; Miramontes, J.; Yom-Tov, E.; Chakraborty, B.; Yan, X.; Xu, J.; Modiri, A.; Aggarwal, J.; Jay Williams, J.; Lyles, C.R. 2020: MHealth app using machine learning to increase physical activity in diabetes and depression: clinical trial protocol for the DIAMANTE Study. Bmj Open 10(8): E034723

Tian, M.; Zhang, X.; Zhang, J. 2020: MHealth as a health system strengthening tool in China. International Journal of Nursing Sciences 7(Suppl 1): S19-S22

Du Toit, M.N.; van der Linde, J.; Swanepoel, D.W. 2021: MHealth developmental screening for preschool children in low-income communities. Journal of Child Health Care: for Professionals Working with Children in the Hospital and Community 25(4): 573-586

Allida, S.; Du, H.; Xu, X.; Prichard, R.; Chang, S.; Hickman, L.D.; Davidson, P.M.; Inglis, S.C. 2020: MHealth education interventions in heart failure. Cochrane Database of Systematic Reviews 7: Cd011845

Godinho, M.A.; Jonnagaddala, J.; Gudi, N.; Islam, R.; Narasimhan, P.; Liaw, S.-T. 2020: MHealth for Integrated People-Centred Health Services in the Western Pacific: a Systematic Review. International Journal of Medical Informatics 142: 104259

Blom, L. 2020: MHealth for image-based diagnostics of acute burns in resource-poor settings: studies on the role of experts and the accuracy of their assessments. Global Health Action 13(1): 1802951

Richardson, P.A.; Harrison, L.E.; Heathcote, L.C.; Rush, G.; Shear, D.; Lalloo, C.; Hood, K.; Wicksell, R.K.; Stinson, J.; Simons, L.E. 2020: MHealth for pediatric chronic pain: state of the art and future directions. Expert Review of Neurotherapeutics 20(11): 1177-1187

Weitzman, P.F.; Zhou, Y.; Kogelman, L.; Rodarte, S.; Vicente, S.R.; Levkoff, S.E. 2021: MHealth for pre-exposure prophylaxis adherence by young adult men who have sex with men. Mhealth 7: 44

Chivilgina, O.; Wangmo, T.; Elger, B.S.; Heinrich, T.; Jotterand, F. 2020: MHealth for schizophrenia spectrum disorders management: a systematic review. International Journal of Social Psychiatry 66(7): 642-665

Turnbull, M.L.; Jin, Y.; Yau, A.H.Y.; Lai, M.S.Y.; Cheung, M.Y.C.; Kwan, W.Yau.W.; Watson, B.M. 2021: MHealth in hyper-connected Hong Kong: examining attitudes and access to mobile devices and health information among older Chinese residents. Mhealth 7: 43

Bendtsen, M.; Seiterö, A.; Bendtsen, P.; Henriksson, H.; Henriksson, P.; Thomas, K.; Löf, M.; Müssener, U. 2021: MHealth intervention for multiple lifestyle behaviour change among high school students in Sweden (LIFE4YOUth): protocol for a randomised controlled trial. Bmc Public Health 21(1): 1406

Kruse, G.R. 2019: MHealth solutions for engaging smokers unmotivated to quit. LANCET. Digital Health 1(4): E153-E154

Park, S.M.; Visbal-Onufrak, M.A.; Haque, M.M.; Were, M.C.; Naanyu, V.; Hasan, M.K.; Kim, Y.L. 2020: MHealth spectroscopy of blood hemoglobin with spectral super-resolution. Optica 7(6): 563-573

Torriani-Pasin, C.; Demers, M.; Polese, J.C.; Bishop, L.; Wade, E.; Hempel, S.; Winstein, C. 2021: MHealth technologies used to capture walking and arm use behavior in adult stroke survivors: a scoping review beyond measurement properties. Disability and Rehabilitation 2021: 1-13

Mulawa, M.I.; Rosengren, A.L.; Amico, K.R.; Hightow-Weidman, L.B.; Muessig, K.E. 2021: MHealth to reduce HIV-related stigma among youth in the United States: a scoping review. Mhealth 7: 35

Buck, B.; Hallgren, K.A.; Campbell, A.T.; Choudhury, T.; Kane, J.M.; Ben-Zeev, D. 2021: MHealth-Assisted Detection of Precursors to Relapse in Schizophrenia. Frontiers in Psychiatry 12: 642200

Desrosiers, A.; Schafer, C.; Esliker, R.; Jambai, M.; Betancourt, T. 2021: MHealth-Supported Delivery of an Evidence-Based Family Home-Visiting Intervention in Sierra Leone: Protocol for a Pilot Randomized Controlled Trial. Jmir Research Protocols 10(2): E25443

Brys, A.D.H.; Stifft, F.; Van Heugten, C.M.; Bossola, M.; Gambaro, G.; Lenaert, B. 2021: MHealth-based experience sampling method to identify fatigue in the context of daily life in haemodialysis patients. Clinical Kidney Journal 14(1): 245-254

Fernandez-Luque, L. 2021: MHealth-based person-centredness: a key tool for the development of participatory health. International Journal for Quality in Health Care: Journal of the International Society for Quality in Health Care 33(1)

Bradway, M.; Woldaregay, A.Z.; Issom, D.-Z.; Pfuhl, G.; Hartvigsen, G.; Årsand, E.; Henriksen, A.é 2021: MHealth: Where Is the Potential for Aiding Informal Caregivers?. Studies in Health Technology and Informatics 281: 885-890

De Aguiar Vallim, T.Q.; Tarling, E.J. 2021: MInd the gAP: Intestinal Alkaline Phosphatase Puts the Breaks on Atherosclerosis. Circulation Research 128(11): 1660-1662

Kohno, H.; Kubo, T. 2018: MKast is dispensable for normal development and sexual maturation of the male European honeybee. Scientific Reports 8(1): 11877

Duval, K.E.A.; Petryk, J.D.; Crary-Burney, M.A.; Demidenko, E.; Wagner, R.J.; Hoopes, P.Jack. 2020: MNP hyperthermia and hypofractionated radiation activate similar immunogenetic and cytotoxic pathways. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 37(1): 929-937

Yamada, M.; Toba, S.; Takitoh, T.; Yoshida, Y.; Mori, D.; Nakamura, T.; Iwane, A.H.; Yanagida, T.; Imai, H.; Yu-Lee, L-Yuan.; Schroer, T.; Wynshaw-Boris, A.; Hirotsune, S. 2010: MNUDC is required for plus-end-directed transport of cytoplasmic dynein and dynactins by kinesin-1. EMBO Journal 29(3): 517-531

Acehan, S.; Gulen, M.; Isıkber, C.; Unlu, N.; Sumbul, H.ıl.ı E.; Gulumsek, E.; Satar, S. 2021: MNUTRIC tool is capable to predict nutritional needs and mortality early in patients suffering from severe pneumonia. Clinical Nutrition Espen 45: 184-191

Kharbanda, O.P.; Priya, H.; Bhadauria, U.S.; Khurana, C.; Das, D. 2019: MOral Health in India: Current Scenario and Future Perspectives. Contemporary Clinical Dentistry 10(4): 586-589

Loop, S.; Katzer, M.; Pieler, T. 2005: MPER1-mediated nuclear export of mCRY1/2 is an important element in establishing circadian rhythm. Embo Reports 6(4): 341-347

Xu, H.; Wang, J.; Jing, H.; Ellenbroek, B.; Shao, F.; Wang, W. 2021: MPFC GABAergic transmission mediated the role of BDNF signaling in cognitive impairment but not anxiety induced by adolescent social stress. Neuropharmacology 184: 108412

Siljehav, V.; Olsson Hofstetter, A.; Jakobsson, P-Johan.; Herlenius, E. 2012: MPGES-1 and prostaglandin E2: vital role in inflammation, hypoxic response, and survival. Pediatric Research 72(5): 460-467

Li, Y.; Chen, J.; Yang, W.; Liu, H.; Wang, J.; Xiao, J.; Xie, S.; Ma, L.; Nie, D. 2020: MPGES-1/PGE2 promotes the growth of T-ALL cells in vitro and in vivo by regulating the expression of MTDH via the EP3/cAMP/PKA/CREB pathway. Cell Death and Disease 11(4): 221

Zhou, Y.; Chen, H.; Li, S.; Chen, M. 2021: MPPI: a database extension to visualize structural interactome in a one-to-many manner. Database: the Journal of Biological Databases and Curation 2021

NavaneethaKrishnan, S.; Rosales, J.L.; Lee, K-Young. 2020: MPTP opening caused by Cdk5 loss is due to increased mitochondrial Ca 2+ uptake. Oncogene 39(13): 2797-2806

Ngoma, M.; Mushi, B.; Morse, R.S.; Ngoma, T.; Mahuna, H.; Lambden, K.; Quinn, E.; Sagan, S.B.; Ho, Y.X.; Lucas, F.L.; Mmari, J.; Miesfeldt, S. 2021: MPalliative Care Link: Examination of a Mobile Solution to Palliative Care Coordination Among Tanzanian Patients with Cancer. Jco Global Oncology 7: 1306-1315

Le Kim, T.; Le Sy, V. 2020: MPartition: a Model-Based Method for Partitioning Alignments. Journal of Molecular Evolution 88(8-9): 641-652

Pendergast, J.S.; Wendroth, R.H.; Stenner, R.C.; Keil, C.D.; Yamazaki, S. 2017: MPeriod2 Brdm1 and other single Period mutant mice have normal food anticipatory activity. Scientific Reports 7(1): 15510

Sans, N.; Wang, P.Y.; Du, Q.; Petralia, R.S.; Wang, Y-Xian.; Nakka, S.; Blumer, J.B.; Macara, I.G.; Wenthold, R.J. 2005: MPins modulates PSD-95 and SAP102 trafficking and influences NMDA receptor surface expression. Nature Cell Biology 7(12): 1179-1190

Reiter, L.; Rinner, O.; Picotti, P.; Hüttenhain, R.; Beck, M.; Brusniak, M-Youn.; Hengartner, M.O.; Aebersold, R. 2011: MProphet: automated data processing and statistical validation for large-scale SRM experiments. Nature Methods 8(5): 430-435

Wen, H.; Sobolev, M.; Vitale, R.; Kizer, J.; Pollak, J.P.; Muench, F.; Estrin, D. 2021: MPulse Mobile Sensing Model for Passive Detection of Impulsive Behavior: Exploratory Prediction Study. Jmir Mental Health 8(1): E25019

Chen, L.; Wilson, K.; Goldlust, I.; Mott, B.T.; Eastman, R.; Davis, M.I.; Zhang, X.; McKnight, C.; Klumpp-Thomas, C.; Shinn, P.; Simmons, J.; Gormally, M.; Michael, S.; Thomas, C.J.; Ferrer, M.; Guha, R. 2016: MQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening. Scientific Reports 6: 37741

Dong, C.; Rao, N.; Du, W.; Gao, F.; Lv, X.; Wang, G.; Zhang, J. 2021: MRBioM: An Algorithm for the Identification of Potential mRNA Biomarkers from Complete Transcriptomic Profiles of Gastric Adenocarcinoma. Frontiers in Genetics 12: 679612

Api, A.M.; Belsito, D.; Botelho, D.; Bruze, M.; Burton, G.A.; Buschmann, J.; Cancellieri, M.A.; Dagli, M.L.; Date, M.; Dekant, W.; Deodhar, C.; Fryer, A.D.; Jones, L.; Joshi, K.; Kumar, M.; Lapczynski, A.; Lavelle, M.; Lee, I.; Liebler, D.C.; Moustakas, H.; Na, M.; Penning, T.M.; Ritacco, G.; Romine, J.; Sadekar, N.; Schultz, T.W.; Selechnik, D.; Siddiqi, F.; Sipes, I.G.; Sullivan, G.; Thakkar, Y.; Tokura, Y. 2021: RIFM fragrance ingredient safety assessment, 4-t-amylcyclohexanone, CAS Registry Number 16587-71-6. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 156(Suppl 1): 112560

Feng, H.; Zhang, X.; Zhang, C. 2015: MRIN for direct assessment of genome-wide and gene-specific mRNA integrity from large-scale RNA-sequencing data. Nature Communications 6: 7816

Morgan, M.; Much, C.; DiGiacomo, M.; Azzi, C.; Ivanova, I.; Vitsios, D.M.; Pistolic, J.; Collier, P.; Moreira, P.N.; Benes, V.; Enright, A.J.; O'Carroll, Dónal. 2017: MRNA 3' uridylation and poly(A) tail length sculpt the mammalian maternal transcriptome. Nature 548(7667): 347-351

Chang, J-Woong.; Zhang, W.; Yeh, H-Sung.; de Jong, E.P.; Jun, S.; Kim, K-Hyun.; Bae, S.S.; Beckman, K.; Hwang, T.Hyun.; Kim, K-Seong.; Kim, D-Hyung.; Griffin, T.J.; Kuang, R.; Yong, J. 2015: MRNA 3'-UTR shortening is a molecular signature of mTORC1 activation. Nature Communications 6: 7218

Miskulin, D.C.; Combe, C. 2021: MRNA COVID-19 Vaccine for people with Kidney Failure: Hope but Prudence Warranted. Clinical Journal of the American Society of Nephrology: Cjasn 16(7): 996-998

Riley, L.E. 2021: MRNA Covid-19 Vaccines in Pregnant Women. New England Journal of Medicine 384(24): 2342-2343

Fu, X.; Chen, T.; Song, Y.; Feng, C.; Chen, H.; Zhang, Q.; Chen, G.; Zhu, X. 2021: MRNA Delivery by a pH-Responsive DNA Nano-Hydrogel. Small 17(29): E2101224

Wang, Y.; Tiruthani, K.; Li, S.; Hu, M.; Zhong, G.; Tang, Y.; Roy, S.; Zhang, L.; Tan, J.; Liao, C.; Liu, R. 2021: MRNA Delivery of a Bispecific Single-Domain Antibody to Polarize Tumor-Associated Macrophages and Synergize Immunotherapy against Liver Malignancies. Advanced Materials 33(23): E2007603

Yau, A.; Yu, H.; Chen, Y. 2019: MRNA Detection with Fluorescence-base Imaging Techniques for Arthritis Diagnosis. Journal of Rheumatology Research 1(2): 39-46

Arribere, J.A.; Kuroyanagi, H.; Hundley, H.A. 2020: MRNA Editing, Processing and Quality Control in Caenorhabditis elegans. Genetics 215(3): 531-568

Arribere, J.A.; Kuroyanagi, H.; Hundley, H.A. 2020: MRNA Editing, Processing and Quality Control in Caenorhabditis elegans. Genetics 215(3): 531-568

Van Hoecke, L.; Verbeke, R.; De Vlieger, D.; Dewitte, H.; Roose, K.; Van Nevel, S.; Krysko, O.; Bachert, C.; Schepens, B.; Lentacker, I.; Saelens, X. 2020: MRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza a Virus Infection in Mice. Molecular Therapy. Nucleic Acids 20: 777-787

Wang, E.; Abdel-Wahab, O. 2021: MRNA Export as a Novel Cancer-Specific Dependency. Cancer Discovery 11(9): 2129-2131

Kumar, P.; Sebastian, A.; Verma, K.; Dixit, R.; Kumari, S.; Singh, J.; Tiwary, S.K.; Narayan, G. 2021: MRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study. Indian Journal of Surgical Oncology 12(Suppl 1): 85-92

Abd El Gayed, E.M.; Rizk, M.S.; Ramadan, A.N.; Bayomy, N.R. 2021: MRNA Expression of the CUB and Sushi Multiple Domains 1 (CSMD1) and its Serum Protein Level as Predictors for Psychosis in the Familial High-Risk Children and Young Adults. Acs Omega 6(37): 24128-24138

Kasimanickam, R.K.; Kasimanickam, V.R. 2021: MRNA Expressions of Candidate Genes in Gestational day 16 Conceptus and Corresponding Endometrium in Repeat Breeder Dairy Cows with Suboptimal Uterine Environment Following Transfer of Different Quality day 7 Embryos. Animals: An Open Access Journal from Mdpi 11(4)

Verta, J-Pekka.; Jones, F. 2020: MRNA Extraction from Gill Tissue for RNA-sequencing. Bio-Protocol 10(5):E3539

Qiu, M.; Zhang, C.; Dai, Y.; Zhang, L.; Wang, Y.; Peng, W.; Chen, Y.; Wen, C.; Li, H.; Zhu, T. 2021: MRNA Levels of MAOA and 5-HT 2 a Receptor in Patients with Pathological Internet Use: Correlations with Comorbid Symptoms. Frontiers in Psychiatry 12: 667699

Tian, L.; Chou, H-Li.; Fukuda, M.; Kumamaru, T.; Okita, T.W. 2020: MRNA Localization in Plant Cells1[OPEN. Plant Physiology 182(1): 97-109

Chen, P.; Wu, S.; Yu, J.; Tang, X.; Dai, C.; Qi, H.; Zhu, J.; Li, W.; Chen, B.; Zhu, J.; Wang, H.; Zhao, S.; Liu, H.; Kuang, P.; He, Y. 2021: MRNA Network: Solution for Tracking Chemotherapy Insensitivity in Small-Cell Lung Cancer. Journal of Healthcare Engineering 2021: 2105176

Moss, N.D.; Sussel, L. 2020: MRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function. Frontiers in Genetics 11: 983

Wang, J.; Li, H.; Chen, L.; Dong, J.; Yang, J.; Gong, Z.; Wang, B.; Zhao, X. 2020: MRNA Profiling for miR-124-mediated Repair in Spinal Cord Injury. Neuroscience 438: 158-168

Iddins, B.O.; Buck, B.; Cato, T.; Partin, A.; Attia, K.; Wesh, C.; Shourbaji, R.; Waugh, M.H. 2021: MRNA SARS-CoV-2 Immunization Confers Robust Antibody Response in Occupational Healthcare Workers and Fosters Workplace Safety. Journal of Occupational and Environmental Medicine 63(5): E314-E317

Fila, M.; Diaz, L.; Szczepanska, J.; Pawlowska, E.; Blasiak, J. 2021: MRNA Trafficking in the Nervous System: a Key Mechanism of the Involvement of Activity-Regulated Cytoskeleton-Associated Protein (Arc) in Synaptic Plasticity. Neural Plasticity 2021: 3468795

Schwarze, L.-I.; Fehse, B. 2021: MRNA Transfection of T-Lymphocytes by Electroporation. Methods in Molecular Biology 2285: 217-226

Moradian, H.; Roch, T.; Lendlein, A.; Gossen, M. 2020: MRNA Transfection-Induced Activation of Primary Human Monocytes and Macrophages: Dependence on Carrier System and Nucleotide Modification. Scientific Reports 10(1): 4181

Goel, R.R.; Painter, M.M.; Apostolidis, S.A.; Mathew, D.; Meng, W.; Rosenfeld, A.M.; Lundgreen, K.A.; Reynaldi, A.; Khoury, D.S.; Pattekar, A.; Gouma, S.; Kuri-Cervantes, L.; Hicks, P.; Dysinger, S.; Hicks, A.; Sharma, H.; Herring, S.; Korte, S.; Baxter, A.E.; Oldridge, D.A.; Giles, J.R.; Weirick, M.E.; McAllister, C.M.; Awofolaju, M.; Tanenbaum, N.; Drapeau, E.M.; Dougherty, J.; Long, S.; D'Andrea, K.; Hamilton, J.T.; McLaughlin, M.; Williams, J.C.; Adamski, S.; Kuthuru, O.; Frank, I.; Betts, M.R.; Vella, L.A.; Grifoni, A.; Weiskopf, D.; Sette, A.; Hensley, S.E.; Davenport, M.P.; Bates, P.; Luning Prak, E.T.; Greenplate, A.R.; Wherry, E.J. 2021: MRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern. Biorxiv: the Preprint Server for Biology 2021

Tande, A.J.; Pollock, B.D.; Shah, N.D.; Binnicker, M.; Berbari, E.F. 2022: MRNA vaccine effectiveness against asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection over seven months. Infection Control and Hospital Epidemiology 43(3): 393-395

Woldemeskel, B.A.; Garliss, C.C.; Blankson, J.N. 2022: MRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells Persist at 6 Months and Recognize the Delta Variant. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 75(1): E898-E901

Yi, C.; Yi, Y.; Li, J. 2020: MRNA Vaccines: Possible Tools to Combat SARS-CoV-2. Virologica Sinica 35(3): 259-262

He, P.Cody.; He, C. 2019: MRNA acetylation: a new addition to the epitranscriptome. Cell Research 29(2): 91-92

Bhat, S.S.; Bielewicz, D.; Gulanicz, T.; Bodi, Z.; Yu, X.; Anderson, S.J.; Szewc, L.; Bajczyk, M.; Dolata, J.; Grzelak, N.; Smolinski, D.J.; Gregory, B.D.; Fray, R.G.; Jarmolowski, A.; Szweykowska-Kulinska, Z. 2020: MRNA adenosine methylase (MTA) deposits m6A on pri-miRNAs to modulate miRNA biogenesis in Arabidopsis thaliana. Proceedings of the National Academy of Sciences of the United States of America 117(35): 21785-21795

Seton-Rogers, S. 2018: MRNA alterations mimic genetic mutations. Nature Reviews. Cancer 18(11): 664-665

Wang, X.; Zhang, Y.; Ding, J.; Wang, F. 2021: MRNA analysis identifies deep intronic variants causing Alport syndrome and overcomes the problem of negative results of exome sequencing. Scientific Reports 11(1): 18097

Li, P.; Gao, Y.; Li, X.; Tian, F.; Wang, F.; Wang, Y.; Zhao, B.; Zhang, R.; Wang, C. 2020: MRNA and miRNA expression profile reveals the role of miR-31 overexpression in neural stem cell. Scientific Reports 10(1): 17537

Mawaribuchi, S.; Aiki, Y.; Ikeda, N.; Ito, Y. 2019: MRNA and miRNA expression profiles in an ectoderm-biased substate of human pluripotent stem cells. Scientific Reports 9(1): 11910

Lu, Y.; Yang, J.; Sun, J.; Lu, W.; Wang, J.-H. 2020: MRNA and miRNA profiles in the nucleus accumbens are associated with psychological stress-induced susceptible and resilient mice. Pharmacology Biochemistry and Behavior 199: 173062

Seong, R-Kyun.; Lee, J.Kyung.; Cho, G.Joon.; Kumar, M.; Shin, O.Sarah. 2020: MRNA and miRNA profiling of Zika virus-infected human umbilical cord mesenchymal stem cells identifies miR-142-5p as an antiviral factor. Emerging Microbes and Infections 9(1): 2061-2075

Sun, J.; Lu, Y.; Yang, J.; Song, Z.; Lu, W.; Wang, J.-H. 2020: MRNA and microRNA Profiles in the Amygdala Are Relevant to Susceptibility and Resilience to Psychological Stress Induced in Mice. Journal of Molecular Neuroscience: Mn 70(11): 1771-1796

Li, Z.; Chen, D.; Wang, Q.; Tian, H.; Tan, M.; Peng, D.; Tan, Y.; Zhu, J.; Liang, W.; Zhang, L. 2021: MRNA and microRNA stability validation of blood samples under different environmental conditions. Forensic Science International. Genetics 55: 102567

Fatemi, S.H.; Folsom, T.D.; Rooney, R.J.; Thuras, P.D. 2013: MRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway. Translational Psychiatry 3: E271

Zhu, L.; Li, J.; Dong, N.; Guan, F.; Liu, Y.; Ma, D.; Goh, E.L.K.; Chen, T. 2016: MRNA changes in nucleus accumbens related to methamphetamine addiction in mice. Scientific Reports 6: 36993

Koska, J.; Stefan, N.; Dubois, S.; Trinidad, C.; Considine, R.V.; Funahashi, T.; Bunt, J.C.; Ravussin, E.; Permana, P.A. 2009: MRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action. International Journal of Obesity 33(8): 842-850

Ibayashi, M.; Aizawa, R.; Tsukamoto, S. 2021: MRNA decapping factor Dcp1a is essential for embryonic growth in mice. Biochemical and Biophysical Research Communications 555: 128-133

Coller, J. 2016: MRNA decapping in 3D. Nature Structural and Molecular Biology 23(11): 954-956

Shuai, Q.; Zhu, F.; Zhao, M.; Yan, Y. 2021: MRNA delivery via non-viral carriers for biomedical applications. International Journal of Pharmaceutics 607: 121020

Gebhardt, A.; Habjan, M.; Benda, C.; Meiler, A.; Haas, D.A.; Hein, M.Y.; Mann, A.; Mann, M.; Habermann, B.; Pichlmair, A. 2015: MRNA export through an additional cap-binding complex consisting of NCBP1 and NCBP3. Nature Communications 6: 8192

Cole, C.N. 2000: MRNA export: the long and winding road. Nature Cell Biology 2(4): E55-E58

Latini, A.; Novelli, L.; Ceccarelli, F.; Barbati, C.; Perricone, C.; De Benedittis, G.; Conti, F.; Novelli, G.; Ciccacci, C.; Borgiani, P. 2021: MRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients. Lupus 30(7): 1086-1093

Pandey, R.; Prakash, V. 2020: MRNA expression analysis of interleukins 17A and 17F in bronchial asthmatic patients from Northern Indian population. Journal of Family Medicine and Primary Care 9(5): 2258-2263

Li, Y.; Wei, Z.; Huang, S.; Yang, B. 2020: MRNA expression and DNA methylation analysis of the inhibitory mechanism of H2O2 on the proliferation of A549 cells. Oncology Letters 20(6): 288

Zahrah, A.; Muharam, R.; Satria Marwali, M.L.; Deraya, I.E. 2021: MRNA expression and DNA methylation level of the MMP-2 gene in peritoneal endometriosis. JPMA. Journal of the Pakistan Medical Association 71(Suppl 2)(2): S112-S115

Jordan, S.E.; Saad, H.; Covarrubias, A.S.; Siemon, J.; Pearson, J.M.; Slomovitz, B.M.; Huang, M.; Pinto, A.; Schlumbrecht, M.; George, S.H. 2020: MRNA expression in low grade serous ovarian cancer: Results of a nano String assay in a diverse population. Gynecologic Oncology 159(2): 554-562

Liu, T.; Xia, R.; Li, C.; Chen, X.; Cai, X.; Li, W. 2021: MRNA expression level of CDH2, LEP, POSTN, TIMP1 and VEGFC modulates 5-fluorouracil resistance in colon cancer cells. Experimental and Therapeutic Medicine 22(3): 1023

Tissing, W.J.E.; Meijerink, J.P.P.; den Boer, M.L.; Brinkhof, B.; Pieters, R. 2005: MRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL. Leukemia 19(5): 727-733

Matt, K.; Hochecker, B.; Schöller-Mann, A.; Bergemann, J.ör. 2020: MRNA expression of ageing-associated genes in calorie reduction is subject to donor variability and can be induced by calorie restriction mimetics. Nutrition and Health 26(3): 253-262

Suminoe, A.; Matsuzaki, A.; Hattori, H.; Koga, Y.; Kinukawa, N.; Ishii, E.; Hara, T. 2004: MRNA expression of apoptosis-associated genes in infant acute lymphoblastic leukemia: low Fas expression is an independent predictor for poor prognosis. Leukemia 18(2): 365-368

Ahn, J.-S.; Chung, K.-Y.; Jang, S.-S.; Kim, U.-H.; Hwang, S.-M.; Jin, S.; Park, B.-H.; Kang, D.-H.; Kwon, E.-G. 2020: MRNA expression of myogenic-adipogenic makers and adipocyte in skeletal muscle of Hanwoo calves at newborn and 6 months of age. Journal of Animal Science and Technology 62(6): 893-902

Dillman, A.A.; Hauser, D.N.; Gibbs, J.Raphael.; Nalls, M.A.; McCoy, M.K.; Rudenko, I.N.; Galter, D.; Cookson, M.R. 2013: MRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex. Nature Neuroscience 16(4): 499-506

Van Hoecke, L.; Verbeke, R.; Dewitte, H.; Lentacker, I.; Vermaelen, K.; Breckpot, K.; Van Lint, S. 2021: MRNA in cancer immunotherapy: beyond a source of antigen. Molecular Cancer 20(1): 48

Hassert, M.; Geerling, E.; Stone, E.T.; Steffen, T.L.; Dickson, A.; Feldman, M.S.; Class, J.; Richner, J.M.; Brien, J.D.; Pinto, A.K. 2020: MRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2. Biorxiv: the Preprint Server for Biology 2020

Hassert, M.; Geerling, E.; Stone, E.T.; Steffen, T.L.; Feldman, M.S.; Dickson, A.L.; Class, J.; Richner, J.M.; Brien, J.D.; Pinto, A.K. 2020: MRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2. Plos Pathogens 16(12): E1009163

Gilboa, E. 2012: MRNA leapfrogs DNA to show promise for therapeutic gene transfer. Molecular Therapy: the Journal of the American Society of Gene Therapy 20(4): 694-695

Liao, J.W.; Ma, P.; Yang, H.H.; Pan, J.Y. 2021: MRNA level of N-methyl-D-aspartic acid receptor NR1 subunit in patients with major depressive disorder and its relationship with clinical features. Zhonghua Yi Xue Za Zhi 101(39): 3227-3231

Yang, W-Shiung.; Lee, W-Jei.; Huang, K-Chin.; Lee, K-Ching.; Chao, C-Ling.; Chen, C-Ling.; Tai, T-Yuan.; Chuang, L-Ming. 2003: MRNA levels of the insulin-signaling molecule SORBS1 in the adipose depots of nondiabetic women. Obesity Research 11(4): 586-590

Mahbub, M.; Hemm, L.; Yang, Y.; Kaur, R.; Carmen, H.; Engl, C.; Huokko, T.; Riediger, M.; Watanabe, S.; Liu, L-Ning.; Wilde, A.; Hess, W.R.; Mullineaux, C.W. 2020: MRNA localization, reaction centre biogenesis and thylakoid membrane targeting in cyanobacteria. Nature Plants 6(9): 1179-1191

Wang, X.; Sun, B.; Jiang, Q.; Wu, R.; Cai, M.; Yao, Y.; Liu, Q.; Shi, H.; Feng, J.; Wang, Y. 2018: MRNA m 6 A plays opposite role in regulating UCP2 and PNPLA2 protein expression in adipocytes. International Journal of Obesity 42(11): 1912-1924

Kampantais, S.; Kotoula, V.; Kounatidis, I.; Vakalopoulos, I.; Gourvas, V.; Lymperi, S.; Dimitriadis, G. 2020: MRNA overexpression of prolyl hydroxylase PHD3 is inversely related to nuclear grade in renal cell carcinoma. Molecular and Clinical Oncology 13(3): 11

Aguilera, Aés. 2005: MRNA processing and genomic instability. Nature Structural and Molecular Biology 12(9): 737-738

Puglisi, J.D. 2000: MRNA processing: the 3'-end justifies the means. Nature Structural Biology 7(4): 263-264

Zhang, Y.; Wu, Q.; Fang, S.; Li, S.; Zheng, H.; Zhang, Y.; Ikhwanuddin, M.; Ma, H. 2020: MRNA profile provides novel insights into stress adaptation in mud crab megalopa, Scylla paramamosain after salinity stress. Bmc Genomics 21(1): 559

Salzmann, A.P.; Bamberg, M.; Courts, C.; Dørum, G.; Gosch, A.; Hadrys, T.; Hadzic, G.; Neis, M.; Schneider, P.M.; Sijen, T.; den Berge, M.v.; Wiegand, P.; Haas, C. 2021: MRNA profiling of mock casework samples: Results of a FoRNAP collaborative exercise. Forensic Science International. Genetics 50: 102409

Baren, J.P.; Stewart, G.D.; Stokes, A.; Gray, K.; Pennington, C.J.; O'Neill, R.; Deans, D.A.C.; Paterson-Brown, S.; Riddick, A.C.P.; Edwards, D.R.; Fearon, K.C.H.; Ross, J.A.; Skipworth, R.J.E. 2012: MRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma. British Journal of Cancer 107(1): 143-149

Xu, Z.; Lu, W.; Miao, Y.; Li, H.; Xie, X.; Zhang, F. 2020: MRNA profiling reveals the potential mechanism of TIPE2 in attenuating cognitive deficits in APP/PS1 mice. International Immunopharmacology 87: 106792

Zander, G.; Hackmann, A.; Bender, L.; Becker, D.; Lingner, T.; Salinas, G.; Krebber, H. 2016: MRNA quality control is bypassed for immediate export of stress-responsive transcripts. Nature 540(7634): 593-596

Yannopoulos, A.; Dimitriadis, E.; Scorilas, A.; Trangas, T.; Markakis, E.; Talieri, M. 2005: MRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete. British Journal of Cancer 93(1): 152-158

Trcek, T.; Lionnet, Tée.; Shroff, H.; Lehmann, R. 2017: MRNA quantification using single-molecule FISH in Drosophila embryos. Nature Protocols 12(7): 1326-1348

Atkins, J.F.; Gesteland, R.F. 2001: MRNA readout at 40. Nature 414(6865): 693

Miller, B.L. 2015: MRNA regulation: A patch for a splice. Nature Chemical Biology 11(7): 454-455

Nakayama, K.; Ohkubo, H.; Hirose, T.; Inayama, S.; Nakanishi, S. 1984: MRNA sequence for human cardiodilatin-atrial natriuretic factor precursor and regulation of precursor mRNA in rat atria. Nature 310(5979): 699-701

Kaartinen, M.; Griffiths, G.M.; Markham, A.F.; Milstein, C. 1983: MRNA sequences define an unusually restricted IgG response to 2-phenyloxazolone and its early diversification. Nature 304(5924): 320-324

Hall, L.; Craig, R.K.; Campbell, P.N. 1979: MRNA species directing synthesis of milk proteins in normal and tumour tissue from human mammary gland. Nature 277(5691): 54-56

Steinman, R.A. 2007: MRNA stability control: a clandestine force in normal and malignant hematopoiesis. Leukemia 21(6): 1158-1171

Ruijtenberg, S.; Sonneveld, S.; Cui, T.Ju.; Logister, I.; de Steenwinkel, D.; Xiao, Y.; MacRae, I.J.; Joo, C.; Tanenbaum, M.E. 2020: MRNA structural dynamics shape Argonaute-target interactions. Nature Structural and Molecular Biology 27(9): 790-801

Carlile, T.M.; Martinez, N.M.; Schaening, C.; Su, A.; Bell, T.A.; Zinshteyn, B.; Gilbert, W.V. 2019: MRNA structure determines modification by pseudouridine synthase 1. Nature Chemical Biology 15(10): 966-974

Ilyichev, A.A.; Orlova, L.A.; Sharabrin, S.V.; Karpenko, L.I. 2020: MRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development. Vavilovskii Zhurnal Genetiki i Selektsii 24(7): 802-807

Beck, J.D.; Reidenbach, D.; Salomon, N.; Sahin, U.; Türeci, Öz.; Vormehr, M.; Kranz, L.M. 2021: MRNA therapeutics in cancer immunotherapy. Molecular Cancer 20(1): 69

Korinek, J.; Spelsberg, T.C.; Mitchell, W.M. 1973: MRNA transcription linked to the morphological and plasma membrane changes induced by cyclic AMP in tumour cells. Nature 246(5434): 455-458

Rabson, A.B.; Steele, P.E.; Garon, C.F.; Martin, M.A. 1983: MRNA transcripts related to full-length endogenous retroviral DNA in human cells. Nature 306(5943): 604-607

Ermolenko, D.N.; Noller, H.F. 2011: MRNA translocation occurs during the second step of ribosomal intersubunit rotation. Nature Structural and Molecular Biology 18(4): 457-462

Liu-Chen, S.; Connolly, B.; Cheng, L.; Subramanian, R.R.; Han, Z. 2018: MRNA treatment produces sustained expression of enzymatically active human ADAMTS13 in mice. Scientific Reports 8(1): 7859

Larsson, E.; Sander, C.; Marks, D. 2010: MRNA turnover rate limits siRNA and microRNA efficacy. Molecular Systems Biology 6: 433

Röltgen, K.; Nielsen, S.C.A.; Arunachalam, P.S.; Yang, F.; Hoh, R.A.; Wirz, O.F.; Lee, A.S.; Gao, F.; Mallajosyula, V.; Li, C.; Haraguchi, E.; Shoura, M.J.; Wilbur, J.L.; Wohlstadter, J.N.; Davis, M.M.; Pinsky, B.A.; Sigal, G.B.; Pulendran, B.; Nadeau, K.C.; Boyd, S.D. 2021: MRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition. Medrxiv: the Preprint Server for Health Sciences 2021

Miao, L.; Zhang, Y.; Huang, L. 2021: MRNA vaccine for cancer immunotherapy. Molecular Cancer 20(1): 41

Wang, Z.; Schmidt, F.; Weisblum, Y.; Muecksch, F.; Barnes, C.O.; Finkin, S.; Schaefer-Babajew, D.; Cipolla, M.; Gaebler, C.; Lieberman, J.A.; Oliveira, T.Y.; Yang, Z.; Abernathy, M.E.; Huey-Tubman, K.E.; Hurley, A.; Turroja, M.; West, K.A.; Gordon, K.; Millard, K.G.; Ramos, V.; Da Silva, J.; Xu, J.; Colbert, R.A.; Patel, R.; Dizon, J.; Unson-O'Brien, C.; Shimeliovich, I.; Gazumyan, A.; Caskey, M.; Bjorkman, P.J.; Casellas, R.; Hatziioannou, T.; Bieniasz, P.D.; Nussenzweig, M.C. 2021: MRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Biorxiv: the Preprint Server for Biology 2021

Neidleman, J.; Luo, X.; McGregor, M.; Xie, G.; Murray, V.; Greene, W.C.; Lee, S.A.; Roan, N.R. 2021: MRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status. Biorxiv: the Preprint Server for Biology 2021

Cafri, G.; Gartner, J.J.; Zaks, T.; Hopson, K.; Levin, N.; Paria, B.C.; Parkhurst, M.R.; Yossef, R.; Lowery, F.J.; Jafferji, M.S.; Prickett, T.D.; Goff, S.L.; McGowan, C.T.; Seitter, S.; Shindorf, M.L.; Parikh, A.; Chatani, P.D.; Robbins, P.F.; Rosenberg, S.A. 2020: MRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer. Journal of Clinical Investigation 130(11): 5976-5988

Wang, Y.; Zhang, Z.; Luo, J.; Han, X.; Wei, Y.; Wei, X. 2021: MRNA vaccine: a potential therapeutic strategy. Molecular Cancer 20(1): 33

Pardi, N.; Hogan, M.J.; Porter, F.W.; Weissman, D. 2018: MRNA vaccines - a new era in vaccinology. Nature Reviews. Drug Discovery 17(4): 261-279

Park, J.W.; Lagniton, P.N.P.; Liu, Y.; Xu, R.-H. 2021: MRNA vaccines for COVID-19: what, why and how. International Journal of Biological Sciences 17(6): 1446-1460

Mullard, A. 2018: MRNA vaccines get another booster. Nature Reviews. Drug Discovery 17(7): 460

Goel, R.R.; Painter, M.M.; Apostolidis, S.A.; Mathew, D.; Meng, W.; Rosenfeld, A.M.; Lundgreen, K.A.; Reynaldi, A.; Khoury, D.S.; Pattekar, A.; Gouma, S.; Kuri-Cervantes, L.; Hicks, P.; Dysinger, S.; Hicks, A.; Sharma, H.; Herring, S.; Korte, S.; Baxter, A.E.; Oldridge, D.A.; Giles, J.R.; Weirick, M.E.; McAllister, C.M.; Awofolaju, M.; Tanenbaum, N.; Drapeau, E.M.; Dougherty, J.; Long, S.; D'Andrea, K.; Hamilton, J.T.; McLaughlin, M.; Williams, J.C.; Adamski, S.; Kuthuru, O.; Frank, I.; Betts, M.R.; Vella, L.A.; Grifoni, A.; Weiskopf, D.; Sette, A.; Hensley, S.E.; Davenport, M.P.; Bates, P.; Luning Prak, E.T.; Greenplate, A.R.; Wherry, E.J. 2021: MRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science 374(6572): Abm0829

Cao, Y.; Gao, G.F. 2021: MRNA vaccines: a matter of delivery. Eclinicalmedicine 32: 100746

Martin, C.; Lowery, D. 2020: MRNA vaccines: intellectual property landscape. Nature Reviews. Drug Discovery 19(9): 578

Servick, K. 2020: MRNA's next challenge: will it work as a drug?. Science 370(6523): 1388-1389

Meyer, M.; Wang, Y.; Edwards, D.; Smith, G.R.; Rubenstein, A.B.; Ramanathan, P.; Mire, C.E.; Pietzsch, C.; Chen, X.; Ge, Y.; Cheng, W.S.; Henry, C.; Woods, A.; Ma, L.; Stewart-Jones, G.B.E.; Bock, K.W.; Minai, M.; Nagata, B.M.; Periasamy, S.; Shi, P.-Y.; Graham, B.S.; Moore, I.N.; Ramos, I.; Troyanskaya, O.G.; Zaslavsky, E.; Carfi, A.; Sealfon, S.C.; Bukreyev, A. 2021: MRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge. Biorxiv: the Preprint Server for Biology 2021

Wu, K.; Werner, A.P.; Moliva, J.I.; Koch, M.; Choi, A.; Stewart-Jones, G.B.E.; Bennett, H.; Boyoglu-Barnum, S.; Shi, W.; Graham, B.S.; Carfi, A.; Corbett, K.S.; Seder, R.A.; Edwards, D.K. 2021: MRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. Biorxiv: the Preprint Server for Biology 2021

Tang, F.; Barbacioru, C.; Wang, Y.; Nordman, E.; Lee, C.; Xu, N.; Wang, X.; Bodeau, J.; Tuch, B.B.; Siddiqui, A.; Lao, K.; Surani, M.Azim. 2009: MRNA-Seq whole-transcriptome analysis of a single cell. Nature Methods 6(5): 377-382

Rauch, S.; Roth, N.; Schwendt, K.; Fotin-Mleczek, M.; Mueller, S.O.; Petsch, B. 2021: MRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents. Npj Vaccines 6(1): 57

Mullard, A. 2016: MRNA-based drug approaches Phase I milestone. Nature Reviews. Drug Discovery 15(9): 595

Sahin, U.; Karikó, K.; Türeci, Özlem. 2014: MRNA-based therapeutics--developing a new class of drugs. Nature Reviews. Drug Discovery 13(10): 759-780

Jericó, D.; Córdoba, K.M.; Jiang, L.; Schmitt, C.; Morán, M.ía.; Sampedro, A.; Alegre, M.; Collantes, M.ía.; Santamaría, E.; Alegre, E.íb.; Culerier, C.; de Mendoza, A.E.-H.; Oyarzabal, J.; Martín, M.A.; Peñuelas, I.án.; Ávila, M.ía.A.; Gouya, L.; Martini, P.G.V.; Fontanellas, A. 2021: MRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks. Molecular Therapy. Nucleic Acids 25: 207-219

Ponsaerts, P.; Van Tendeloo, V.F.I.; Cools, N.; Van Driessche, A.; Lardon, F.; Nijs, G.; Lenjou, M.; Mertens, G.; Van Broeckhoven, C.; Van Bockstaele, D.R.; Berneman, Z.N. 2002: MRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation. Leukemia 16(7): 1324-1330

Gong, C.; Tang, Y.; Maquat, L.E. 2013: MRNA-mRNA duplexes that autoelicit Staufen1-mediated mRNA decay. Nature Structural and Molecular Biology 20(10): 1214-1220

Zhang, H.; Yue, P.; Tong, X.; Bai, J.; Yang, J.; Guo, J. 2021: MRNA-seq and miRNA-seq profiling analyses reveal molecular mechanisms regulating induction of fruiting body in Ophiocordyceps sinensis. Scientific Reports 11(1): 12944

Weissman, D.; Karikó, K. 2015: MRNA: Fulfilling the Promise of Gene Therapy. Molecular Therapy: the Journal of the American Society of Gene Therapy 23(9): 1416-1417

Garg, A.; Singhal, N.; Kumar, R.; Kumar, M. 2020: MRNALoc: a novel machine-learning based in-silico tool to predict mRNA subcellular localization. Nucleic Acids Research 48(W1): W239-W243

Tang, Q.; Nie, F.; Kang, J.; Chen, W. 2021: MRNALocater: Enhance the prediction accuracy of eukaryotic mRNA subcellular localization by using model fusion strategy. Molecular Therapy: the Journal of the American Society of Gene Therapy 29(8): 2617-2623

Lai, W-Jung.C.; Kayedkhordeh, M.; Cornell, E.V.; Farah, E.; Bellaousov, S.; Rietmeijer, R.; Salsi, E.; Mathews, D.H.; Ermolenko, D.N. 2018: MRNAs and lnc RNAs intrinsically form secondary structures with short end-to-end distances. Nature Communications 9(1): 4328

Iost, I.; Dreyfus, M. 1994: MRNAs can be stabilized by DEAD-box proteins. Nature 372(6502): 193-196

Fujitaka, K.; Murakami, T.; Takeuchi, M.; Kakimoto, T.; Mochida, H.; Arakawa, K. 2021: MRNAs in urinary nano-extracellular vesicles as potential biomarkers for non-invasive kidney biopsy. Biomedical Reports 14(1): 11

Buccitelli, C.; Selbach, M. 2020: MRNAs, proteins and the emerging principles of gene expression control. Nature Reviews. Genetics 21(10): 630-644

Rogers, O.C.; Johnson, D.M.; Firnberg, E. 2019: MRhubarb: Engineering of monomeric, red-shifted, and brighter variants of iRFP using structure-guided multi-site mutagenesis. Scientific Reports 9(1): 15653

Liu, W.; Hu, P.; Liu, J.; Chen, L. 2021: MSEPT9 can Monitor the Response and Predict the Prognosis of Stage IV Colorectal Cancer Patients with Liver Metastasis Undergoing Potentially Curative Surgery. Journal of Surgical Research 267: 485-494

Mondal, D.; Haghpanah, Z.; Huxman, C.J.; Tanter, S.; Sun, D.; Gorbet, M.; Willett, T.L. 2021: MSLA-based 3D printing of acrylated epoxidized soybean oil - nano-hydroxyapatite composites for bone repair. Materials Science and Engineering. C Materials for Biological Applications 130: 112456

Weber, C.M.; Hafner, A.; Kirkland, J.G.; Braun, S.M.G.; Stanton, B.Z.; Boettiger, A.N.; Crabtree, G.R. 2021: MSWI/SNF promotes Polycomb repression both directly and through genome-wide redistribution. Nature Structural and Molecular Biology 28(6): 501-511

Bindels, D.S.; Haarbosch, L.; van Weeren, L.; Postma, M.; Wiese, K.E.; Mastop, M.; Aumonier, S.; Gotthard, G.; Royant, A.; Hink, M.A.; Gadella, T.W.J. 2017: MScarlet: a bright monomeric red fluorescent protein for cellular imaging. Nature Methods 14(1): 53-56

Collins, J.M. 2021: MSphere of Influence: Host Metabolism Is an Integral Part of the Immune Response to Infectious Diseases. Msphere 6(4): E0024721

Levin, T.C. 2021: MSphere of Influence: how i Learned to Love Bacteria and their Tangled Evolutionary Tree. Msphere 6(5): E0078021

Quintana, M.D.P. 2021: MSphere of Influence: Structural Insights into the Molecular Mechanism Underlying Placental Malaria. Msphere 6(3): E0039121

Mayer Bridwell, A.E. 2021: MSphere of Influence: the Key Role of Neutrophils in Tuberculosis and Type 2 Diabetes Comorbidity. Msphere 6(3): E0025121

Nguyen, T-Hoang.; Dobbyn, A.; Brown, R.C.; Riley, B.P.; Buxbaum, J.D.; Pinto, D.; Purcell, S.M.; Sullivan, P.F.; He, X.; Stahl, E.A. 2020: MTADA is a framework for identifying risk genes from de novo mutations in multiple traits. Nature Communications 11(1): 2929

Bortnick, A.; Murre, C. 2018: MTECs Aire on the side of caution. Nature Immunology 19(2): 100-101

Horst, K.; Lichte, P.; Bläsius, F.; Weber, C.D.; Tonglet, M.; Kobbe, P.; Heussen, N.; Hildebrand, F. 2022: MTICCS and its inter-rater reliability to predict the need for massive transfusion in severely injured patients. European Journal of Trauma and Emergency Surgery: Official Publication of the European Trauma Society 48(1): 367-372

Li, J.; Zhang, Y.; Liang, X.-F.; He, S.; Tang, S.; Li, L.; Chen, X. 2020: MTOR - Mediated protein synthesis by inhibiting protein catabolism in Chinese perch (Siniperca chuatsi). Biochemical and Biophysical Research Communications 533(1): 23-29

Nakano, T.; Warner, K.A.; Oklejas, A.E.; Zhang, Z.; Rodriguez-Ramirez, C.; Shuman, A.G.; Nör, J.E. 2021: MTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells. Journal of Dental Research 100(4): 377-386

Schnitzbauer, A.A.; Filmann, N.; Adam, R.é; Bachellier, P.; Bechstein, W.O.; Becker, T.; Bhoori, S.; Bilbao, I.; Brockmann, J.; Burra, P.; Chazoullières, O.; Cillo, U.; Colledan, M.; Duvoux, C.; Ganten, T.M.; Gugenheim, J.; Heise, M.; van Hoek, B.; Jamieson, N.; de Jong, K.P.; Klein, C.G.; Klempnauer, J.ür.; Kneteman, N.; Lerut, J.; Mäkisalo, H.; Mazzaferro, V.; Mirza, D.F.; Nadalin, S.; Neuhaus, P.; Pageaux, G.-P.; Pinna, A.D.; Pirenne, J.; Pratschke, J.; Powel, J.; Rentsch, M.; Rizell, M.; Rossi, G.; Rostaing, L.; Roy, A.é; Scholz, T.; Settmacher, U.; Soliman, T.; Strasser, S.; Söderdahl, G.; Troisi, R.I.; Turrión, V.S.án.; Schlitt, H.J.; Geissler, E.K. 2020: MTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients with Active Tumors. Annals of Surgery 272(5): 855-862

Exner, S.; Arrey, G.; Prasad, V.; Grötzinger, C. 2020: MTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms. Frontiers in Oncology 10: 578380

Abel, E.D. 2021: MTOR Mediated Metabolic Rewiring and Ischemic Preconditioning, its Complicated. Circulation Research 128(5): 652-654

Wang, H.; Xiao, Y.; Su, L.; Cui, N.; Liu, D. 2018: MTOR Modulates CD8+ T Cell Differentiation in Mice with Invasive Pulmonary Aspergillosis. Open Life Sciences 13: 129-136

Shan, L.; Ding, Y.; Fu, Y.; Zhou, L.; Dong, X.; Chen, S.; Wu, H.; Nai, W.; Zheng, H.; Xu, W.; Bai, X.; Jia, C.; Dai, M. 2016: MTOR Overactivation in Mesenchymal cells Aggravates CCl 4 - Induced liver Fibrosis. Scientific Reports 6: 36037

Taylor, H.E.; Calantone, N.; Lichon, D.; Hudson, H.; Clerc, I.; Campbell, E.M.; D'Aquila, R.T. 2020: MTOR Overcomes Multiple Metabolic Restrictions to Enable HIV-1 Reverse Transcription and Intracellular Transport. Cell Reports 31(12): 107810

Zanini, S.; Renzi, S.; Giovinazzo, F.; Bermano, G. 2020: MTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs). Frontiers in Endocrinology 11: 562505

Cong, Y.; Li, Q.; Zhang, X.; Chen, Y.; Yu, K. 2020: MTOR Promotes Tissue Factor Expression and Activity in EGFR-Mutant Cancer. Frontiers in Oncology 10: 1615

Colombero, C.; Remy, D.; Antoine-Bally, S.; Macé, A.-S.; Monteiro, P.; ElKhatib, N.; Fournier, M.; Dahmani, A.; Montaudon, E.; Montagnac, G.; Marangoni, E.; Chavrier, P. 2021: MTOR Repression in Response to Amino Acid Starvation Promotes ECM Degradation Through MT1-MMP Endocytosis Arrest. Advanced Science 8(17): E2101614

Chang, J.Y.; Kim, J.H.; Kang, J.; Park, Y.; Park, S.J.; Cheon, J.H.; Kim, W.H.; Kim, H.; Park, J.J.; Kim, T.I. 2020: MTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage Ii Colorectal Cancer. Yonsei Medical Journal 61(7): 572-578

Jeffries, M.A.; McLane, L.E.; Khandker, L.; Mather, M.L.; Evangelou, A.V.; Kantak, D.; Bourne, J.N.; Macklin, W.B.; Wood, T.L. 2021: MTOR Signaling Regulates Metabolic Function in Oligodendrocyte Precursor Cells and Promotes Efficient Brain Remyelination in the Cuprizone Model. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 41(40): 8321-8337

Wu, X.; Li, S.; Hu, X.; Xiang, X.; Halloran, M.; Yang, L.; Williams, T.M.; Houghton, P.J.; Shen, C.; He, Z. 2019: MTOR Signaling Upregulates CDC6 via Suppressing miR-3178 and Promotes the Loading of DNA Replication Helicase. Scientific Reports 9(1): 9805

Triki, M.; Rinaldi, G.; Planque, M.; Broekaert, D.; Winkelkotte, A.M.; Maier, C.R.; Janaki Raman, S.; Vandekeere, A.; Van Elsen, J.; Orth, M.F.; Grünewald, T.G.P.; Schulze, A.; Fendt, S.-M. 2020: MTOR Signaling and SREBP Activity Increase FADS2 Expression and can Activate Sapienate Biosynthesis. Cell Reports 31(12): 107806

Martin, P.-Y.; Doly, S.ép.; Hamieh, A.M.; Chapuy, E.; Canale, V.; Drop, M.; Chaumont-Dubel, S.év.; Bantreil, X.; Lamaty, F.éd.ér.; Bojarski, A.J.; Zajdel, P.; Eschalier, A.; Marin, P.; Courteix, C. 2020: MTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment. Progress in Neurobiology 193: 101846

Crutcher, E.; Pal, R.; Naini, F.; Zhang, P.; Laugsch, M.; Kim, J.; Bajic, A.; Schaaf, C.P. 2019: MTOR and autophagy pathways are dysregulated in murine and human models of Schaaf-Yang syndrome. Scientific Reports 9(1): 15935

Easton, J.B.; Houghton, P.J. 2006: MTOR and cancer therapy. Oncogene 25(48): 6436-6446

Sabatini, D.M. 2006: MTOR and cancer: insights into a complex relationship. Nature Reviews. Cancer 6(9): 729-734

Huber, T.B.; Walz, G.; Kuehn, E.Wolfgang. 2011: MTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression. Kidney International 79(5): 502-511

Kim, J.; Guan, K-Liang. 2019: MTOR as a central hub of nutrient signalling and cell growth. Nature Cell Biology 21(1): 63-71

Saoudaoui, S.; Bernard, M.; Cardin, G.B.; Malaquin, N.; Christopoulos, A.; Rodier, F. 2021: MTOR as a senescence manipulation target: a forked road. Advances in Cancer Research 150: 335-363

Liu, G.Y.; Sabatini, D.M. 2020: MTOR at the nexus of nutrition, growth, ageing and disease. Nature Reviews. Molecular Cell Biology 21(4): 183-203

Van Skike, C.E.; Hussong, S.A.; Hernandez, S.F.; Banh, A.Q.; DeRosa, N.; Galvan, V. 2021: MTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 41(19): 4305-4320

Zhu, C.; Xia, L.; Li, F.; Zhou, L.; Weng, Q.; Li, Z.; Wu, Y.; Mao, Y.; Zhang, C.; Wu, Y.; Li, M.; Ying, S.; Chen, Z.; Shen, H.; Li, W. 2018: MTOR complexes differentially orchestrates eosinophil development in allergy. Scientific Reports 8(1): 6883

Costa-Mattioli, M.; Monteggia, L.M. 2013: MTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nature Neuroscience 16(11): 1537-1543

Cunningham, J.T.; Rodgers, J.T.; Arlow, D.H.; Vazquez, F.; Mootha, V.K.; Puigserver, P. 2007: MTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450(7170): 736-740

Li, T.; Weng, J.; Zhang, Y.; Liang, K.; Fu, G.; Li, Y.; Bai, X.; Gao, Y. 2019: MTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma. Cell Death and Disease 10(8): 619

Bordi, M.; Darji, S.; Sato, Y.; Mellén, M.; Berg, M.J.; Kumar, A.; Jiang, Y.; Nixon, R.A. 2019: MTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy. Cell Death and Disease 10(8): 563

Ramaiah, M.J. 2020: MTOR inhibition and p53 activation, microRNAs: the possible therapy against pandemic COVID-19. Gene Reports 20: 100765

Radiske, A.; Gonzalez, M.C.; Nôga, D.A.; Rossato, J.I.; Bevilaqua, L.R.M.; Cammarota, M.ín. 2021: MTOR inhibition impairs extinction memory reconsolidation. Learning and Memory 28(1): 1-6

Scheller, T.; Hellerbrand, C.; Moser, C.; Schmidt, K.; Kroemer, A.; Brunner, S.M.; Schlitt, H.J.; Geissler, E.K.; Lang, S.A. 2015: MTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma. British Journal of Cancer 112(5): 841-850

Majumder, P.K.; Febbo, P.G.; Bikoff, R.; Berger, R.; Xue, Q.; McMahon, L.M.; Manola, J.; Brugarolas, J.; McDonnell, T.J.; Golub, T.R.; Loda, M.; Lane, H.A.; Sellers, W.R. 2004: MTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nature Medicine 10(6): 594-601

Li, Y.; Xu, Y.; Liu, X.; Yan, X.; Lin, Y.; Tan, Q.; Hou, Y. 2021: MTOR inhibitor INK128 promotes wound healing by regulating MDSCs. Stem Cell Research and Therapy 12(1): 170

Petrasek, T.; Vojtechova, I.; Klovrza, O.; Tuckova, K.; Vejmola, C.; Rak, J.; Sulakova, A.; Kaping, D.; Bernhardt, N.; de Vries, P.J.; Otahal, J.; Waltereit, R. 2021: MTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus. Journal of Neurodevelopmental Disorders 13(1): 14

Parazzini, F.; Gerli, S.; Favilli, A.; Vignali, M.; Ricci, E.; Cipriani, S.; Chiaffarino, F.; Dell'acqua, A.; Harari, S.; Bianchi, S. 2021: MTOR inhibitors and risk of ovarian cysts: a systematic review and meta-analysis. Bmj Open 11(9): E048190

He, K.; Zheng, X.; Li, M.; Zhang, L.; Yu, J. 2016: MTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation. Oncogene 35(2): 148-157

Igarashi, N.; Honjo, M.; Aihara, M. 2021: MTOR inhibitors potentially reduce TGF-β2-induced fibrogenic changes in trabecular meshwork cells. Scientific Reports 11(1): 14111

Sintes, J.; Gentile, M.; Zhang, S.; Garcia-Carmona, Y.; Magri, G.; Cassis, L.; Segura-Garzón, D.; Ciociola, A.; Grasset, E.K.; Bascones, S.; Comerma, L.; Pybus, M.; Lligé, D.; Puga, I.; Gutzeit, C.; He, B.; DuBois, W.; Crespo, M.; Pascual, J.; Mensa, A.; Aróstegui, J.Ignacio.; Juan, M.; Yagüe, J.; Serrano, S.; Lloreta, J.; Meffre, E.; Hahne, M.; Cunningham-Rundles, C.; Mock, B.A.; Cerutti, A. 2017: MTOR intersects antibody-inducing signals from TACI in marginal zone B cells. Nature Communications 8(1): 1462

Johnson, S.C.; Rabinovitch, P.S.; Kaeberlein, M. 2013: MTOR is a key modulator of ageing and age-related disease. Nature 493(7432): 338-345

Karbowniczek, M.; Spittle, C.S.; Morrison, T.; Wu, H.; Henske, E.P. 2008: MTOR is activated in the majority of malignant melanomas. Journal of Investigative Dermatology 128(4): 980-987

Lin, X.; Yang, J.; Wang, J.; Huang, H.; Wang, H-Xia.; Chen, P.; Wang, S.; Pan, Y.; Qiu, Y-Rong.; Taylor, G.A.; Vallance, B.A.; Gao, J.; Zhong, X-Ping. 2016: MTOR is critical for intestinal T-cell homeostasis and resistance to Citrobacter rodentium. Scientific Reports 6: 34939

Beauchamp, R.L.; Erdin, S.; Witt, L.; Jordan, J.T.; Plotkin, S.R.; Gusella, J.F.; Ramesh, V. 2020: MTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. Journal of Biological Chemistry 296: 100157

Guo, F.; Li, J.; Zhang, S.; Du, W.; Amarachintha, S.; Sipple, J.; Phelan, J.; Grimes, H.L.; Zheng, Y.; Pang, Q. 2014: MTOR kinase inhibitor sensitizes T-cell lymphoblastic leukemia for chemotherapy-induced DNA damage via suppressing FANCD2 expression. Leukemia 28(1): 203-206

Jung, S.Hee.; Hwang, H.Jung.; Kang, D.; Park, H.A.; Lee, H.Chul.; Jeong, D.; Lee, K.; Park, H.Joo.; Ko, Y-Gyu.; Lee, J-Seon. 2019: MTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53. Oncogene 38(10): 1639-1650

Yang, H.; Rudge, D.G.; Koos, J.D.; Vaidialingam, B.; Yang, H.J.; Pavletich, N.P. 2013: MTOR kinase structure, mechanism and regulation. Nature 497(7448): 217-223

Wu, T.; Zhao, Y.; Wang, H.; Li, Y.; Shao, L.; Wang, R.; Lu, J.; Yang, Z.; Wang, J.; Zhao, Y. 2016: MTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors. Scientific Reports 6: 20250

Liang, S-Qing.; Bührer, E.D.; Berezowska, S.; Marti, T.M.; Xu, D.; Froment, Lène.; Yang, H.; Hall, S.R.R.; Vassella, E.; Yang, Z.; Kocher, G.J.; Amrein, M.A.; Riether, C.; Ochsenbein, A.F.; Schmid, R.A.; Peng, R-Wang. 2019: MTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer. Oncogene 38(5): 622-636

Chawsheen, M.A.; Dash, P.R. 2021: MTOR modulates resistance to gemcitabine in lung cancer in an MTORC2 dependent mechanism. Cellular Signalling 81: 109934

Danesh Pazhooh, R.; Rahnamay Farnood, P.; Asemi, Z.; Mirsafaei, L.; Yousefi, B.; Mirzaei, H. 2021: MTOR pathway and DNA damage response: a therapeutic strategy in cancer therapy. Dna Repair 104: 103142

Nie, X.; Zheng, J.; Cruciger, M.; Yang, P.; Mao, J.J. 2020: MTOR plays a pivotal role in multiple processes of enamel organ development principally through the mTORC1 pathway and in part via regulating cytoskeleton dynamics. Developmental Biology 467(1-2): 77-87

Matsubara, S.; Ding, Q.; Miyazaki, Y.; Kuwahata, T.; Tsukasa, K.; Takao, S. 2013: MTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions. Scientific Reports 3: 3230

Chen, R.; Duan, J.; Li, L.; Ma, Q.; Sun, Q.; Ma, J.; Li, C.; Zhou, X.; Chen, H.; Jing, Y.; Zhao, S.; Wu, X.; Zhang, H. 2017: MTOR promotes pituitary tumor development through activation of PTTG1. Oncogene 36(7): 979-988

Guo, F.; Li, J.; Du, W.; Zhang, S.; O'Connor, M.; Thomas, G.; Kozma, S.; Zingarelli, B.; Pang, Q.; Zheng, Y. 2013: MTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells. Leukemia 27(10): 2040-2046

Wang, L.; Liu, G.; Wu, N.; Dai, B.; Han, S.; Liu, Q.; Huang, F.; Chen, Z.; Xu, W.; Xia, D.; Gao, C. 2021: MTOR regulates GPVI-mediated platelet activation. Journal of Translational Medicine 19(1): 201

Zhang, X.; Li, L.; Li, Y.; Li, Z.; Zhai, W.; Sun, Q.; Yang, X.; Roth, M.; Lu, S. 2021: MTOR regulates PRMT1 expression and mitochondrial mass through STAT1 phosphorylation in hepatic cell. Biochimica et Biophysica Acta. Molecular Cell Research 1868(6): 119017

Araki, K.; Turner, A.P.; Shaffer, V.Oliva.; Gangappa, S.; Keller, S.A.; Bachmann, M.F.; Larsen, C.P.; Ahmed, R. 2009: MTOR regulates memory CD8 T-cell differentiation. Nature 460(7251): 108-112

Chen, G.; Tang, L.; Wei, W.; Li, Z.; Li, Y.; Duan, X.; Chen, H. 2016: MTOR regulates neuroprotective effect of immunized CD4+Foxp3+ T cells in optic nerve ischemia. Scientific Reports 6: 37805

Tokumura, K.; Iwahashi, S.; Park, G.; Ochiai, S.; Okayama, Y.; Fusawa, H.; Fukasawa, K.; Iezaki, T.; Hinoi, E. 2020: MTOR regulates skeletogenesis through canonical and noncanonical pathways. Biochemical and Biophysical Research Communications 533(1): 30-35

Dancey, J. 2010: MTOR signaling and drug development in cancer. Nature Reviews. Clinical Oncology 7(4): 209-219

Chen, J.; Long, F. 2018: MTOR signaling in skeletal development and disease. Bone Research 6: 1

Zhang, Y.C.; Wei, Q.Z.; Hu, Y.K.; Wu, L.; Li, D.L.; Wang, Z.J.; Liu, Q.Z.; Yang, X.F. 2021: MTOR signaling pathway-mediated autophagy involved in inhibition of osteoblast differentiation induced by cadmium in human bone marrow mesenchymal stem cells. Zhonghua Yu Fang Yi Xue Za Zhi 55(9): 1123-1128

Li, K.; Wu, H.; Wang, A.; Charron, J.; Mishina, Y.; Habib, S.L.; Liu, H.; Li, B. 2021: MTOR signaling regulates gastric epithelial progenitor homeostasis and gastric tumorigenesis via MEK1-ERKs and BMP-Smad1 pathways. Cell Reports 35(5): 109069

Petroulakis, E.; Mamane, Y.; Le Bacquer, O.; Shahbazian, D.; Sonenberg, N. 2006: MTOR signaling: implications for cancer and anticancer therapy. British Journal of Cancer 94(2): 195-199

Mossmann, D.; Park, S.; Hall, M.N. 2018: MTOR signalling and cellular metabolism are mutual determinants in cancer. Nature Reviews. Cancer 18(12): 744-757

Luo, Y-Xiao.; Han, H.; Shao, J.; Gao, Y.; Yin, X.; Zhu, W-Li.; Han, Y.; Shi, H-Shui. 2016: MTOR signalling in the nucleus accumbens shell is critical for augmented effect of TFF3 on behavioural response to cocaine. Scientific Reports 6: 27895

Sedda, S.; Dinallo, V.; Marafini, I.; Franzè, E.; Paoluzi, O.A.; Izzo, R.; Giuffrida, P.; Di Sabatino, A.; Corazza, G.R.; Monteleone, G. 2020: MTOR sustains inflammatory response in celiac disease. Scientific Reports 10(1): 10798

Kahn, B.B.; Myers, M.G. 2006: MTOR tells the brain that the body is hungry. Nature Medicine 12(6): 615-617

Schlingmann, K.P.; Jouret, F.ço.; Shen, K.; Nigam, A.; Arjona, F.J.; Dafinger, C.; Houillier, P.; Jones, D.P.; Kleinerüschkamp, F.; Oh, J.; Godefroid, N.; Eltan, M.; Güran, T.ül.; Burtey, S.ép.; Parotte, M.-C.; König, J.; Braun, A.; Bos, C.; Ibars Serra, M.; Rehmann, H.; Zwartkruis, F.J.T.; Renkema, K.Y.; Klingel, K.; Schulze-Bahr, E.; Schermer, B.; Bergmann, C.; Altmüller, J.; Thiele, H.; Beck, B.B.; Dahan, K.; Sabatini, D.; Liebau, M.C.; Vargas-Poussou, R.; Knoers, N.V.A.M.; Konrad, M.; de Baaij, J.H.F. 2021: MTOR-Activating Mutations in RRAGD Are Causative for Kidney Tubulopathy and Cardiomyopathy. Journal of the American Society of Nephrology: Jasn 32(11): 2885-2899

Granata, S.; Carratù, P.; Stallone, G.; Zaza, G. 2021: MTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis. Frontiers in Pharmacology 12: 710543

Xu, D.; Xie, R.; Xu, Z.; Zhao, Z.; Ding, M.; Chen, W.; Zhang, J.; Mao, E.; Chen, E.; Chen, Y.; Yang, K.; Zhou, T.; Fei, J. 2020: MTOR-Myc axis drives acinar-to-dendritic cell transition and the CD4 + T cell immune response in acute pancreatitis. Cell Death and Disease 11(6): 416

Zhu, M.-J.; Liu, B.-Y.; Shi, L.; Wang, X.; Wang, Y. 2020: MTOR-autophagy promotes pulmonary senescence through IMP1 in chronic toxicity of methamphetamine. Journal of Cellular and Molecular Medicine 24(20): 12082-12093

Yeh, H.-S.; Yong, J. 2020: MTOR-coordinated Post-Transcriptional Gene Regulations: from Fundamental to Pathogenic Insights. Journal of Lipid and Atherosclerosis 9(1): 8-22

Nguyen, L.H.; Anderson, A.E. 2018: MTOR-dependent alterations of Kv1.1 subunit expression in the neuronal subset-specific Pten knockout mouse model of cortical dysplasia with epilepsy. Scientific Reports 8(1): 3568

Napolitano, G.; Esposito, A.; Choi, H.; Matarese, M.; Benedetti, V.; Di Malta, C.; Monfregola, J.; Medina, D.Luis.; Lippincott-Schwartz, J.; Ballabio, A. 2018: MTOR-dependent phosphorylation controls TFEB nuclear export. Nature Communications 9(1): 3312

Li, C.; Chen, H.; Lan, Z.; He, S.; Chen, R.; Wang, F.; Liu, Z.; Li, K.; Cheng, L.; Liu, Y.; Sun, K.; Wan, X.; Chen, X.; Peng, H.; Li, L.; Zhang, Y.; Jing, Y.; Huang, M.; Wang, Y.; Wang, Y.; Jiang, J.; Zha, X.; Chen, L.; Zhang, H. 2019: MTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis. Cell Death and Differentiation 26(10): 2015-2028

LaSarge, C.L.; Pun, R.Y.K.; Gu, Z.; Riccetti, M.R.; Namboodiri, D.V.; Tiwari, D.; Gross, C.; Danzer, S.C. 2021: MTOR-driven neural circuit changes initiate an epileptogenic cascade. Progress in Neurobiology 200: 101974

Shimada, B.K.; Yorichika, N.; Higa, J.K.; Baba, Y.; Kobayashi, M.; Aoyagi, T.; Suhara, T.; Matsui, T. 2021: MTOR-mediated calcium transients affect cardiac function in ex vivo ischemia-reperfusion injury. Physiological reports 9(6): e14807

Gremke, N.; Polo, P.; Dort, A.; Schneikert, J.; Elmshäuser, S.; Brehm, C.; Klingmüller, U.; Schmitt, A.; Reinhardt, H.Christian.; Timofeev, O.; Wanzel, M.; Stiewe, T. 2020: MTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability. Nature Communications 11(1): 4684

Pagani, M.; Barsotti, N.; Bertero, A.; Trakoshis, S.; Ulysse, L.; Locarno, A.; Miseviciute, I.; De Felice, A.; Canella, C.; Supekar, K.; Galbusera, A.; Menon, V.; Tonini, R.; Deco, G.; Lombardo, M.V.; Pasqualetti, M.; Gozzi, A. 2021: MTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity. Nature Communications 12(1): 6084

Lawal, B.; Lee, C.-Y.; Mokgautsi, N.; Sumitra, M.R.; Khedkar, H.; Wu, A.T.H.; Huang, H.-S. 2021: MTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2',4'-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), with Consequent Anticancer Implications. Frontiers in Oncology 11: 656738

Dai, Q.; Xu, Z.; Ma, X.; Niu, N.; Zhou, S.; Xie, F.; Jiang, L.; Wang, J.; Zou, W. 2017: MTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression. Cell Death and Differentiation 24(11): 1886-1899

Khan, N. 2021: MTOR: a possible therapeutic target against SARS-CoV-2 infection. Archives of Stem Cell and Therapy 2(1): 5-7

Zoncu, R.; Efeyan, A.; Sabatini, D.M. 2011: MTOR: from growth signal integration to cancer, diabetes and ageing. Nature Reviews. Molecular Cell Biology 12(1): 21-35

Reho, J.J.; Guo, D.-F.; Morgan, D.A.; Rahmouni, K. 2021: MTORC1 (Mechanistic Target of Rapamycin Complex 1) Signaling in Endothelial and Smooth Muscle Cells Is Required for Vascular Function. Hypertension 77(2): 594-604

Dmitriev, A.; König, A.; Lang, V.; Diehl, S.; Kaufmann, R.; Pinter, A.; Buerger, C. 2021: MTORC1 - a potential player in the pathogenesis of hidradenitis suppurativa?. Journal of the European Academy of Dermatology and Venereology: Jeadv 35(7): E444-E447

Selen, E.S.; Wolfgang, M.J. 2021: MTORC1 Activation is Not Sufficient to Suppress Hepatic PPARα Signaling or Ketogenesis. Journal of Biological Chemistry 2021: 100884

An, E.; Friend, K. 2020: MTORC1 Enhances Early Phase Ribosome Processivity. Frontiers in Molecular Biosciences 7: 117

Ludwig, K.; Husain, R.A.; Rubio, I. 2020: MTORC1 Is not Principally Involved in the Induction of Human Endotoxin Tolerance. Frontiers in Immunology 11: 1515

Iwahashi, S.; Tokumura, K.; Park, G.; Ochiai, S.; Okayama, Y.; Fusawa, H.; Ohta, K.; Fukasawa, K.; Iezaki, T.; Hinoi, E. 2020: MTORC1 Overactivation Leads to Abnormalities in Skeletal Development. Biological and Pharmaceutical Bulletin 43(12): 1983-1986

Lim, J.; Munivez, E.; Jiang, M-Ming.; Song, I-Wen.; Gannon, F.; Keene, D.R.; Schweitzer, R.; Lee, B.H.; Joeng, K.Sang. 2017: MTORC1 Signaling is a Critical Regulator of Postnatal Tendon Development. Scientific Reports 7(1): 17175

Rosario, F.J.; Powell, T.L.; Gupta, M.B.; Cox, L.; Jansson, T. 2020: MTORC1 Transcriptional Regulation of Ribosome Subunits, Protein Synthesis, and Molecular Transport in Primary Human Trophoblast Cells. Frontiers in Cell and Developmental Biology 8: 583801

Choi, J-Heon.; Jo, H.Seok.; Lim, S.; Kim, H-Tai.; Lee, K.Woo.; Moon, K.Hwan.; Ha, T.; Kwak, S.Soo.; Kim, Y.; Lee, E.Jung.; Joe, C.O.; Kim, J.Woo. 2018: MTORC1 accelerates retinal development via the immunoproteasome. Nature Communications 9(1): 2502

Obraztsova, K.; Basil, M.C.; Rue, R.; Sivakumar, A.; Lin, S.M.; Mukhitov, A.R.; Gritsiuta, A.I.; Evans, J.F.; Kopp, M.; Katzen, J.; Robichaud, A.; Atochina-Vasserman, E.N.; Li, S.; Carl, J.; Babu, A.; Morley, M.P.; Cantu, E.; Beers, M.F.; Frank, D.B.; Morrisey, E.E.; Krymskaya, V.P. 2020: MTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline. Nature Communications 11(1): 5640

Ito, N.; Nishibori, Y.; Ito, Y.; Takagi, H.; Akimoto, Y.; Kudo, A.; Asanuma, K.; Sai, Y.; Miyamoto, K-Ichi.; Takenaka, H.; Yan, K. 2011: MTORC1 activation triggers the unfolded protein response in podocytes and leads to nephrotic syndrome. Laboratory Investigation; a Journal of Technical Methods and Pathology 91(11): 1584-1595

Malik, N.; Dunn, K.M.; Cassels, J.; Hay, J.; Estell, C.; Sansom, O.J.; Michie, A.M. 2019: MTORC1 activity is essential for erythropoiesis and B cell lineage commitment. Scientific Reports 9(1): 16917

Gandin, V.; Masvidal, L.; Cargnello, M.; Gyenis, L.; McLaughlan, S.; Cai, Y.; Tenkerian, C.; Morita, M.; Balanathan, P.; Jean-Jean, O.; Stambolic, V.; Trost, M.; Furic, L.; Larose, L.; Koromilas, A.E.; Asano, K.; Litchfield, D.; Larsson, O.; Topisirovic, I. 2016: MTORC1 and CK2 coordinate ternary and eIF4F complex assembly. Nature Communications 7: 11127

Riehle, K.J.; Yeh, M.M.; Yu, J.J.; Kenerson, H.L.; Harris, W.P.; Park, J.O.; Yeung, R.S. 2015: MTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 28(1): 103-110

Castets, P.; Rion, N.; Théodore, M.; Falcetta, D.; Lin, S.; Reischl, M.; Wild, F.; Guérard, L.; Eickhorst, C.; Brockhoff, M.; Guridi, M.; Ibebunjo, C.; Cruz, J.; Sinnreich, M.; Rudolf, Rüdiger.; Glass, D.J.; Rüegg, M.A. 2019: MTORC1 and PKB/Akt control the muscle response to denervation by regulating autophagy and HDAC4. Nature Communications 10(1): 3187

Lei, G.; Zhuang, L.; Gan, B. 2021: MTORC1 and ferroptosis: Regulatory mechanisms and therapeutic potential. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 43(8): E2100093

Losiewicz, M.K.; Elghazi, L.; Fingar, D.C.; Rajala, R.V.S.; Lentz, S.I.; Fort, P.E.; Abcouwer, S.F.; Gardner, T.W. 2020: MTORC1 and mTORC2 expression in inner retinal neurons and glial cells. Experimental Eye Research 197: 108131

Kim, L.C.; Cook, R.S.; Chen, J. 2017: MTORC1 and mTORC2 in cancer and the tumor microenvironment. Oncogene 36(16): 2191-2201

Ding, X.; Bloch, W.; Iden, S.; Rüegg, M.A.; Hall, M.N.; Leptin, M.; Partridge, L.; Eming, S.A. 2016: MTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. Nature Communications 7: 13226

Matsumoto, A.; Pasut, A.; Matsumoto, M.; Yamashita, R.; Fung, J.; Monteleone, E.; Saghatelian, A.; Nakayama, K.I.; Clohessy, J.G.; Pandolfi, P.Paolo. 2017: MTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature 541(7636): 228-232

Sengupta, S.; Peterson, T.R.; Laplante, M.; Oh, S.; Sabatini, D.M. 2010: MTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468(7327): 1100-1104

Pereyra, M.; Katche, C.; de Landeta, A.Belén.; Medina, J.H. 2018: MTORC1 controls long-term memory retrieval. Scientific Reports 8(1): 8759

Gaudette, B.T.; Jones, D.D.; Bortnick, A.; Argon, Y.; Allman, D. 2020: MTORC1 coordinates an immediate unfolded protein response-related transcriptome in activated B cells preceding antibody secretion. Nature Communications 11(1): 723

Zhang, Y.; Swanda, R.V.; Nie, L.; Liu, X.; Wang, C.; Lee, H.; Lei, G.; Mao, C.; Koppula, P.; Cheng, W.; Zhang, J.; Xiao, Z.; Zhuang, L.; Fang, B.; Chen, J.; Qian, S-Bing.; Gan, B. 2021: MTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nature Communications 12(1): 1589

Ling, N.X.Y.; Kaczmarek, A.; Hoque, A.; Davie, E.; Ngoei, K.R.W.; Morrison, K.R.; Smiles, W.J.; Forte, G.M.; Wang, T.; Lie, S.; Dite, T.A.; Langendorf, C.G.; Scott, J.W.; Oakhill, J.S.; Petersen, J. 2020: MTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress. Nature Metabolism 2(1): 41-49

Alayev, A.; Salamon, R.S.; Berger, S.M.; Schwartz, N.S.; Cuesta, R.; Snyder, R.B.; Holz, M.K. 2016: MTORC1 directly phosphorylates and activates ERα upon estrogen stimulation. Oncogene 35(27): 3535-3543

Dodd, K.M.; Yang, J.; Shen, M.H.; Sampson, J.R.; Tee, A.R. 2015: MTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 34(17): 2239-2250

Peng, H.; Liu, J.; Sun, Q.; Chen, R.; Wang, Y.; Duan, J.; Li, C.; Li, B.; Jing, Y.; Chen, X.; Mao, Q.; Xu, K-F.; Walker, C.L.; Li, J.; Wang, J.; Zhang, H. 2013: MTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development. Oncogene 32(39): 4702-4711

Huynh, H.; Wan, Y. 2018: MTORC1 impedes osteoclast differentiation via calcineurin and NFATc1. Communications Biology 1: 29

Yilmaz, Ömer.H.; Katajisto, P.; Lamming, D.W.; Gültekin, Y.; Bauer-Rowe, K.E.; Sengupta, S.; Birsoy, K.; Dursun, A.; Yilmaz, V.Onur.; Selig, M.; Nielsen, G.Petur.; Mino-Kenudson, M.; Zukerberg, L.R.; Bhan, A.K.; Deshpande, V.; Sabatini, D.M. 2012: MTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature 486(7404): 490-495

Villar, V.H.; Nguyen, T.Ly.; Delcroix, V.; Terés, S.; Bouchecareilh, M.; Salin, Bénédicte.; Bodineau, Cément.; Vacher, P.; Priault, M.; Soubeyran, P.; Durán, Rúl.V. 2017: MTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation. Nature Communications 8: 14124

James, M.H.; Quinn, R.K.; Ong, L.Kooi.; Levi, E.M.; Charnley, J.L.; Smith, D.W.; Dickson, P.W.; Dayas, C.V. 2014: MTORC1 inhibition in the nucleus accumbens 'protects' against the expression of drug seeking and 'relapse' and is associated with reductions in GluA1 AMPAR and CAMKIIα levels. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 39(7): 1694-1702

Chen, Y.; Li, W-Wen.; Peng, P.; Zhao, W-Heng.; Tian, Y-Jun.; Huang, Y.; Xia, S.; Chen, Y. 2019: MTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial-mesenchymal transition. Acta Pharmacologica Sinica 40(8): 1085-1094

Bravo-Sagua, R.; López-Crisosto, C.; Parra, V.; Rodriguez-Peña, M.; Rothermel, B.A.; Quest, A.F.G.; Lavandero, S. 2016: MTORC1 inhibitor rapamycin and ER stressor tunicamycin induce differential patterns of ER-mitochondria coupling. Scientific Reports 6: 36394

Le Tourneau, C.; Faivre, S.; Serova, M.; Raymond, E. 2008: MTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?. British Journal of Cancer 99(8): 1197-1203

Labbé, Sébastien.M.; Mouchiroud, M.; Caron, A.; Secco, B.; Freinkman, E.; Lamoureux, G.; Gélinas, Y.; Lecomte, R.; Bossé, Y.; Chimin, P.; Festuccia, W.T.; Richard, D.; Laplante, M. 2016: MTORC1 is Required for Brown Adipose Tissue Recruitment and Metabolic Adaptation to Cold. Scientific Reports 6: 37223

Faham, N.; Zhao, L.; Welm, A.L. 2018: MTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential. Npj Breast Cancer 4: 36

Cheong, H.; Klionsky, D.J. 2015: MTORC1 maintains metabolic balance. Cell Research 25(10): 1085-1086

Zhang, W.; Ding, M-Lei.; Zhang, J-Nian.; Qiu, J-Ru.; Shen, Y-Hui.; Ding, X-Yi.; Deng, L-Fu.; Zhang, W-Bin.; Zhu, J. 2015: MTORC1 maintains the tumorigenicity of SSEA-4(+) high-grade osteosarcoma. Scientific Reports 5: 9604

You, J-Sung.; Kim, K.; Steinert, N.D.; Chen, J.; Hornberger, T.A. 2021: MTORC1 mediates fiber type-specific regulation of protein synthesis and muscle size during denervation. Cell Death Discovery 7(1): 74

Zhou, Y.; Liang, Y.; Kreek, M.J. 2020: MTORC1 pathway is involved in the kappa opioid receptor activation-induced increase in excessive alcohol drinking in mice. Pharmacology Biochemistry and Behavior 195: 172954

Zhang, Y.; Stefanovic, B. 2017: MTORC1 phosphorylates LARP6 to stimulate type I collagen expression. Scientific Reports 7: 41173

Martin, S.K.; Fitter, S.; El Khawanky, N.; Grose, R.H.; Walkley, C.R.; Purton, L.E.; Ruegg, M.A.; Hall, M.N.; Gronthos, S.; Zannettino, A.C.W. 2018: MTORC1 plays an important role in osteoblastic regulation of B-lymphopoiesis. Scientific Reports 8(1): 14501

Luo, X.; Yin, J.; Miao, S.; Feng, W.; Ning, T.; Xu, S.; Huang, S.; Zhang, S.; Liao, Y.; Hao, C.; Wu, B.; Ma, D. 2021: MTORC1 promotes mineralization via p53 pathway. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(2): e21325

McHugh, J. 2019: MTORC1 promotes pathological bone-cartilage interplay. Nature Reviews. Rheumatology 15(4): 190

Yan, B.; Zhang, Z.; Jin, D.; Cai, C.; Jia, C.; Liu, W.; Wang, T.; Li, S.; Zhang, H.; Huang, B.; Lai, P.; Wang, H.; Liu, A.; Zeng, C.; Cai, D.; Jiang, Y.; Bai, X. 2016: MTORC1 regulates PTHrP to coordinate chondrocyte growth, proliferation and differentiation. Nature Communications 7: 11151

Liu, Y.; Xu, H.; An, M. 2017: MTORC1 regulates apoptosis and cell proliferation in pterygium via targeting autophagy and FGFR3. Scientific Reports 7(1): 7339

Ahmed, K.Ashfaque.; Xiang, J. 2017: MTORC1 regulates mannose-6-phosphate receptor transport and T-cell vulnerability to regulatory T cells by controlling kinesin KIF13A. Cell Discovery 3: 17011

Kato, H.; Nakajima, S.; Saito, Y.; Takahashi, S.; Katoh, R.; Kitamura, M. 2012: MTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway. Cell Death and Differentiation 19(2): 310-320

Catania, C.; Binder, E.; Cota, D. 2011: MTORC1 signaling in energy balance and metabolic disease. International Journal of Obesity 35(6): 751-761

Yang, K.; Zhang, Y.; Xu, C.; Li, X.; Li, D. 2016: MTORC1 signaling is crucial for regulatory T cells to suppress macrophage-mediated inflammatory response after acute myocardial infarction. Immunology and Cell Biology 94(3): 274-284

Kaur, H.; Moreau, R.ég. 2021: MTORC1 silencing during intestinal epithelial Caco-2 cell differentiation is mediated by the activation of the AMPK/TSC2 pathway. Biochemical and Biophysical Research Communications 545: 183-188

Kelsey, I.; Zbinden, M.; Byles, V.; Torrence, M.; Manning, B.D. 2017: MTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci. Scientific Reports 7(1): 16112

Komatsu, N.; Fujita, Y.; Matsuda, M.; Aoki, K. 2015: MTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells. Oncogene 34(45): 5607-5616

Zabala-Letona, A.; Arruabarrena-Aristorena, A.; Martín-Martín, N.; Fernandez-Ruiz, S.; Sutherland, J.D.; Clasquin, M.; Tomas-Cortazar, J.; Jimenez, J.; Torres, I.; Quang, P.; Ximenez-Embun, P.; Bago, R.; Ugalde-Olano, A.; Loizaga-Iriarte, A.; Lacasa-Viscasillas, I.; Unda, M.; Torrano, Vónica.; Cabrera, D.; van Liempd, S.M.; Cendon, Y.; Castro, E.; Murray, S.; Revandkar, A.; Alimonti, A.; Zhang, Y.; Barnett, A.; Lein, G.; Pirman, D.; Cortazar, A.R.; Arreal, L.; Prudkin, L.; Astobiza, I.; Valcarcel-Jimenez, L.; Zuñiga-García, P.; Fernandez-Dominguez, I.; Piva, M.; Caro-Maldona 2017: MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer. Nature 547(7661): 109-113

Ding, H.; Song, Y.; Huang, X.; Wang, L.; Luo, S.; Zhang, H.; Pan, H.; Jiang, W.; Qian, J.; Yao, G.; Wen, L.; Zhang, Y. 2020: MTORC1-dependent TFEB nucleus translocation and pro-survival autophagy induced by zeolitic imidazolate framework-8. Biomaterials Science 8(15): 4358-4369

Pazini, F.L.; Rosa, J.M.; Camargo, A.; Fraga, D.B.; Moretti, M.; Siteneski, A.; Rodrigues, A.Lúcia.S. 2020: MTORC1-dependent signaling pathway underlies the rapid effect of creatine and ketamine in the novelty-suppressed feeding test. Chemico-BiologicalInteractions 332: 109281

Palmieri, M.; Pal, R.; Nelvagal, H.R.; Lotfi, P.; Stinnett, G.R.; Seymour, M.L.; Chaudhury, A.; Bajaj, L.; Bondar, V.V.; Bremner, L.; Saleem, U.; Tse, D.Y.; Sanagasetti, D.; Wu, S.M.; Neilson, J.R.; Pereira, F.A.; Pautler, R.G.; Rodney, G.G.; Cooper, J.D.; Sardiello, M. 2017: MTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nature Communications 8: 14338

Lampada, A.; O'Prey, J.; Szabadkai, G.; Ryan, K.M.; Hochhauser, D.; Salomoni, P. 2017: MTORC1-independent autophagy regulates receptor tyrosine kinase phosphorylation in colorectal cancer cells via an mTORC2-mediated mechanism. Cell Death and Differentiation 24(6): 1045-1062

Pema, M.; Drusian, L.; Chiaravalli, M.; Castelli, M.; Yao, Q.; Ricciardi, S.; Somlo, S.; Qian, F.; Biffo, S.; Boletta, A. 2016: MTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex. Nature Communications 7: 10786

Haloul, M.; Oliveira, E.R.A.; Kader, M.; Wells, J.Z.; Tominello, T.R.; El Andaloussi, A.; Yates, C.C.; Ismail, N. 2019: MTORC1-mediated polarization of M1 macrophages and their accumulation in the liver correlate with immunopathology in fatal ehrlichiosis. Scientific Reports 9(1): 14050

Seo, S.Un.; Woo, S.Min.; Lee, H-Shik.; Kim, S.Hyun.; Min, K-Jin.; Kwon, T.Kyu. 2018: MTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy. Oncogene 37(38): 5205-5220

Wrobel, L.; Siddiqi, F.H.; Hill, S.M.; Son, S.M.; Karabiyik, C.; Kim, H.; Rubinsztein, D.C. 2020: MTORC2 Assembly Is Regulated by USP9X-Mediated Deubiquitination of RICTOR. Cell Reports 33(13): 108564

Guo, Z.; Zhao, K.; Feng, X.; Yan, D.; Yao, R.; Chen, Y.; Bao, L.; Wang, Z. 2019: MTORC2 Regulates Lipogenic Gene Expression through PPAR γ to Control Lipid Synthesis in Bovine Mammary Epithelial Cells. Biomed Research International 2019: 5196028

Wen, Y-Tseng.; Zhang, J-Rong.; Kapupara, K.; Tsai, R-Kung. 2019: MTORC2 activation protects retinal ganglion cells via Akt signaling after autophagy induction in traumatic optic nerve injury. Experimental and Molecular Medicine 51(8): 1-11

Suryawanshi, R.K.; Patil, C.D.; Agelidis, A.; Koganti, R.; Ames, J.M.; Koujah, L.; Yadavalli, T.; Madavaraju, K.; Shantz, L.M.; Shukla, D. 2021: MTORC2 confers neuroprotection and potentiates immunity during virus infection. Nature Communications 12(1): 6020

Huang, W.; Zhu, P.Jun.; Zhang, S.; Zhou, H.; Stoica, L.; Galiano, M.; Krnjević, Kšimir.; Roman, G.; Costa-Mattioli, M. 2013: MTORC2 controls actin polymerization required for consolidation of long-term memory. Nature Neuroscience 16(4): 441-448

Khan, M.W.; Biswas, D.; Ghosh, M.; Mandloi, S.; Chakrabarti, S.; Chakrabarti, P. 2015: MTORC2 controls cancer cell survival by modulating gluconeogenesis. Cell Death Discovery 1: 15016

Lambrianidou, A.; Sereti, E.; Soupsana, K.; Komini, C.; Dimas, K.; Trangas, T. 2021: MTORC2 deploys the mRNA binding protein IGF2BP1 to regulate c-MYC expression and promote cell survival. Cellular Signalling 80: 109912

Yang, H-Wei.; Hong, H-Ling.; Luo, W-Wei.; Dai, C-Mei.; Chen, X-Yi.; Wang, L-Ping.; Li, Q.; Li, Z-Qing.; Liu, P-Qing.; Li, Z-Ming. 2018: MTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt/GSK-3β/C/EBPα signaling pathway. Acta Pharmacologica Sinica 39(12): 1837-1846

Wang, X.; Proud, C.G. 2016: MTORC2 is a tyrosine kinase. Cell Research 26(1): 1-2

Wang, X.; Proud, C.G. 2016: MTORC2 is a tyrosine kinase. Cell Research 26(2): 266

Sanvee, G.M.; Hitzfeld, L.; Bouitbir, J.; Krähenbühl, S. 2021: MTORC2 is an important target for simvastatin-associated toxicity in C2C12 cells and mouse skeletal muscle - Roles of Rap1 geranylgeranylation and mitochondrial dysfunction. Biochemical Pharmacology 192: 114750

Yin, Y.; Hua, H.; Li, M.; Liu, S.; Kong, Q.; Shao, T.; Wang, J.; Luo, Y.; Wang, Q.; Luo, T.; Jiang, Y. 2016: MTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR. Cell Research 26(1): 46-65

Maiti, S.; Mondal, S.; Satyavarapu, E.M.; Mandal, C. 2017: MTORC2 regulates hedgehog pathway activity by promoting stability to Gli2 protein and its nuclear translocation. Cell Death and Disease 8(7): E2926

Tian, L.; Chen, C.; Guo, Y.; Zhang, F.; Mi, J.; Feng, Q.; Lin, S.; Xi, N.; Tian, J.; Yu, L.; Chen, Y.; Cao, M.; Lai, C.; Fan, J.; Zhang, Y.; Chen, G. 2021: MTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer. Neoplasia 23(7): 643-652

Hallowell, R.W.; Collins, S.L.; Craig, J.M.; Zhang, Y.; Oh, M.; Illei, P.B.; Chan-Li, Y.; Vigeland, C.L.; Mitzner, W.; Scott, A.L.; Powell, J.D.; Horton, M.R. 2017: MTORC2 signalling regulates M2 macrophage differentiation in response to helminth infection and adaptive thermogenesis. Nature Communications 8: 14208

Zhu, P.Jun.; Chen, C-Ju.; Mays, J.; Stoica, L.; Costa-Mattioli, M. 2018: MTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors. Nature Neuroscience 21(6): 799-802

Martinez Calejman, C.; Trefely, S.; Entwisle, S.W.; Luciano, A.; Jung, S.M.; Hsiao, W.; Torres, A.; Hung, C.M.; Li, H.; Snyder, N.W.; Villén, J.; Wellen, K.E.; Guertin, D.A. 2020: MTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis. Nature Communications 11(1): 575

Chen, L.; Wu, J.; Pier, E.; Zhao, Y.; Shen, Z. 2013: MTORC2-PKBα/Akt1 Serine 473 phosphorylation axis is essential for regulation of FOXP3 Stability by chemokine CCL3 in psoriasis. Journal of Investigative Dermatology 133(2): 418-428

Holmes, B.; Benavides-Serrato, A.; Saunders, J.T.; Kumar, S.; Nishimura, R.N.; Gera, J. 2021: MTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics. Neoplasia 23(9): 951-965

Holmes, B.; Benavides-Serrato, A.; Freeman, R.S.; Landon, K.A.; Bashir, T.; Nishimura, R.N.; Gera, J. 2018: MTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma. Oncogene 37(6): 732-743

Lv, Z.; Yue, Z.; Shao, Y.; Li, C.; Zhao, X.; Guo, M. 2021: MTORC2/Rictor is essential for coelomocyte endocytosis in Apostichopus japonicus. Developmental and Comparative Immunology 118: 104000

Ballesteros-Álvarez, J.é; Andersen, J.K. 2021: MTORC2: the other mTOR in autophagy regulation. Aging Cell 20(8): E13431

Josselyn, S.A.; Frankland, P.W. 2013: MTORC2: actin on your memory. Nature Neuroscience 16(4): 379-380

Crino, P.B. 2020: MTORopathies: a Road Well-Traveled. Epilepsy Currents 20(6_Suppl): 64s-66s

Chatre, L.; Ricchetti, M. 2021: MTRIP, an Imaging Tool to Investigate Mitochondrial DNA Dynamics in Physiology and Disease at the Single-Cell Resolution. Methods in Molecular Biology 2275: 247-263

Cheymol, J.; Lechat, P. 1947: MTreatment of mercury intoxication. Annales Pharmaceutiques Francaises 5(4): 262-265

Jacobson, G.P. 2021: MVEMP: the new Kid on the Block. Journal of the American Academy of Audiology 32(5): 275

Moreno-Fernández, R.D.; Pérez-Martín, M.; Castilla-Ortega, E.; Rosell Del Valle, C.; García-Fernández, M.I.; Chun, J.; Estivill-Torrús, G.; Rodríguez de Fonseca, F.; Santín, L.J.; Pedraza, C. 2017: MaLPA1-null mice as an endophenotype of anxious depression. Translational Psychiatry 7(4): E1077

Takahashi, C.; Kusakabe, M.; Suzuki, T.; Miyatake, K.; Nishida, E. 2015: Mab21-l3 regulates cell fate specification of multiciliate cells and ionocytes. Nature Communications 6: 6017

Nishida, H.; Sawada, K. 2001: Macho-1 encodes a localized mRNA in ascidian eggs that specifies muscle fate during embryogenesis. Nature 409(6821): 724-729

Xie, S-Juan.; Diao, L-Ting.; Cai, N.; Zhang, L-Ting.; Xiang, S.; Jia, C-Chang.; Qiu, D-Bo.; Liu, C.; Sun, Y-Jia.; Lei, H.; Hou, Y-Rui.; Tao, S.; Hu, Y-Xia.; Xiao, Z-Dong.; Zhang, Q. 2021: MascRNA and its parent lncRNA MALAT1 promote proliferation and metastasis of hepatocellular carcinoma cells by activating ERK/MAPK signaling pathway. Cell Death Discovery 7(1): 110

Zhang, Z.; Liang, X.; Qin, W.; Yu, S.; Xie, Y. 2020: MatFR: a MATLAB toolbox for feature ranking. Bioinformatics 36(19): 4968-4969

McBroome, J.; Thornlow, B.; Hinrichs, A.S.; De Maio, N.; Goldman, N.; Haussler, D.; Corbett-Detig, R.; Turakhia, Y. 2021: MatUtils: Tools to Interpret and Manipulate Mutation Annotated Trees. Biorxiv: the Preprint Server for Biology 2021

Marongiu, L.; Shain, E.B.; Martinelli, M.; Pagliari, M.; Allgayer, H. 2020: MaxRatio improves the detection of samples with abnormal amplification profiles on QIAgen's artus HIV-1 qPCR assay. F1000research 9: 1030

Jiang, R.; Li, W.V.; Li, J.J. 2021: MbImpute: an accurate and robust imputation method for microbiome data. Genome Biology 22(1): 192

Nilforooshan, M.A. 2020: Mbend: an R package for bending non-positive-definite symmetric matrices to positive-definite. Bmc Genetics 21(1): 97

Hicks, S.C.; Liu, R.; Ni, Y.; Purdom, E.; Risso, D. 2021: Mbkmeans: Fast clustering for single cell data using mini-batch k-means. Plos Computational Biology 17(1): E1008625

Barbieri, N.L.; Pimenta, R.L.; de Melo, D.A.; Nolan, L.K.; de Souza, M.M.S.; Logue, C.M. 2021: Mcr-1 Identified in Fecal Escherichia coli and Avian Pathogenic E. coli (APEC) from Brazil. Frontiers in Microbiology 12: 659613

Liu, Y.-Y.; Zhou, Q.; He, W.; Lin, Q.; Yang, J.; Liu, J.-H. 2020: Mcr-1 and plasmid prevalence in Escherichia coli from livestock. LANCET. Infectious Diseases 20(10): 1126

Hou, S.; Pfreundt, U.; Miller, D.; Berman-Frank, I.; Hess, W.R. 2016: MdRNA-Seq analysis of marine microbial communities from the northern Red Sea. Scientific Reports 6: 35470

Inoue, S.; Hartman, A.; Branch, C.D.; Bucana, C.D.; Bekele, B.N.; Stephens, L.Clifton.; Chada, S.; Ramesh, R. 2007: Mda-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft. Molecular Therapy: the Journal of the American Society of Gene Therapy 15(2): 287-294

Kondo, S.; Kondo, Y.; Hara, H.; Kaakaji, R.; Peterson, J.W.; Morimura, T.; Takeuchi, J.; Barnett, G.H. 1996: Mdm2 gene mediates the expression of mdr1 gene and P-glycoprotein in a human glioblastoma cell line. British Journal of Cancer 74(8): 1263-1268

Mastronikolis, N.; Ragos, V.; Fotiades, P.; Papanikolaou, V.; Kyrodimos, E.; Chrysovergis, A.; Mastronikolis, S.; Tsiambas, E. 2020: Mdm2 oncogene in laryngeal squamous cell carcinoma. Journal of Buon: Official Journal of the Balkan Union of Oncology 25(2): 594-596

Bull, E.K.; Chakrabarty, S.; Brodsky, I.; Haines, D.S. 1998: Mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells. Oncogene 16(17): 2249-2257

Yap, D.B.; Hsieh, J.K.; Chan, F.S.; Lu, X. 1999: Mdm2: a bridge over the two tumour suppressors, p53 and Rb. Oncogene 18(53): 7681-7689

Mikutis, S.; Gu, M.; Sendinc, E.; Hazemi, M.E.; Kiely-Collins, H.; Aspris, D.; Vassiliou, G.S.; Shi, Y.; Tzelepis, K.; Bernardes, G.ça.J.L. 2020: MeCLICK-Seq, a Substrate-Hijacking and RNA Degradation Strategy for the Study of RNA Methylation. Acs Central Science 6(12): 2196-2208

Ciuculete, D.M.; Voisin, S.; Kular, L.; Jonsson, J.ör.; Rask-Andersen, M.; Mwinyi, J.; Schiöth, H.B. 2020: MeQTL and ncRNA functional analyses of 102 GWAS-SNPs associated with depression implicate HACE1 and SHANK2 genes. Clinical Epigenetics 12(1): 99

Yang, T-Ying.; Hung, W-Wen.; Lin, L.; Hung, W-Chun.; Tseng, S-Pin. 2017: MecA-related structure in methicillin-resistant coagulase-negative staphylococci from street food in Taiwan. Scientific Reports 7: 42205

Mori, Y.; Ichiyanagi, K. 2021: MelRNA-seq for Expression Analysis of SINE RNAs and other Medium-Length Non-Coding RNAs. Mobile Dna 12(1): 15

Calderone, A.; Castagnoli, L.; Cesareni, G. 2013: Mentha: a resource for browsing integrated protein-interaction networks. Nature Methods 10(8): 690-691

Zhang, S.; Xie, D.; Zhang, Q. 2021: Mesenchymal stem cells plus bone repair materials as a therapeutic strategy for abnormal bone metabolism: Evidence of clinical efficacy and mechanisms of action implied. Pharmacological Research 172: 105851

Mazumdar, Z.H.; Sharma, D.; Mukherjee, A.; Basu, S.; Shukla, P.K.; Jha, T.; Sengupta, D. 2020: Meso-Thiophenium Porphyrins and their Zn(II) Complexes: a new Category of Cationic Photosensitizers. Acs Medicinal Chemistry Letters 11(10): 2041-2047

Dukh, M.; Tabaczynski, W.A.; Seetharaman, S.; Ou, Z.; Kadish, K.M.; D'Souza, F.; Pandey, R.K. 2020: Meso- and β-Pyrrole-Linked Chlorin-Bacteriochlorin Dyads for Promoting Far-Red FRET and Singlet Oxygen Production. Chemistry 26(65): 14996-15006

Berenbaum, M.C.; Akande, S.L.; Bonnett, R.; Kaur, H.; Ioannou, S.; White, R.D.; Winfield, U.J. 1986: Meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. British Journal of Cancer 54(5): 717-725

Graham Linck, E.J.; Richmond, P.A.; Tarailo-Graovac, M.; Engelke, U.; Kluijtmans, L.A.J.; Coene, K.L.M.; Wevers, R.A.; Wasserman, W.; van Karnebeek, C.D.M.; Mostafavi, S. 2020: MetPropagate: network-guided propagation of metabolomic information for prioritization of metabolic disease genes. Npj Genomic Medicine 5: 25

Graham Linck, E.J.; Richmond, P.A.; Tarailo-Graovac, M.; Engelke, U.; Kluijtmans, L.A.J.; Coene, K.L.M.; Wevers, R.A.; Wasserman, W.; van Karnebeek, C.D.M.; Mostafavi, S. 2020: MetPropagate: network-guided propagation of metabolomic information for prioritization of metabolic disease genes. Npj Genomic Medicine 5(1): 25

Williams, A.F.; White, A.J.P.; Spivey, A.C.; Cordier, C.J. 2020: Meta-Selective C-H functionalisation of aryl boronic acids directed by a MIDA-derived boronate ester. Chemical Science 11(12): 3301-3306

Spencer, A.R.A.; Korde, R.; Font, M.; Larrosa, I. 2020: Meta-Selective olefination of fluoroarenes with alkynes using CO2 as a traceless directing group. Chemical Science 11(16): 4204-4208

Liu, Y.; Chen, C.; Sun, L.-Y.; Gao, H.; Zhen, J.-B.; Yang, K.-W. 2020: Meta-Substituted benzenesulfonamide: a potent scaffold for the development of metallo-β-lactamase ImiS inhibitors. Rsc Medicinal Chemistry 11(2): 259-267

Kolmogorov, M.; Bickhart, D.M.; Behsaz, B.; Gurevich, A.; Rayko, M.; Shin, S.Bong.; Kuhn, K.; Yuan, J.; Polevikov, E.; Smith, T.P.L.; Pevzner, P.A. 2020: MetaFlye: scalable long-read metagenome assembly using repeat graphs. Nature Methods 17(11): 1103-1110

Matsuda, F.; Maeda, K.; Taniguchi, T.; Kondo, Y.; Yatabe, F.; Okahashi, N.; Shimizu, H. 2021: Mfapy: An open-source Python package for 13C-based metabolic flux analysis. Metabolic Engineering Communications 13: E00177

Andrés-León, E.; Núñez-Torres, Río.; Rojas, A.M. 2016: MiARma-Seq: a comprehensive tool for miRNA, mRNA and circRNA analysis. Scientific Reports 6: 25749

Stojković, V.; Weinberg, D.E.; Fujimori, D.G.ć 2021: MiCLIP-MaPseq Identifies Substrates of Radical SAM RNA-Methylating Enzyme Using Mechanistic Cross-Linking and Mismatch Profiling. Methods in Molecular Biology 2298: 105-122

Castoldi, M.; Schmidt, S.; Benes, V.; Hentze, M.W.; Muckenthaler, M.U. 2008: MiChip: an array-based method for microRNA expression profiling using locked nucleic acid capture probes. Nature Protocols 3(2): 321-329

Peace, R.J.; Sheikh Hassani, M.; Green, J.R. 2019: MiPIE: NGS-based Prediction of miRNA Using Integrated Evidence. Scientific Reports 9(1): 1548

Hippen, A.A.; Falco, M.M.; Weber, L.M.; Erkan, E.P.; Zhang, K.; Doherty, J.A.; Vähärautio, A.; Greene, C.S.; Hicks, S.C. 2021: MiQC: An adaptive probabilistic framework for quality control of single-cell RNA-sequencing data. Plos Computational Biology 17(8): E1009290

Chen, C.; Zhou, Y.; Ding, P.; He, L. 2021: MiR-1 Targeted Downregulation of Bcl-2 Increases Chemosensitivity of Lung Cancer Cells. Genetic Testing and Molecular Biomarkers 25(8): 540-545

Gutiérrez-Pérez, P.; Santillán, E.M.; Lendl, T.; Wang, J.; Schrempf, A.; Steinacker, T.L.; Asparuhova, M.; Brandstetter, M.; Haselbach, D.; Cochella, L. 2021: MiR-1 sustains muscle physiology by controlling V-ATPase complex assembly. Science Advances 7(42): Eabh 1434

Jiao, D.; Jiang, C.; Zhu, L.; Zheng, J.; Liu, X.; Liu, X.; Chen, J.; Tang, X.; Chen, Q. 2021: MiR-1/133a and miR-206/133b clusters overcome HGF induced gefitinib resistance in non-small cell lung cancers with EGFR sensitive mutations. Journal of Drug Targeting 2021: 1-14

Lund, A.H. 2010: MiR-10 in development and cancer. Cell Death and Differentiation 17(2): 209-214

Ge, Y.; Shu, J.; Shi, G.; Yan, F.; Li, Y.; Ding, H. 2021: MiR-100 Suppresses the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma Cells via Targeting CXCR7. Journal of Immunology Research 2021: 9920786

Wang, C.; Zhang, Y.; Jiang, Z.; Bai, H.; Du, Z. 2022: MiR-100 alleviates the inflammatory damage and apoptosis of H2O2-induced human umbilical vein endothelial cells via inactivation of Notch signaling by targeting MMP9. Vascular 30(1): 151-161

Yang, G.; Gong, Y.; Wang, Q.; Wang, L.; Zhang, X. 2017: MiR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation. Oncogene 36(8): 1023-1037

Lin, L.; Huang, Y.; Zhuang, W.; Lin, P.; Ma, X. 2020: MiR-100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR. Experimental Hematology and Oncology 9: 25

Wang, W.; Liu, Y.; Guo, J.; He, H.; Mi, X.; Chen, C.; Xie, J.; Wang, S.; Wu, P.; Cao, F.; Bai, L.; Si, Q.; Xiang, R.; Luo, Y. 2018: MiR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer. Oncogenesis 7(12): 97

Zhu, Y.; Lin, A.; Zheng, Y.; Xie, X.; He, Q.; Zhong, W. 2020: MiR-100 rs1834306 A>G Increases the Risk of Hirschsprung Disease in Southern Chinese Children. Pharmacogenomics and Personalized Medicine 13: 283-288

Gebeshuber, C.A.; Martinez, J. 2013: MiR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling. Oncogene 32(27): 3306-3310

Ye, Y.; Li, S.-L.; Wang, J.-J. 2020: MiR-100-5p Downregulates mTOR to Suppress the Proliferation, Migration, and Invasion of Prostate Cancer Cells. Frontiers in Oncology 10: 578948

Zhang, J.; Li, Z.; Huang, J.; Chen, S.; Yin, H.; Tian, J.; Qu, L. 2020: MiR-101 inhibits feline herpesvirus 1 replication by targeting cellular suppressor of cytokine signaling 5 (SOCS5). Veterinary Microbiology 245: 108707

Huang, Z.; Wu, X.; Li, J. 2021: MiR-101 suppresses colon cancer cell migration through the regulation of EZH2. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 113(4): 255-260

Meng, X.; Sun, Y.; Liu, S.; Mu, Y. 2021: MiR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5. Oncology Letters 21(4): 282

Li, Z.; Qu, Z.; Wang, Y.; Qin, M.; Zhang, H. 2020: MiR-101-3p sensitizes non-small cell lung cancer cells to irradiation. Open Medicine 15(1): 413-423

Natarelli, L.; Geißler, C.; Csaba, G.; Wei, Y.; Zhu, M.; di Francesco, A.; Hartmann, P.; Zimmer, R.; Schober, A. 2018: MiR-103 promotes endothelial maladaptation by targeting lncWDR59. Nature Communications 9(1): 2645

Han, L-Li.; Yin, X-Ran.; Zhang, S-Qun. 2018: MiR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2. International Journal of Oncology 53(6): 2433-2444

Li, W.; Wang, S.-S.; Shan, B.-Q.; Qin, J.-B.; Zhao, H.-Y.; Tian, M.-L.; He, H.; Cheng, X.; Zhang, X.-H.; Jin, G.-H. 2022: MiR-103-3p targets Ndel1 to regulate neural stem cell proliferation and differentiation. Neural Regeneration Research 17(2): 401-408

Chen, H-Yi.; Lang, Y-Dong.; Lin, H-Nan.; Liu, Y-Ru.; Liao, C-Chieh.; Nana, Aé.Wendindondé.; Yen, Y.; Chen, R-Hwa. 2019: MiR-103/107 prolong Wnt/β-catenin signaling and colorectal cancer stemness by targeting Axin2. Scientific Reports 9(1): 9687

Li, P.; Liu, C.; Qian, L.; Zheng, Z.; Li, C.; Lian, Z.; Liu, J.; Zhang, Z.; Wang, L. 2021: MiR-10396b-3p inhibits mechanical stress-induced ligamentum flavum hypertrophy by targeting IL-11. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(6): e21676

Li, J.; He, W.; Wang, Y.; Zhao, J.; Zhao, X. 2020: MiR-103a-3p alleviates oxidative stress, apoptosis, and immune disorder in oxygen-glucose deprivation-treated BV2 microglial cells and rats with cerebral ischemia-reperfusion injury by targeting high mobility group box 1. Annals of Translational Medicine 8(20): 1296

Zhou, J.; Zhao, Y.; Li, Z.; Zhu, M.; Wang, Z.; Li, Y.; Xu, T.; Feng, D.; Zhang, S.; Tang, F.; Yao, J. 2020: MiR-103a-3p regulates mitophagy in Parkinson's disease through Parkin/Ambra1 signaling. Pharmacological Research 160: 105197

Zhang, H.-Y.; Ma, J.-H. 2020: MiR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC). Cancer Management and Research 12: 11491-11499

Heng, J.; Wu, D.; Lu, S.; Zhao, Y. 2020: MiR-106a Targets Anoctamin 1 (ANO1) to Regulate Lipopolysaccharide (LPS)-Induced Inflammatory Response in Macrophages. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 26: E922479

Sanctuary, M.R.; Huang, R.H.; Jones, A.A.; Luck, M.E.; Aherne, C.M.; Jedlicka, P.; de Zoeten, E.F.; Collins, C.B. 2019: MiR-106a deficiency attenuates inflammation in murine IBD models. Mucosal Immunology 12(1): 200-211

Jung, J.-H.; Ikeda, G.; Tada, Y.; von Bornstädt, D.; Santoso, M.R.; Wahlquist, C.; Rhee, S.; Jeon, Y.-J.; Yu, A.C.; O'brien, C.G.; Red-Horse, K.; Appel, E.A.; Mercola, M.; Woo, J.; Yang, P.C. 2021: MiR-106a-363 cluster in extracellular vesicles promotes endogenous myocardial repair via Notch3 pathway in ischemic heart injury. Basic Research in Cardiology 116(1): 19

Yu, D.; Shin, H-Soo.; Lee, Y.Song.; Lee, Y.Chan. 2014: MiR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells. Laboratory Investigation; a Journal of Technical Methods and Pathology 94(12): 1370-1381

Zhang, J.; Chen, D.; Liang, S.; Wang, J.; Liu, C.; Nie, C.; Shan, Z.; Wang, L.; Fan, Q.; Wang, F. 2018: MiR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC. Oncology Letters 15(4): 4619-4626

Shi, Y.; Zhang, B.; Zhu, J.; Huang, W.; Han, B.; Wang, Q.; Qi, C.; Wang, M.; Liu, F. 2020: MiR-106b-5p Inhibits IRF1/IFN-β Signaling to Promote M2 Macrophage Polarization of Glioblastoma. Oncotargets and Therapy 13: 7479-7492

Qian, J.; Fu, P.; Li, S.; Li, X.; Chen, Y.; Lin, Z. 2021: MiR-107 affects cartilage matrix degradation in the pathogenesis of knee osteoarthritis by regulating caspase-1. Journal of Orthopaedic Surgery and Research 16(1): 40

Zhuang, Y.; Wang, S.; Fei, H.; Ji, F.; Sun, P. 2020: MiR-107 inhibition upregulates CAB39 and activates AMPK-Nrf2 signaling to protect osteoblasts from dexamethasone-induced oxidative injury and cytotoxicity. Aging 12(12): 11754-11767

Zhao, M.; Wang, Y.; Jiang, C.; Wang, Q.; Mi, J.; Zhang, Y.; Zuo, L.; Geng, Z.; Song, X.; Ge, S.; Li, J.; Wen, H.; Wang, J.; Wang, Z.; Su, F. 2021: MiR-107 regulates the effect of MCM7 on the proliferation and apoptosis of colorectal cancer via the PAK2 pathway. Biochemical Pharmacology 190: 114610

Wang, S.; Ma, G.; Zhu, H.; Lv, C.; Chu, H.; Tong, N.; Wu, D.; Qiang, F.; Gong, W.; Zhao, Q.; Tao, G.; Zhou, J.; Zhang, Z.; Wang, M. 2016: MiR-107 regulates tumor progression by targeting NF1 in gastric cancer. Scientific Reports 6: 36531

Xu, D.; Li, W.; Zhang, T.; Wang, G. 2020: MiR-10a overexpression aggravates renal ischemia-reperfusion injury associated with decreased PIK3CA expression. Bmc Nephrology 21(1): 248

Liu, Y.; Zhang, Y.; Wu, H.; Li, Y.; Zhang, Y.; Liu, M.; Li, X.; Tang, H. 2017: MiR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis. Cell Death and Disease 8(4): E2739

Chen, L.; Al-Mossawi, M.H.; Ridley, A.; Sekine, T.; Hammitzsch, A.; de Wit, J.; Simone, D.; Shi, H.; Penkava, F.; Kurowska-Stolarska, M.; Pulyakhina, I.; Knight, J.C.; Kim, T.J.; Bowness, P. 2017: MiR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis. Annals of the Rheumatic Diseases 76(3): 620-625

Ling, P.; Tang, R.; Wang, H.; Deng, X.; Chen, J. 2021: MiR-1184 regulates inflammatory responses and cell apoptosis by targeting TRADD in an LPS-induced cell model of sepsis. Experimental and Therapeutic Medicine 21(6): 630

Chen, S.; Wang, Y.; Xu, M.; Zhang, L.; Su, Y.; Wang, B.; Zhang, X. 2020: MiR-1184 regulates the proliferation and apoptosis of colon cancer cells via targeting CSNK2A1. Molecular and Cellular Probes 53: 101625

Lopez, J.Pablo.; Lim, R.; Cruceanu, C.; Crapper, L.; Fasano, C.; Labonte, B.; Maussion, G.; Yang, J.P.; Yerko, V.; Vigneault, E.; El Mestikawy, S.; Mechawar, N.; Pavlidis, P.; Turecki, G. 2014: MiR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nature Medicine 20(7): 764-768

Liu, X.; Bi, L.; Wang, Q.; Wen, M.; Li, C.; Ren, Y.; Jiao, Q.; Mao, J-Hua.; Wang, C.; Wei, G.; Wang, Y. 2018: MiR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer. Oncogene 37(25): 3426-3439

Chen, L.; Lü, M-H.; Zhang, D.; Hao, N-B.; Fan, Y-H.; Wu, Y-Y.; Wang, S-M.; Xie, R.; Fang, D-C.; Zhang, H.; Hu, C-J.; Yang, S-M. 2014: MiR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. Cell Death and Disease 5: E1034

Wu, Y.; Dai, F.; Zhang, Y.; Zheng, X.; Li, L.; Zhang, Y.; Cao, J.; Gao, W. 2021: MiR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition. Molecular Therapy Oncolytics 22: 152-165

Zhan, G.; Jiang, H.; Yang, R.; Yang, K. 2021: MiR-122 and miR-197 expressions in hepatic carcinoma patients before and after chemotherapy and their effect on patient prognosis. American Journal of Translational Research 13(6): 6731-6737

Haussecker, D.; Kay, M.A. 2010: MiR-122 continues to blaze the trail for microRNA therapeutics. Molecular Therapy: the Journal of the American Society of Gene Therapy 18(2): 240-242

Wang, M.; Zheng, H.; Zhou, X.; Zhang, J.; Shao, G. 2020: MiR-122 promotes diabetic retinopathy through targeting TIMP3. Animal Cells and Systems 24(5): 275-281

Valdmanis, P.N.; Kim, H.Kyun.; Chu, K.; Zhang, F.; Xu, J.; Munding, E.M.; Shen, J.; Kay, M.A. 2018: MiR-122 removal in the liver activates imprinted micro RNAs and enables more effective microRNA-mediated gene repression. Nature Communications 9(1): 5321

Shin, J.Il.; Eisenhut, M. 2013: MiR-122, IL28B genotype and the response to interferon in chronic hepatitis C virus infection. Nature Reviews. Immunology 13(12): 902

Li, J.; Zeng, X.; Wang, W. 2021: MiR-122-5p downregulation attenuates lipopolysaccharide-induced acute lung injury by targeting IL1RN. Experimental and Therapeutic Medicine 22(5): 1278

Liu, Y.; Chen, W.; Chen, J.; Ma, Y.; Cen, Y.; Wang, S.; He, X.; You, M.; Yang, G. 2021: MiR-122-5p regulates hepatocytes damage caused by BaP and DBP co-exposure through SOCS1/STAT3 signaling in vitro. Ecotoxicology and Environmental Safety 223: 112570

Liu, L.; Zhu, M.; Liu, X.; Fei, L.; Shen, J.; Chen, D. 2021: MiR-122-5p regulates the tight junction of the blood-testis barrier of mice via occludin : miR-122-5p can regulate the tight junction. Basic and Clinical Andrology 31(1): 7

Zhang, J.; Huang, H. 2021: MiR-122-5p/KIF5B/AMPK/AKT regulatory network regulates the progression of NAFLD. American Journal of Translational Research 13(2): 696-707

Ran, F.; Zhang, Y.; Shi, Y.; Liu, J.; Li, H.; Ding, L.; Ye, Q. 2021: MiR-1224-3p Promotes Breast Cancer Cell Proliferation and Migration through PGM5-Mediated Aerobic Glycolysis. Journal of Oncology 2021: 5529770

Wang, J.; Hu, Y.; Ye, C.; Liu, J. 2020: MiR-1224-5p inhibits the proliferation and invasion of ovarian cancer via targeting SND1. Human Cell 33(3): 780-789

Zhou, X.; Qi, L. 2021: MiR-124 Is Downregulated in Serum of Acute Cerebral Infarct Patients and Shows Diagnostic and Prognostic Value. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 27: 10760296211035446

Baudet, M-Laure.; Zivraj, K.H.; Abreu-Goodger, C.; Muldal, A.; Armisen, J.; Blenkiron, C.; Goldstein, L.D.; Miska, E.A.; Holt, C.E. 2011: MiR-124 acts through CoREST to control onset of Sema3A sensitivity in navigating retinal growth cones. Nature Neuroscience 15(1): 29-38

Kozuka, T.; Omori, Y.; Watanabe, S.; Tarusawa, E.; Yamamoto, H.; Chaya, T.; Furuhashi, M.; Morita, M.; Sato, T.; Hirose, S.; Ohkawa, Y.; Yoshimura, Y.; Hikida, T.; Furukawa, T. 2019: MiR-124 dosage regulates prefrontal cortex function by dopaminergic modulation. Scientific Reports 9(1): 3445

Ma, W.; Zhang, X.; Liu, Y. 2021: MiR-124 promotes apoptosis and inhibits the proliferation of vessel endothelial cells through P38/MAPK and PI3K/AKT pathways, making it a potential mechanism of vessel endothelial injury in acute myocardial infarction. Experimental and Therapeutic Medicine 22(6): 1383

Cheng, L-Chun.; Pastrana, E.; Tavazoie, M.; Doetsch, F. 2009: MiR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nature Neuroscience 12(4): 399-408

Feng, Y.; Jiang, W.; Zhao, W.; Lu, Z.; Gu, Y.; Dong, Y. 2020: MiR-124 regulates liver cancer stem cells expansion and sorafenib resistance. Experimental Cell Research 394(2): 112162

Liu, F.; Qiu, F.; Chen, H. 2021: MiR-124-3p Ameliorates Isoflurane-Induced Learning and Memory Impairment via Targeting STAT3 and Inhibiting Neuroinflammation. Neuroimmunomodulation 28(4): 248-254

Majid, A.; Wang, J.; Nawaz, M.; Abdul, S.; Ayesha, M.; Guo, C.; Liu, Q.; Liu, S.; Sun, M.-Z. 2020: MiR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells via Targeting CRKL. Frontiers in Molecular Biosciences 7: 223

Xiang, H.; Luo, M.; Hou, P.; Xiao, Z.; Huang, Z.; Feng, Q.; Zhang, R.; Li, Y.; Wu, L. 2021: MiR-124-3p combined with miR-506-3p delay hepatic carcinogenesis via modulating sirtuin 1. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 2021: 1-33

Li, J.; Guo, Y.; Chen, Y-Yi.; Liu, Q.; Chen, Y.; Tan, L.; Zhang, S-Hui.; Gao, Z-Rong.; Zhou, Y-Hui.; Zhang, G-Ying.; Feng, Y-Zhi. 2020: MiR-124-3p increases in high glucose induced osteocyte-derived exosomes and regulates galectin-3 expression: A possible mechanism in bone remodeling alteration in diabetic periodontitis. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 34(11): 14234-14249

Li, Z.; Zhao, H.; Chu, S.; Liu, X.; Qu, X.; Li, J.; Liu, D.; Li, H. 2020: MiR-124-3p promotes BMSC osteogenesis via suppressing the GSK-3β/β-catenin signaling pathway in diabetic osteoporosis rats. In Vitro Cellular and Developmental Biology. Animal 56(9): 723-734

Zhang, S.; Pan, S. 2021: MiR-124-3p targeting of TGF-β1 inhibits the proliferation of hypertrophic scar fibroblasts. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 30(3): 263-271

Franke, K.; Otto, W.; Johannes, S.; Baumgart, J.; Nitsch, R.; Schumacher, S. 2012: MiR-124-regulated RhoG reduces neuronal process complexity via ELMO/Dock180/Rac1 and Cdc42 signalling. EMBO Journal 31(13): 2908-2921

Chen, Y.; Sun, J-Xian.; Chen, W-Kun.; Wu, G-Cheng.; Wang, Y-Qing.; Zhu, K-Ying.; Wang, J. 2019: MiR-124/VAMP3 is a novel therapeutic target for mitigation of surgical trauma-induced microglial activation. Signal Transduction and Targeted Therapy 4: 27

Chen, Y.; Sun, J-Xian.; Chen, W-Kun.; Wu, G-Cheng.; Wang, Y-Qing.; Zhu, K-Ying.; Wang, J. 2019: MiR-124/VAMP3 is a novel therapeutic target for mitigation of surgical trauma-induced microglial activation. Signal Transduction and Targeted Therapy 4(1): 27

Yang, X.-M.; Song, Y.-Q.; Li, L.; Liu, D.-M.; Chen, G.-D. 2021: MiR-1249-5p regulates the osteogenic differentiation of ADSCs by targeting PDX1. Journal of Orthopaedic Surgery and Research 16(1): 10

Sanuki, R.; Onishi, A.; Koike, C.; Muramatsu, R.; Watanabe, S.; Muranishi, Y.; Irie, S.; Uneo, S.; Koyasu, T.; Matsui, R.; Chérasse, Y.; Urade, Y.; Watanabe, D.; Kondo, M.; Yamashita, T.; Furukawa, T. 2011: MiR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression. Nature Neuroscience 14(9): 1125-1134

Williams, A.L.; Khadka, V.S.; Anagaran, M.C.T.; Lee, K.; Avelar, A.; Deng, Y.; Shohet, R.V. 2020: MiR-125 family regulates XIRP1 and FIH in response to myocardial infarction. Physiological Genomics 52(8): 358-368

Zhang, M.Y.; Wang, L.Q.; Chim, C.S. 2021: MiR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration. Cell Communication and Signaling: Ccs 19(1): 62

Cheng, C.; Li, W.; Peng, X.; Liu, X.; Zhang, Z.; Liu, Z.; Deng, T.; Luo, R.; Fang, W.; Deng, X. 2021: MiR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis. Molecular Therapy. Methods and Clinical Development 20: 615-624

Jiang, M.; Shi, L.; Yang, C.; Ge, Y.; Lin, L.; Fan, H.; He, Y.; Zhang, D.; Miao, Y.; Yang, L. 2019: MiR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer. Cell Death and Disease 10(1): 32

Qin, H.; Gui, Y.; Ma, R.; Zhang, H.; Guo, Y.; Ye, Y.; Li, J.; Zhao, L.; Wang, Y. 2021: MiR-1258 Attenuates Tumorigenesis Through Targeting E2F1 to Inhibit PCNA and MMP2 Transcription in Glioblastoma. Frontiers in Oncology 11: 671144

Chen, K.; He, H.; Xie, Y.; Zhao, L.; Zhao, S.; Wan, X.; Yang, W.; Mo, Z. 2015: MiR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA/ROCK1/ERK1/2 pathway in multiple symmetric lipomatosis. Scientific Reports 5: 11909

Liang, L.; Gao, C.; Li, Y.; Sun, M.; Xu, J.; Li, H.; Jia, L.; Zhao, Y. 2017: MiR-125a-3p/FUT5-FUT6 axis mediates colorectal cancer cell proliferation, migration, invasion and pathological angiogenesis via PI3K-Akt pathway. Cell Death and Disease 8(8): E2968

Ye, Y.; Liu, Q.; Li, C.; He, P. 2021: MiR-125a-5p Regulates Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells under Oxidative Stress. Biomed Research International 2021: 6684709

Zhu, X.-D.; Gao, Z.-J.; Zheng, G.-D. 2020: MiR-125a-5p inhibits cancer stem cells phenotype and epithelial to mesenchymal transition in glioblastoma. Revista da Associacao Medica Brasileira 66(4): 445-451

Luo, L.; Xiao, L.; Lian, G.; Wang, H.; Xie, L. 2020: MiR-125a-5p inhibits glycolysis by targeting hexokinase-Ii to improve pulmonary arterial hypertension. Aging 12(10): 9014-9030

Bhatlekar, S.; Manne, B.K.; Basak, I.; Edelstein, L.C.; Tugolukova, E.; Stoller, M.L.; Cody, M.J.; Morley, S.C.; Nagalla, S.; Weyrich, A.S.; Rowley, J.W.; O'Connell, R.M.; Rondina, M.T.; Campbell, R.A.; Bray, P.F. 2020: MiR-125a-5p regulates megakaryocyte proplatelet formation via the actin-bundling protein L-plastin. Blood 136(15): 1760-1772

Haemmig, S.; Baumgartner, U.; Glück, A.; Zbinden, S.; Tschan, M.P.; Kappeler, A.; Mariani, L.; Vajtai, I.; Vassella, E. 2014: MiR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas. Cell Death and Disease 5: E1279

Wang, P.; Zheng, D.; Qi, H.; Gao, Q. 2021: MiR-125b enhances metastasis and progression of cancer via the TXNIP and HIF1α pathway in pancreatic cancer. Cancer Biomarkers: Section a of Disease Markers 31(1): 27-38

Qu, M.; Fang, F.; Zou, X.; Zeng, Q.; Fan, Z.; Chen, L.; Yue, W.; Xie, X.; Pei, X. 2016: MiR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19 INK4D. Cell Death and Disease 7(10): E2430

Piatopoulou, D.; Avgeris, M.; Marmarinos, A.; Xagorari, M.; Baka, M.; Doganis, D.; Kossiva, L.; Scorilas, A.; Gourgiotis, D. 2017: MiR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment. British Journal of Cancer 117(6): 801-812

Bhattacharjya, S.; Nath, S.; Ghose, J.; Maiti, G.P.; Biswas, N.; Bandyopadhyay, S.; Panda, C.K.; Bhattacharyya, N.P.; Roychoudhury, S. 2013: MiR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progression. Cell Death and Differentiation 20(3): 430-442

Zhang, Q.; Yu, K.; Cao, Y.; Luo, Y.; Liu, Y.; Zhao, C. 2021: MiR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3. Life Sciences 270: 119071

Joo, M.S.; Lee, C.G.; Koo, J.H.; Kim, S.G. 2013: MiR-125b transcriptionally increased by Nrf2 inhibits AhR repressor, which protects kidney from cisplatin-induced injury. Cell Death and Disease 4: E899

Zhu, Y.; Zhang, S.; Li, Z.; Wang, H.; Li, Z.; Hu, Y.; Chen, H.; Zhang, X.; Cui, L.; Zhang, J.; He, W. 2019: MiR-125b-5p and miR-99a-5p downregulate human γδ T-cell activation and cytotoxicity. Cellular and Molecular Immunology 16(2): 112-125

Yang, D.; Zhan, M.; Chen, T.; Chen, W.; Zhang, Y.; Xu, S.; Yan, J.; Huang, Q.; Wang, J. 2017: MiR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer. Scientific Reports 7: 43109

Guo, H.; Gao, J.; Qian, Y.; Wang, H.; Liu, J.; Peng, Q.; Zhou, Y.; Wang, K. 2021: MiR-125b-5p inhibits cell proliferation by targeting ASCT2 and regulating the PI3K/AKT/mTOR pathway in an LPS-induced intestinal mucosa cell injury model. Experimental and Therapeutic Medicine 22(2): 838

Pelullo, M.; Savi, D.; Quattrucci, S.; Cimino, G.; Pizzuti, A.; Screpanti, I.; Talora, C.; Cialfi, S. 2021: MiR-125b/NRF2/HO-1 axis is involved in protection against oxidative stress of cystic fibrosis: a pilot study. Experimental and Therapeutic Medicine 21(6): 585

Zhang, Y.; Yang, P.; Sun, T.; Li, D.; Xu, X.; Rui, Y.; Li, C.; Chong, M.; Ibrahim, T.; Mercatali, L.; Amadori, D.; Lu, X.; Xie, D.; Li, Q-Jing.; Wang, X-Fan. 2013: MiR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nature Cell Biology 15(3): 284-294

Fu, R.; Tong, J.-S. 2020: MiR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells. Journal of Cellular and Molecular Medicine 24(13): 7600-7608

Ouyang, J.; Song, F.; Li, H.; Yang, R.; Huang, H. 2020: MiR-126 targeting GOLPH3 inhibits the epithelial-mesenchymal transition of gastric cancer BGC-823 cells and reduces cell invasion. European Journal of Histochemistry: Ejh 64(4)

Ferretti, C.; La Cava, A. 2014: MiR-126, a new modulator of innate immunity. Cellular and Molecular Immunology 11(3): 215-217

Gao, Q.; Zhang, L.; Qi, R.; Qiu, L.; Gao, X.; Xiao, T.; Chen, H. 2021: MiR-126-3p and miR-16-5p as novel serum biomarkers for disease activity and treatment response in symptomatic dermographism. Clinical Immunology 222: 108636

Ren, Y.; Bao, R.; Guo, Z.; Kai, J.; Cai, C.-G.; Li, Z. 2021: MiR-126-5p regulates H9c2 cell proliferation and apoptosis under hypoxic conditions by targeting IL-17A. Experimental and Therapeutic Medicine 21(1): 67

Xia, Y.; Wei, K.; Yang, F-Ming.; Hu, L-Qing.; Pan, C-Feng.; Pan, X-Long.; Wu, W-Bing.; Wang, J.; Wen, W.; He, Z-Cheng.; Xu, J.; Xu, X-Feng.; Zhu, Q.; Chen, L. 2019: MiR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC. Cell Death and Disease 10(2): 112

Zheng, Y.; Xie, M.; Zhang, N.; Liu, J.; Song, Y.; Zhou, L.; Yang, M. 2021: MiR-1262 suppresses gastric cardia adenocarcinoma via targeting oncogene ULK1. Journal of Cancer 12(4): 1231-1239

He, L.; Liao, X.; Zhu, G.; Kuang, J. 2020: MiR-126a-3p targets HIF-1α and alleviates obstructive sleep apnea syndrome with hypertension. Human Cell 33(4): 1036-1045

Zhai, L.; Wu, R.; Han, W.; Zhang, Y.; Zhu, D. 2017: MiR-127 enhances myogenic cell differentiation by targeting S1PR3. Cell Death and Disease 8(3): E2707

Shi, L.; Wang, Y.; Lu, Z.; Zhang, H.; Zhuang, N.; Wang, B.; Song, Z.; Chen, G.; Huang, C.; Xu, D.; Zhang, Y.; Zhang, W.; Gao, Y. 2017: MiR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop. Oncogene 36(12): 1631-1643

Zhao, Y.; Wang, P.; Wu, Q. 2020: MiR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B. Molecular and Cellular Probes 53: 101597

Xi, Q.; Chen, Y.; Yang, G.-Z.; Zhang, J.-Y.; Zhang, L.-J.; Guo, X.-D.; Zhao, J.-Y.; Xue, Z.-Y.; Li, Y.; Zhang, R. 2020: MiR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer. Frontiers in Immunology 11: 890

Shvarts-Serebro, I.; Sheinin, A.; Gottfried, I.; Adler, L.; Schottlender, N.; Ashery, U.; Barak, B. 2021: MiR-128 as a Regulator of Synaptic Properties in 5xFAD Mice Hippocampal Neurons. Journal of Molecular Neuroscience: Mn 71(12): 2593-2607

Adlakha, Y.K.; Saini, N. 2013: MiR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis. Cell Death and Disease 4: E542

Gao, P.; Wang, H.; Liu, J.; Wu, Y.; Hei, W.; He, Z.; Cai, C.; Guo, X.; Cao, G.; Li, B. 2020: MiR-128 regulated the proliferation and autophagy in porcine adipose-derived stem cells through targeting the JNK signaling pathway. Journal of Receptor and Signal Transduction Research 2020: 1-6

Wang, P.; Zhang, Y.; Wang, Z.; Yang, A.; Li, Y.; Zhang, Q. 2021: MiR-128 regulates epilepsy sensitivity in mice by suppressing SNAP-25 and SYT1 expression in the hippocampus. Biochemical and Biophysical Research Communications 545: 195-202

Hamdorf, M.; Idica, A.; Zisoulis, D.G.; Gamelin, L.; Martin, C.; Sanders, K.J.; Pedersen, I.M. 2015: MiR-128 represses L1 retrotransposition by binding directly to L1 RNA. Nature Structural and Molecular Biology 22(10): 824-831

Wang, L.; Wang, K.; Tian, Z. 2020: MiR-128-3p Inhibits NRP1 Expression and Promotes Inflammatory Response to Acute Kidney Injury in Sepsis. Inflammation 43(5): 1772-1779

Ding, L.; Gao, X.; Yu, S.; Sheng, L. 2020: MiR-128-3p enhances the protective effect of dexmedetomidine on acute lung injury in septic mice by targeted inhibition of MAPK14. Journal of Bioenergetics and Biomembranes 52(4): 237-245

Yang, P.; Han, J.; Li, S.; Luo, S.; Tu, X.; Ye, Z. 2021: MiR-128-3p inhibits apoptosis and inflammation in LPS-induced sepsis by targeting TGFBR2. Open Medicine 16(1): 274-283

Liu, S.; Gao, S.; Yang, Z.; Zhang, P. 2021: MiR-128-3p reduced acute lung injury induced by sepsis via targeting PEL12. Open Medicine 16(1): 1109-1120

Chen, C.; Deng, Y.; Hu, X.; Ren, H.; Zhu, J.; Fu, S.; Xie, J.; Peng, Y. 2018: MiR-128-3p regulates 3T3-L1 adipogenesis and lipolysis by targeting Pparg and Sertad2. Journal of Physiology and Biochemistry 74(3): 381-393

Zhu, M.; Wu, Y.; Wang, Z.; Lin, M.; Su, B.; Li, C.; Liang, F.; Chen, X. 2021: MiR-128-3p serves as an oncogenic microRNA in osteosarcoma cells by downregulating ZC3H12D. Oncology Letters 21(2): 152

Hao, W.; Zhu, Y.; Guo, Y.; Wang, H. 2021: MiR-1287-5p upregulation inhibits the EMT and pro-inflammatory cytokines in LPS-induced human nasal epithelial cells (HNECs). Transplant Immunology 68: 101429

Bolukbasi, M.Fatih.; Mizrak, A.; Ozdener, G.Baris.; Madlener, S.; Ströbel, T.; Erkan, E.Pekcan.; Fan, J-Bing.; Breakefield, X.O.; Saydam, O. 2012: MiR-1289 and "Zipcode"-like Sequence Enrich mRNAs in Microvesicles. Molecular Therapy. Nucleic Acids 1: E10

Zhu, H.; Xue, C.; Yao, M.; Wang, H.; Zhang, P.; Qian, T.; Zhou, S.; Li, S.; Yu, B.; Wang, Y.; Gu, X. 2018: MiR-129 controls axonal regeneration via regulating insulin-like growth factor-1 in peripheral nerve injury. Cell Death and Disease 9(7): 720

Karaayvaz, M.; Zhai, H.; Ju, J. 2013: MiR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cell Death and Disease 4: E659

Wang, B.; Li, Y.; You, C. 2021: MiR-129-3p Targeting of MCU Protects Against Glucose Fluctuation-Mediated Neuronal Damage via a Mitochondrial-Dependent Intrinsic Apoptotic Pathway. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy 14: 153-163

Chen, R.; Ye, B.; Xie, H.; Huang, Y.; Wu, Z.; Wu, H.; Wang, X.; Miao, H.; Liang, W. 2020: MiR-129-3p alleviates chondrocyte apoptosis in knee joint fracture-induced osteoarthritis through CPEB1. Journal of Orthopaedic Surgery and Research 15(1): 552

Cao, J.; Shen, Y.; Zhu, L.; Xu, Y.; Zhou, Y.; Wu, Z.; Li, Y.; Yan, X.; Zhu, X. 2012: MiR-129-3p controls cilia assembly by regulating CP110 and actin dynamics. Nature Cell Biology 14(7): 697-706

Yin, C.; Tian, Y.; Yu, Y.; Yang, C.; Su, P.; Zhao, Y.; Wang, X.; Zhang, K.; Pei, J.; Li, D.; Chen, Z.; Zhang, Y.; Miao, Z.; Qian, A. 2020: MiR-129-5p Inhibits Bone Formation Through TCF4. Frontiers in Cell and Developmental Biology 8: 600641

Zhao, C.; Gu, Y.; Wang, Y.; Qin, Q.; Wang, T.; Huang, M.; Zhang, H.; Qu, Y.; Zhang, J.; Du, Z.; Jiang, X.-X.; Xu, L. 2021: MiR-129-5p Promotes Osteogenic Differentiation of BMSCs and Bone Regeneration via Repressing Dkk3. Stem Cells International 2021: 7435605

Huang, X.; Hou, X.; Chuan, L.; Wei, S.; Wang, J.; Yang, X.; Ru, J. 2020: MiR-129-5p alleviates LPS-induced acute kidney injury via targeting HMGB1/TLRs/NF-kappaB pathway. International Immunopharmacology 89(Part A): 107016

Xing, J.; Liu, J.; Liu, J.; Xu, Z. 2020: MiR-129-5p ameliorates ischemia-reperfusion injury by targeting HMGB1 in myocardium. General Physiology and Biophysics 39(5): 461-470

Wang, J.; Xia, Y.; Li, J.; Wang, W. 2021: MiR-129-5p in exosomes inhibits diabetes-associated osteogenesis in the jaw via targeting FZD4. Biochemical and Biophysical Research Communications 566: 87-93

Gao, B.; Wang, L.; Zhang, N.; Han, M.; Zhang, Y.; Liu, H.; Sun, D.; Xiao, X.; Liu, Y. 2021: MiR-129-5p inhibits clear cell renal cell carcinoma cell proliferation, migration and invasion by targeting SPN. Cancer Cell International 21(1): 263

Zeng, A.; Yin, J.; Li, Y.; Li, R.; Wang, Z.; Zhou, X.; Jin, X.; Shen, F.; Yan, W.; You, Y. 2018: MiR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma. Cell Death and Disease 9(3): 394

Qiu, L.; Zhang, L.; Qi, R.; Gao, X.; Chen, H.; Xiao, T. 2020: MiR-1291 Functions as a Potential Serum Biomarker for Bullous Pemphigoid. Disease Markers 2020: 9505312

Chen, B.; Zheng, S.; Jiang, F. 2021: MiR-1293 acts as a tumor promotor in lung adenocarcinoma via targeting phosphoglucomutase 5. Peerj 9: E12140

Chu, X.; Wang, Y.; Pang, L.; Huang, J.; Sun, X.; Chen, X. 2018: MiR-130 aggravates acute myocardial infarction-induced myocardial injury by targeting PPAR-γ. Journal of Cellular Biochemistry 119(9): 7235-7244

Yang, C.; Xu, Y.; Cheng, F.; Hu, Y.; Yang, S.; Rao, J.; Wang, X. 2017: MiR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9. Cell Death and Disease 8(8): E2999

Luo, D.; Fan, H.; Ma, X.; Yang, C.; He, Y.; Ge, Y.; Jiang, M.; Xu, Z.; Yang, L. 2021: MiR-1301-3p Promotes Cell Proliferation and Facilitates Cell Cycle Progression via Targeting SIRT1 in Gastric Cancer. Frontiers in Oncology 11: 664242

Wu, Y.; Shen, Q.; Chen, X.; Wu, Y.; Niu, Y.; Lv, F. 2020: MiR-1301-3p promotes the proliferation and migration of lung cancer cells via direct repression of polymerase i and transcript release factor. Oncology Letters 20(6): 286

Qiao, D.-H.; He, X.-M.; Yang, H.; Zhou, Y.; Deng, X.; Cheng, L.; Zhou, X.-Y. 2021: MiR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer. American Journal of Otolaryngology 42(2): 102920

Song, J.; Hu, Y.; Li, H.; Huang, X.; Zheng, H.; Hu, Y.; Wang, J.; Jiang, X.; Li, J.; Yang, Z.; Fan, H.; Guo, L.; Shi, H.; He, Z.; Yang, F.; Wang, X.; Dong, S.; Li, Q.; Liu, L. 2018: MiR-1303 regulates BBB permeability and promotes CNS lesions following CA16 infections by directly targeting MMP9. Emerging Microbes and Infections 7(1): 155

Qiu, Z.; Ma, X.; Xie, J.; Liu, Z.; Zhang, Y.; Xia, C. 2021: MiR-1307-5p regulates proliferation and apoptosis of chondrocytes in osteoarthritis by specifically inhibiting transforming growth factor beta-induced gene. American Journal of Translational Research 13(7): 7756-7766

Guduric-Fuchs, J.; Pedrini, E.; Lechner, J.; Chambers, S.E.J.; O'Neill, C.L.; Mendes Lopes de Melo, J.; Pathak, V.; Church, R.H.; McKeown, S.; Bojdo, J.; Mcloughlin, K.J.; Stitt, A.W.; Medina, R.J. 2021: MiR-130a activates the VEGFR2/STAT3/HIF1α axis to potentiate the vasoregenerative capacity of endothelial colony-forming cells in hypoxia. Molecular Therapy. Nucleic Acids 23: 968-981

Cavallari, C.; Figliolini, F.; Tapparo, M.; Cedrino, M.; Trevisan, A.; Positello, L.; Rispoli, P.; Solini, A.; Migliaretti, G.; Camussi, G.; Brizzi, M.Felice. 2020: MiR-130a and Tgfβ Content in Extracellular Vesicles Derived from the Serum of Subjects at High Cardiovascular Risk Predicts their In-Vivo Angiogenic Potential. Scientific Reports 10(1): 706

Kumar, V.; Mansfield, J.; Fan, R.; MacLean, A.; Li, J.; Mohan, M. 2018: MiR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques. Journal of Immunology 200(8): 2677-2689

Luo, H.; Chen, B.; Weng, B.; Tang, X.; Chen, Y.; Yang, A.; Chu, D.; Zeng, X.; Ran, M. 2020: MiR-130a promotes immature porcine Sertoli cell growth by activating SMAD5 through the TGF-β-PI3K/AKT signaling pathway. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 34(11): 15164-15179

Acunzo, M.; Visone, R.; Romano, G.; Veronese, A.; Lovat, F.; Palmieri, D.; Bottoni, A.; Garofalo, M.; Gasparini, P.; Condorelli, G.; Chiariello, M.; Croce, C.M. 2012: MiR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 31(5): 634-642

Wang, Y.; Zhang, X.; Tang, W.; Lin, Z.; Xu, L.; Dong, R.; Li, Y.; Li, J.; Zhang, Z.; Li, X.; Zhao, L.; Wei, J-Jun.; Shao, C.; Kong, B.; Liu, Z. 2017: MiR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma. Cell Death and Differentiation 24(12): 2089-2100

Fan, Q.; Huang, T.; Sun, X.; Yang, X.; Wang, J.; Liu, Y.; Ni, T.; Gu, S.; Li, Y.; Wang, Y. 2021: MiR-130a-3p promotes cell proliferation and invasion by targeting estrogen receptor α and androgen receptor in cervical cancer. Experimental and Therapeutic Medicine 21(5): 414

Zhu, L.; Jing, J.; Qin, S.; Zheng, Q.; Lu, J.; Zhu, C.; Liu, Y.; Fang, F.; Li, Y.; Ling, Y. 2021: MiR-130a-3p regulates steroid hormone synthesis in goat ovarian granulosa cells by targeting the PMEPA1 gene. Theriogenology 165: 92-98

Wei, M.-C.; Wang, Y.-M.; Wang, D.-W. 2021: MiR-130a-Mediated KLF3 can Inhibit the Growth of Lung Cancer Cells. Cancer Management and Research 13: 2995-3004

Du, X.; Wang, L.; Li, Q.; Wu, W.; Shang, P.; Chamba, Y.; Pan, Z.; Li, Q. 2020: MiR-130a/TGF-β1 axis is involved in sow fertility by controlling granulosa cell apoptosis. Theriogenology 157: 407-417

Bao, D.; Li, M.; Zhou, D.; Zhuang, C.; Ge, Z.; Wei, Q.; Zhang, L. 2021: MiR-130b-3p is high-expressed in polycystic ovarian syndrome and promotes granulosa cell proliferation by targeting SMAD4. Journal of Steroid Biochemistry and Molecular Biology 209: 105844

Coskun, S.; Karadag, M.; Gokcen, C.; Oztuzcu, S. 2021: MiR-132 and miR-942 Expression Levels in Children with Attention Deficit and Hyperactivity Disorder: a Controlled Study. Clinical Psychopharmacology and Neuroscience: the Official Scientific Journal of the Korean College of Neuropsychopharmacology 19(2): 262-268

Tong, L.; Li, M.-D.; Nie, P.-Y.; Chen, Y.; Chen, Y.-L.; Ji, L.-L. 2021: MiR-132 downregulation alleviates behavioral impairment of rats exposed to single prolonged stress, reduces the level of apoptosis in PFC, and upregulates the expression of MeCP2 and BDNF. Neurobiology of Stress 14: 100311

Deng, Y.; Zhang, J.; Sun, X.; Ma, G.; Luo, G.; Miao, Z.; Song, L. 2020: MiR-132 improves the cognitive function of rats with Alzheimer's disease by inhibiting the MAPK1 signal pathway. Experimental and Therapeutic Medicine 20(6): 159

Lagos, D.; Pollara, G.; Henderson, S.; Gratrix, F.; Fabani, M.; Milne, R.S.B.; Gotch, F.; Boshoff, C. 2010: MiR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nature Cell Biology 12(5): 513-519

Mellios, N.; Sugihara, H.; Castro, J.; Banerjee, A.; Le, C.; Kumar, A.; Crawford, B.; Strathmann, J.; Tropea, D.; Levine, S.S.; Edbauer, D.; Sur, M. 2011: MiR-132, an experience-dependent microRNA, is essential for visual cortex plasticity. Nature Neuroscience 14(10): 1240-1242

Pan, Q.; Kuang, X.; Cai, S.; Wang, X.; Du, D.; Wang, J.; Wang, Y.; Chen, Y.; Bihl, J.; Chen, Y.; Zhao, B.; Ma, X. 2020: MiR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury. Stem Cell Research and Therapy 11(1): 260

Han, S.; Lin, F.; Ruan, Y.; Zhao, S.; Yuan, R.; Ning, J.; Jiang, K.; Xie, J.; Li, H.; Li, C.; Rao, T.; Yu, W.; Xia, Y.; Zhou, X.; Cheng, F. 2021: MiR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway. International Immunopharmacology 99: 108022

Zhao, J.; Yang, M.; Li, Q.; Pei, X.; Zhu, X. 2020: MiR-132-5p regulates apoptosis and autophagy in MPTP model of Parkinson's disease by targeting ULK1. Neuroreport 31(13): 959-965

Xie, H.; Liu, M.; Jin, Y.; Lin, H.; Zhang, Y.; Zheng, S. 2020: MiR-1323 suppresses bone mesenchymal stromal cell osteogenesis and fracture healing via inhibiting BMP4/SMAD4 signaling. Journal of Orthopaedic Surgery and Research 15(1): 237

Yamamoto, H.; Lu, J.; Oba, S.; Kawamata, T.; Yoshimi, A.; Kurosaki, N.; Yokoyama, K.; Matsushita, H.; Kurokawa, M.; Tojo, A.; Ando, K.; Morishita, K.; Katagiri, K.; Kotani, A. 2016: MiR-133 regulates Evi1 expression in AML cells as a potential therapeutic target. Scientific Reports 6: 19204

Akerman, A.W.; Collins, E.N.; Peterson, A.R.; Collins, L.B.; Harrison, J.K.; DeVaughn, A.; Townsend, J.M.; Vanbuskirk, R.L.; Riopedre-Maqueira, J.; Reyes, A.; Oh, J.E.; Raybuck, C.M.; Jones, J.A.; Ikonomidis, J.S. 2021: MiR-133a Replacement Attenuates Thoracic Aortic Aneurysm in Mice. Journal of the American Heart Association 10(16): E019862

Wang, G.; Wang, F.; Zhang, L.; Yan, C.; Zhang, Y. 2021: MiR-133a silencing rescues glucocorticoid-induced bone loss by regulating the MAPK/ERK signaling pathway. Stem Cell Research and Therapy 12(1): 215

Han, S.; Ding, X.; Wang, S.; Xu, L.; Li, W.; Sun, W. 2020: MiR-133a-3p Regulates Hepatocellular Carcinoma Progression Through Targeting CORO1C. Cancer Management and Research 12: 8685-8693

Zhu, Y.-F.; Wang, R.; Chen, W.; Cao, Y.-D.; Li, L.-P.; Chen, X. 2021: MiR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε. Acta Histochemica 123(1): 151653

Li, M.; Shen, Y.-J.; Chai, S.; Bai, Y.-L.; Li, Z.-H. 2021: MiR-133a-3p inhibits the osteogenic differentiation of bone marrow mesenchymal stem cells by regulating ankyrin repeat domain 44. General Physiology and Biophysics 40(4): 329-339

Li, J.; Liu, X.; Wang, W.; Li, C. 2020: MiR-133a-3p promotes apoptosis and induces cell cycle arrest by targeting CREB1 in retinoblastoma. Archives of Medical Science: Ams 16(4): 941-956

Tian, X.; Li, L.; Fu, G.; Wang, J.; He, Q.; Zhang, C.; Qin, B.; Wang, J. 2021: MiR-133a-3p regulates the proliferation and apoptosis of intestinal epithelial cells by modulating the expression of TAGLN2. Experimental and Therapeutic Medicine 22(2): 824

He, M.-Q.; Wan, J.-F.; Zeng, H.-F.; Tang, Y.-Y.; He, M.-Q. 2021: MiR-133a-5p suppresses gastric cancer through TCF4 down-regulation. Journal of Gastrointestinal Oncology 12(3): 1007-1019

Guo, Y.; Lu, G.; Mao, H.; Zhou, S.; Tong, X.; Wu, J.; Sun, Q.; Xu, H.; Fang, F. 2020: MiR-133b Suppresses Invasion and Migration of Gastric Cancer Cells via the COL1A1/TGF-β Axis. Oncotargets and Therapy 13: 7985-7995

Weng, Y.; Lin, N.; Yin, L.; Liu, A. 2021: MiR-133b has protective effect on rats with acute lung injury caused by severe acute pancreatitis through targeting sp1 gene. International Journal of Clinical and Experimental Pathology 14(1): 86-96

Hu, C.; Wu, J.; Wang, L.; Liu, X.; Da, B.; Liu, Y.; Huang, L.; Chen, Q.; Tong, Y.; Jiang, Z. 2021: MiR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8. Pathology Research and Practice 223: 153459

Peng, X.; Lin, L.; Zhou, X.; Yang, D.; Cao, Y.; Yin, T.; Liu, Y. 2020: MiR-133b inhibits myocardial ischemia-reperfusion-induced cardiomyocyte apoptosis and accumulation of reactive oxygen species in rats by targeting YES1. Nan Fang Yi Ke da Xue Xue Bao 40(10): 1390-1398